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Abstract
Invisible to the human eye, yet ubiquitous. . . The occurrence and the potential adverse
effects of micropollutants in the environment are uncontested. Due to incomplete removal by
conventional wastewater treatment technologies, the aquatic environment is contaminated
with pharmaceuticals and other micropollutants (biocides, pesticides). This thesis discusses
the occurrence and photolytic fate of micropollutants in the Vidy Bay of Lake Geneva,
Switzerland and the resulting environmental risk.
The spatio-temporal variations in the concentrations of 39 micropollutants were investigated
during a 10-month sampling campaign, at different locations around a wastewater outfall in
Vidy Bay. A pronounced wastewater plume was observed from April to October, leading to
locally elevated pharmaceutical concentrations compared to the surrounding water column.
The plume depth followed the thermal lake stratiﬁcation, which moved to lower depths
over the course of the warm seasons. Pharmaceutical hotspots associated with the plume
were detected as far as 1.5 km downstream of the wastewater outfall, but concentrations
typically decreased with increasing distance from the source. A strong linear correlation
between electrical conductivity and concentrations of wastewater-derived micropollutants
was identiﬁed. This relation will allow future estimates of wastewater-derived micropollutant
concentrations via simple conductivity measurements in the vicinity of the plume. On the
other hand, from November to January, when uniform temperature prevailed throughout
the water column, the plume surfaced or was not detected due to enhanced mixing of
the water column. In contrast to pharmaceuticals, most pesticides showed homogeneous
concentrations throughout the Vidy Bay during the whole study period, indicating that the
efﬂuent wastewater was not their dominant source.
To overcome the limitations of punctual sampling, a more complete picture of the distribution
of wastewater-derived micropollutants in Vidy Bay was obtained by augmenting ﬁeld
measurements with a validated model, which incorporates the most important physical
and chemical attenuation processes. Given the importance of photolysis in the fate of
many organic pollutants, we proposed a model which combines the current hydrodynamics
via 3D particle tracking, and the depth-dependent photodegradation of micropollutants.
Moreover, the total ecotoxicological risk associated with the predicted concentrations of all
micropollutants concentrations was determined.
Direct discharge of efﬂuent wastewater into the Bay resulted in a limited zone, in which
micropollutant concentrations were sufﬁciently high that commonly applied water quality
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criteria were exceeded. The resulting ecotoxicoloigcal risk could mainly be attributed to only
three among the 24 wastewater-derived compounds investigated, namely three antibiotics.
As expected, photodegradation was an important removal mechanism for many compounds
and thus, along with dilution, contributed to a reduction in the ecotoxicological risk over
time and distance from the WW outfall especially for surface plumes in winter. In contrast,
during thermal stratiﬁcation, the importance of photodegradation processes in attenuating
the plume extent is greatly reduced, due to light screening by the water column. Analysis of
various scenarios showed that wind conditions and solar irradiation play an essential role
in determining hydrodynamic currents and mixing processes, as well as photodegradation
kinetics and thermal stratiﬁcation.
The presence of human metabolites of pharmaceuticals and their phototransformation
products may also contribute to the ecotoxicological risk, as they may be more persistent than
the parent compound and retain biological activity. Hence, the occurrence of various human
metabolites of pharmaceuticals in Vidy Bay was also investigated. On average, the detected
concentrations of human metabolites were similar to, or lower than, their associated parent
compound. Moreover, the metabolites targeted in this study were determined to be more
susceptible to environmental degradation processes than their parent. Nevertheless, their
presence in the aquatic environment may still lead to an increase of the ecotoxicological risk.
In continuation, the propensity of selected human metabolites to undergo photodegradation
and resulting photodegradation products was studied in detail. In particular, we determined
the direct photolysis kinetics and identiﬁed the major photoproducts of four human
metabolites of the antibiotic sulfamethoxazole, which is one of the substances that exceed
water quality criteria in Vidy Bay. The majority of the investigated metabolites were found to
be more photostable than the parent compound under environmentally relevant conditions,
in contrast to observed ﬁeld data, indicating that other transformation processes such as
indirect photolysis processes and biodegradation may also contribute to the total degradation
in the investigated environment. In addition, identiﬁcation of the major phototransformation
products of several human metabolites showed that one was retransformed back to the
parent compound via a photoreduction. As such, human metabolites could represent a thus
overlooked environmental source of pharmaceuticals in the environment.
This work has revealed new insights regarding the environmental impact of direct discharge
of efﬂuent wastewater into lakes. Moreover, it allowed for the identiﬁcation of important
processes and parameters affecting the fate of micropollutants in the aquatic environment,
as well as of the problematic compounds which should be considered priority substances
for wastewater treatment plant optimization and further monitoring campaigns. Applying a
precautionary principle, the results of the present study underline the importance of reducing
or preventing the release of micropollutants to the environment.
Key words: micropolluants, pharmaceuticals, human metabolites, antibiotics, sulfamethoxa-
zole, UPLC-MS/MS, ecotoxicity, pesticides, wastewater, Lake Geneva, hydrodynamic model,
photodegradation, environmental risk assessment.
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Résumé
Invisibles à l’œil nu, ils sont pourtant partout. . . La présence et les risques potentiels des
micropollutants dans l’environnement sont incontestés. Les stations d’épuration actuelles
ne peuvent les éliminer des eaux usées ; ceux-ci se retrouvent dans les eaux de surface. Cette
thèse étudie la présence et les transformations photoly-tiques des micropolluants dans la Baie
de Vidy, au nord du lac Léman, ainsi que le risque environnemental qui en résulte. La Baie de
Vidy est une zone potentiellement contaminée du Léman car elle reçoit les rejets des eaux de
la station d’épuration (STEP) de la ville de Lausanne.
Les variations spatio-temporelles des concentrations de 39 micropolluants ont été étudiées
lors d’une campagne de prélèvements de 10 mois dans la Baie de Vidy, à différentes positions
et profondeurs, autour du point de rejet de l’émissaire de la STEP de Vidy. La présence d’un
panache de micropolluants a ainsi pu être mise en évidence d’avril à octobre. La position de ce
panache de pollution varie selon la stratiﬁcation thermique du lac, il est plus profond lors de
la saison chaude. Des concentrations de micropolluants plus élevées que la moyenne ont été
détectées jusqu’à 1.5 km du point de rejet, cependant, les concentrations diminuent avec la
distance de la source. Une forte corrélation entre la conductivité de l’eau et les concentrations
de micropolluants issus des eaux usées a par ailleurs été mise en évidence. Cette relation peut
être utile pour estimer les concentrations de ces micropolluants à l’aide de simples mesures
de la conductivité. De novembre à janvier, le lac n’étant pas stratiﬁé, le panache peut atteindre
la surface, mais il n’est souvent pas observé en raison du plus fort mélange de la colonne
d’eau. Contrairement aux produits pharmaceutiques, une concentration homogène pour la
plupart des pesticides est observée dans la Baie de Vidy, ce qui indique qu’ils ne proviennent
principalement pas du réseau d’eaux usées.
Pour obtenir une image précise et complète de la distribution des micropolluants issus de
l’émissaire des eaux usées dans la Baie de Vidy, et pour contourner certaines limitations
liées à l’échantillonnage ponctuel, un modèle couplant les mesures expérimentales avec les
processus de transport et de dégradation a été développé. Ce modèle hydrodynamique 3D de
traçage prend également en compte les phénomènes de photo-dégradation, en fonction de
la profondeur. Finalement, les risques écotoxicologiques liés aux concentrations prédites de
micropolluants ont été déterminés.
Le rejet des efﬂuents de la STEP dans la Baie de Vidy crée une zone dans laquelle les
concentrations de certains micropolluants sont supérieures aux critères de qualité des eaux
de surface, qui visent à protéger la faune et la ﬂore aquatique. Ces risques écotoxicologiques
xi
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sont particulièrement liés à trois substances parmi les 24 étudiées, toutes trois étant des
antibiotiques. Comme attendu, la photodégradation est un processus important d’abattement
de nombreuses substances et, avec le phénomène de dilution, contribue à la réduction des
risques écotoxicologiques des efﬂuents de la STEP, principalement lorsque le panache est
proche de la surface. Par contre, lorsque la stratiﬁcation thermique maintient le panache en
profondeur, la photodégradation perd de son importance en raison de l’atténuation de la
lumière par les couches superﬁcielles. La modélisation démontre le rôle essentiel que jouent
les vents pour la mise en place des courants hydrodynamiques et pour le processus de mélange
des eaux alors que l’irradiation solaire est déterminante pour la cinétique de photodégradation
et pour la stratiﬁcation thermique des eaux.
La présence de métabolites humains de médicaments ainsi que de substances issues de
photodégradation peuvent également contribuer à l’augmentation du risque écotoxicologique,
car ils peuvent être plus persistants que leur substance parente, et tout autant toxiques.
Pour ces raisons, la présence dans la Baie de Vidy de plusieurs métabolites humains a
également été étudiée. Les concentrations mesurées des métabolites sont plus faibles ou
similaires à celles de leur parent. Par ailleurs, les métabolites ciblés se sont révélés plus
susceptibles à une dégradation environnementale que leur parent. Néanmoins, leur présence
dans l’environnement aquatique ne peut qu’augmenter le risque écotoxicologique.
Finalement, les processus de photodégradation d’un antibiotique, le sulfamethoxazole (SMX),
et ceux de ses métabolites humains, ont été étudiés plus en détail aﬁn de vériﬁer les mesures
de terrain et d’identiﬁer leurs sous-produits. Le SMX est l’une des substances dont les
concentrations observées dans la Baie de Vidy dépassent les normes de qualité pour les eaux
de surface. Les cinétiques de dégradation du SMX et de ses principaux métabolites ont ainsi
été déterminées. Contrairement aux observations de terrain, la plupart des métabolites se sont
révélés plus résistants à la dégradation par le soleil que leur parent, ce qui indique que d’autres
processus tels que la photodégradation indirecte ou la biodégradation contribuent également
à leur élimination dans le milieu naturel. Cependant, l’identiﬁcation des photoproduits a
permis la mise en évidence d’une retransformation d’un métabolite en son principe actif
parent par l’effet du soleil. Ainsi, les métabolites humains peuvent représenter une source de
produits pharmaceutiques dans l’environnement.
Ce travail donne une meilleure compréhension sur l’étendue de l’impact environnemental
d’un rejet direct d’eaux usées dans un lac. Il permet également de reconnaître les facteurs et
les processus clés qui inﬂuencent la persistance ou la dégradation des micropolluants dans
un environnement lacustre. Il identiﬁe par ailleurs certains micropolluants problématiques
comme cibles de futures campagnes de terrain et comme substances prioritaires pour
l’optimisation des procédés de traitement des eaux usées. En respectant le principe de
précaution, l’ensemble des résultats de cette étude souligne l’importance d’éliminer, ou
tout au moins de réduire, les rejets de micropolluants dans l’environnement.
Mots clés : micropolluants, médicaments, métabolites humains, antibiotiques, sulfamethoxa-
zole, UPLC-MS/MS, ecotoxicité, pesticides, eaux usées, lac Léman, modèle hydrodynamique,
photodégradation, risque environnemental.
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1 Introduction
1.1 Introduction
Invisible to the human eye, yet ubiquitous. . . The occurrence and the potential adverse effects
of micropollutants in the environment have been the object of many studies in recent years,
and are starting to receive attention from the general public. In research, much focus has been
laid on the so-called emerging pollutants, namely pharmaceuticals, which reach the sewer
system and wastewater treatment plants mainly via domestic use. Technologies commonly
applied for wastewater treatment are not designed to remove these micropollutants, and as a
consequence the aquatic environment is ubiquitously contaminated with pharmaceuticals
and other micropollutants (biocides, pesticides). A wide variety of micropollutants have been
detected in the ng-μg·L−1 range in various land-use settings and climatic regions throughout
the planet. Yet, research to date has focused on their fate during wastewater treatment and
their occurrence in river waters. Though some studies have investigated their degradation
in lake water columns, the variety of studied compounds is limited and the current state of
knowledge on their fate in the environment is far from satisfying. To better preserve lakes as a
freshwater resource and environmental habitat, it is essential to gain a better understanding
of micropollutants in surface waters.
Lake Geneva represents the most important freshwater reservoir of Western Europe, providing
potable water for over 700’000 people. The city of Lausanne on the northern shore of the
lake beneﬁts from this freshwater source, drawing water from the Vidy Bay. On the other
hand, the city’s efﬂuent wastewater is discharged directly into the Bay, yielding a potentially
contaminated site. This thesis investigates the presence of a selection of micropollutants in the
Vidy Bay of Lake Geneva, quantiﬁes the importance of photodegradation with respect to their
fate in natural waters, and ﬁnally proposes a model to estimate the spread and persistence of
micropollutants surrounding the wastewater outfall in Vidy Bay.
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This introduction describes some relevant concepts and a provides a brief summary of relevant
literature to date, leading the reader from the consumption of a pharmaceutical to its release
into the environment, by describing the potential sources, pathways and transformation of
a pharmaceutically active substance (section 1.2). Details pertaining to the study site of the
Vidy Bay will be emphasized (blue box) when pertinent. This section also discusses some
intimately linked issues such as the potential effects and risks of trace concentrations of these
micropollutants in natural waters. Next, some important photodegradation principles will
explained in relation to recent scientiﬁc work (section 1.3). Finally, the research objectives and
the general approach of each research chapter will be presented (section 1.4).
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1.2 Micropollutants in the environment- from source to sink
1.2.1 What are micropollutants?
Before leaping into the topic, let us deﬁne the term micropollutants and their main sources.
Micropollutants are organic compounds present in the environment in low concentrations
(μg·L−1 or ng·L−1) and originate from chemicals that form an integral part of our daily lives,
such as human pharmaceuticals, biocides, pesticides, personal care products, industrial
chemicals, etc. Over 100’000 chemicals are registered in the European Union, of which
30’000 to 70’000 are regularly used1 and may ﬁnd their way into the environment. This
thesis focuses on a subset of compounds that were determined most pertinent for the Vidy
Bay catchment2. The selection comprises mainly pharmaceuticals, but also the human
metabolites of pharmaceuticals, as well as biocides, pesticides, fungicides and corrosion-
inhibitors.
Pharmaceuticals will be a strong focus of this thesis, as they represent an important part of the
chemical enterprise; thousands of tons of drugs are used every year, and consumption has
been rising constantly. In the European Union, approximately 3000 substances are registered
for pharmaceutical purposes3. Pharmaceuticals are deﬁned as substances responsible for
physiological or pharmacological action and are used in diagnosis, cure, mitigation, treatment
or prevention of disease. Most pharmaceuticals are designed to be persistent enough to
reach the target location in the human body, where the physiological effects are desired4.
Yet this caracteristic becomes detrimental if these substances reach the environment. Many
questions remain open as to their fate in the environment, and their effects on biota at the
concentrations that have been observed. But how is it that pharmaceuticals ﬁnd their way
into the environment?
1.2.2 Sources of micropollutants
The main sources for pharmaceuticals in the environment are industry, hospitals, house-
hold consumers and veterinary drugs from livestock (Figure 1.4). Contamination of the
environment can begin at the manufacturing plant where pharmaceuticals are disposed of
as solid waste or in wastewater efﬂuent. Pharmaceuticals disposed of as solid waste can
be destroyed through incineration. On the contrary, solid waste disposed in landﬁlls may
persist in water drained from the landﬁll or percolate to groundwater aquifers (leaky landﬁll)4.
Pharmaceuticals from households and hospitals are consumed, partially metabolized, and are
either released in feces and urine to the sewer system or disposed of as solid waste. Improper
disposal of unused drugs down the toilet constitutes another source of pharmaceuticals in
wastewater. Once in wastewater, these compounds are transported by sewers to wastewater
treatment plants (WWTPs). In some cases, they may be directly discharged into aquatic
environments without treatment, e.g. during high rain events that lead to a surpass of the
WWTP capacity, or through leaking sewers5.
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Figure 1.1: Exposure routes of pharmaceuticals into wastewaters and the aquatic environment. Adapted
from4.
Compounds transiting the WWTP may be removed by one of the mechanisms discussed below,
yet studies have shown that many compounds are removed by less than 50%4. Therefore,
centralized sewage treatment plants represent an important point source for micropollutants
into the aquatic environment4. Compounds sorbed to sewage sludge sludge may ﬁnd their
way to the environment through application of sewage sludge as a soil fertilizer. In Switzerland,
however, land application of sewage sludge has been forbidden since 2003; instead, sewage
sludge is incinerated. The path taken by veterinary drugs to the environment is more direct, as
the latter are more likely to directly contaminate soil, groundwater and surface waters without
any sewage treatment. Indeed, surface and groundwater can be contaminated by runoff of
manure from ﬁelds after rainfall6.
The sources of pesticides and herbicides to the aquatic environment are multiple, and can be
qualiﬁed as diffuse or point-source. Pesticides are evidently used for agricultural purposes,
but are also applied in urban areas, on lawns, streets, building materials and for protection
of materials (e.g. anti-fouling agents). Point sources of agricultural pesticides are generally
due to misuse (over-application) and improper disposal (direct discharge to surface waters).
However, the most signiﬁcant pathways of agricultural pesticides into surface waters are
diffuse pollution such as surface runoff, subsurface hydrological pathways, and spray drift7.
On the other hand, most urban pesticides are likely to be ﬂushed from gardens, streets
and buildings into the sewer system and to the wastewater treatment plant, which, due
to incomplete removal, also represent point sources of pesticides to the environment8. In
Switzerland, agriculture is one of the dominant land uses. Accordingly, diffuse transport from
land has been identiﬁed as an important source of pesticides to surface waters. However, in
catchments of mixed land use, the contribution of urban area inputs may be at least as large
as those from agricultural areas9.
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The Lake Geneva catchment falls into this mixed land-use category, hence both diffuse
and point source (from WWTPs) pollution are expected. Approximately 40% of the
catchment is arable or pastured land, presenting a potential diffuse source of pesticides.
Another possible source of contamination to the lake is the Rhône river, which ﬂows in
from the west, and accounts for over 75% of the total input to the lake. The Rhône
is inﬂuenced by agricultural practices, as well as several industrial sites along the
Rhône Valley. Pollution associated to urban areas such as discharged WWTP efﬂuents is
expected to be important along the northern shore of the lake, as it accommodates the
greater part of the population.
Effectively, the Vidy Bay, on the northern shore of Lake Geneva by the city of Lausanne
(135’000 inhabitants), is thought to be one of the most contaminated areas of the
lake. The Bay represents 0.3% of the lake’s total volume. Aside from lake currents, a
major input of water to Vidy Bay is the efﬂuent discharge from Lausanne’s wastewater
treatment plant. Other sources of water to Vidy Bay are the Chamberonne River and the
Flon stormwater outlet, which are impacted by agricultural and urban areas respectively,
and, aside from diffuse run-off from land, may present sources of agricultural or urban
pesticides. As to pharmaceuticals, wastewater from Lausanne’s various hospitals and
health care centers adds up to less than 0.4% of the total volume of treated wastewater.
Hence household consumption, via discharge through WWTPs, likely represents the
main source of pharmaceuticals into the Bay (bold in Figure 1.1).
Following this scheme, the next sections will focus on pharmaceuticals, from consumption,
through the wastewater treatment system, to presence, fate and effects in the aqueous
environment. Each section aims to give a brief overview of the important research to date, and
highlight research needs.
1.2.3 Human metabolism and excretion of pharmaceuticals
After intake by humans, pharmaceuticals are metabolized to various extents, which is partly
a function of the substance and the individual patient. The proportion of an ingested
pharmaceutical that is excreted in unchanged form varies over a wide range4,10,11: only
5% of paracetamol and 26% of diclofenac are found unchanged in urine and feces, yet this
fraction increases to 45% for the antibiotic ciproﬂoxacin and can reach 96% in the case of the
betablocker atenolol12.
Once absorbed by the human body, the active substance can undergo two main metabolic
transformation processes (Figure 1.2). Phase I transformations involve the introduction of a
functional group such as –OH, -SH, (>C)2O (epoxide), -NH2, or –COOH (e.g. Figure 1.3, ring
hydroxylation of propranolol). Frequently, this reaction is mediated by a cytochrome P450
enzyme.
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Figure 1.2: Human metabolism of pharmaceuticals into phase I and phase II metabolites. Adapted
from13,14.
Phase II metabolism, also refered to as conjugation, consists in the addition of a readily
available in vivo molecule (generally glucuronic acid or sulfate) to a susceptible functional
group (e.g. Figure 1.3, glucuronidation and sulfation of propranolol). Both transformation
phases lead to an increase of polarity (and thus excretability) of the compound. Though
drug metabolism was initially deﬁned as a detoxication mechanism, current research now
recognizes that metabolism does not necessarily transform the parent compound into a less
toxic substance15. Thus, after consumption, a variable fraction of unchanged pharmaceutical
and various metabolites are excreted via urine and feces, leading to presence of active
substances in raw wastewater.
Figure 1.3: Main metabolic pathways of betablocker propranolol in humans (adapted from16).
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1.2.4 Occurrence and fate in wastewater
The ﬁrst studies reporting the presence of pharmaceuticals in raw and efﬂuent wastewater go
back to the 1980’s. Ever since, the occurrence and fate of pharmaceuticals in wastewater has
been the focus of numerous studies. Detected concentrations in raw and inﬂuent wastewater
vary greatly between individual pharmaceuticals and among studies, ranging from the high
ng·L−1 to low μg·L−1 range (4,17 and references therein), however the undisputed conclusion
remains that removal is incomplete for a large majority of compounds in conventional
wastewater treatment plants (WWTP).
The physical-chemical properties of a compound, namely aqueous solubility, volatility,
acidity and lipophilicity will inﬂuence its behaviour during the various steps of conventional
wastewater treatment. Ultimately, the fate of an organic compound mainly depends on
its capacity to associate with particles (physical-chemical removal) and its biodegradability.
Descriptors of organic partitioning, such as KOW (octanol-water partitioning coefﬁcient) or Kd
(sorption coefﬁcient) are often used to predict the extent of sorption to sludge18; available
data suggests that Kd is the most suitable parameter to estimate removal by adsorption
19–21.
Sorption can be considered a signiﬁcant removal mechanism only for a small fraction of drugs;
namely hydrophobic compounds with high KOW (Log KOW ca. 5.5–6) and/or Kd values greater
than 300 kg·L−1 20. As such, preliminary and primary treatments, where sorption processes
dominate, generally showed poor removal of pharmaceuticals17. Hence, the greatest removal
occurs during the biological treatment18. Overall removal efﬁciencies vary from <5% to 95%4.
This large variance can be explained in part by the different physico-chemical properties of
each pharmaceutical. Nevertheless, no evident correlations have been identiﬁed between
propensity to biodegrade and compound structure to allow for predictions of biological
removal efﬁciencies3. Thus, we rely on empirical data (e.g. batch experiments3) and in situ
observations to assess the extent of biological removal for a given compound.
Paracetamol, gemﬁbrocil, and bezaﬁbrate are examples of compounds susceptible to
biological removal, and will be considered in this thesis. Conversley, carbamazepine,
diclofenac, sulfamethoxazole, gabapentine, or metoprolol are all relatively recalcitrant to
conventional treatment (18 and references therein).
Removal is also signiﬁcantly inﬂuenced by operating conditions, such as the treatment
process, the age of the activated sludge, hydraulic and solid retention time (HRT and SRT) and
environmental conditions17. Several reviews highlight the opposing conclusions of various
studies as to the effect or non-effect of varying HRT and SRT, as well as the inﬂuence of ambient
temperature18,22. Nevertheless, with respect to temperature, the majority of investigations
report enhanced degradation during warmer seasons22. Consequently, lower removal was
observed during the cold season, as illustrated by a study on ﬁve pharmaceuticals (ibuprofen,
naproxen, ketoprofen, diclofenac and bezaﬁbrate), which found a three- to ﬁve-fold increase
of concentrations in efﬂuent water during the winter months23.
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Recent work investigated the occurrence and removal of 58 pharmaceuticals, endocrine
disruptors, corrosion inhibitors, biocides, and pesticides in the Vidy WWTP of the city
of Lausanne. The target compounds were selected through a prioritization study for the
Lake Geneva region, based on consumption loads, the degree of human metabolism,
estimated removal in WWTPs, and – if known – ecotoxicological relevance2. Average
efﬂuent concentrations of the chosen priority compounds ranged from 0.025 to 6μg·L−1.
Only a few of the compounds exhibited a removal efﬁciency greater than 50%. The
low removal efﬁciencies were expected, as the priority compounds were selected in
part based on their poor removal during WW treatment. The increased recalcitrance
of some micropollutants in the present study compared to previous work might also
be related to the low water temperatures in the WWTP during the sampling period
(Febuary-March 2009)24.
Available data shows that metabolites are present in wastewater efﬂuent in concentrations
comparable or higher than their parent compound. Leclercq et al. found 2–5 times
higher concentrations of the main metabolite of carbamazepine (10,11-dihydro-10,11-trans-
dihydroxycarbamazepine) in wastewater of three different treatment plants, in addition to
other metabolites of this antiepileptic drug25. Hilton reported high concentrations of N4-
acetylsulfamethoxazole, a metabolite of sulfamethoxazole, in treated sewage26. Other studies
have also observed concentrations of metabolites (ibuprofene and diclofenac, among others)
that regularly exceeded those of the parent compound27–33. Negative removal efﬁciencies
observed during the treatment process for certain compounds led scientists to the problem
of human metabolites in wastewater. Indeed, there is evidence that metabolites may be
retransformed to the parent form during biological treatment, through cleavage of the
glucuronide bond for example32,34,35. As some metabolites retain biological activity or may
represent a source of parent compound in WWTPs, researchers agree on the need of including
metabolites in water monitoring surveys and environmental risk assesments36.
As mentioned earlier, urban pesticides, from lawns, streets and buildings, ﬁnd their way
to WWTPs, where, as for their pharmaceuticals, both detected concentrations and removal
efﬁciencies vary largely24.
Ongoing efforts focus on the improvement of wastewater treatment with regard to the removal
of pharmaceuticals and other micropollutants. The addition of an advanced treatment
step such as membrane ﬁltration, activated carbon, ozonation, advanced oxidation or UV-
treatment, to conventional treatment have shown promising results18, but remain very energy-
demanding37.
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Two advanced treatments, ozonation and adsorption onto powdered activated carbon
coupled to ultraﬁltration, were tested on a large scale in the WWTP of Vidy (Lausanne,
Switzerland), yielding >80% removal of 58 investigated micropolluants, for a 30% energy
requirement increase38.
Further studies have shown that alternate treatment processes such as wetlands and lagoons
also allowed for increased micropollutant removal18. Until such technologies become
more widespread, concerning loads of pharmaceuticals are released to surface waters after
wastewater treatment.
1.2.5 Occurrence in surface water
Owing to the constant release of pharmaceuticals via WW outfalls, the presence of mi-
cropollutants in surface waters is no surprise. Accordingly, since the 1980’s, an increasing
number of studies conﬁrm the presence of a large variety of pharmaceuticals and other
micropollutants in surface waters of various land-use settings around the world, with rising
frequency of detection13,39. The reported concentrations vary with compound, but are
generally remain below 100 ng·L−1, though substantially higher concentrations have been
observed (up to several μg·L−1) . Non-steroidal anti-inﬂammatory drugs (NSAIDs) are the
compound class showing highest concentrations (e.g. diclofenac and paracetamol). Other
pharmaceuticals regularly detected in signiﬁcant concentrations in surface waters include
sulfamethoxazole (antibiotic), carbamazepine (anti-epileptic), gemﬁbrozil (lipid regulator)
and atenolol (betablocker)39. To date, most investigations have focused on streams or rivers39,
whereas data pertaining to the occurrence of pharmaceuticals in lakes is scarce.
The observed concentrations of pharmaceuticals in surface waters are inﬂuenced by a number
of factors: consumption in the catchment area, degree of human metabolism, extent of
degradation during WW treatment, dilution factors in receiving surface waters, hydrological
chacrteristics of the water body and environmental removal processes, to name a few.
Accordingly, a number of studies reported the spatial, seasonal and temporal variability
of observed concentrations in surface waters.
With respect to spatial distribution of pharmaceuticals, highest concentrations are generally
observed close to point sources, such as discharges for WWTP efﬂuent and tended to
decrease with increasing distance from the contamination source10,39. When the analysis
is extended over long river stretchs (e.g. the Rhine river, ca. 700 km), the concentrations of
pharmaceuticals are expected to increase with increasing distance from river source, owing
to increasing anthropogenic pressure40,41. Nevertheless, the reported spatial variations were
rarely consistent among all the investigated compounds of a given study and among different
studies40,42. This illustrates the inﬂuence of compound-speciﬁc physico-chemical properties
and the physical characteristics of their surrounding environment.
9
Chapter 1. Introduction
Only a limited number of studies have examined the depth dependence of micropollutant
concentrations. Conely et al. found a positive relation between surface and subsurface
river samples of certain compounds, but owing to the small concentration difference
concluded that the investigated river system was thoroughly mixed. Altogether, there is
little comprehensive data describing ﬂuctuations of pharmaceutical concentrations with
depth, nor much information on spatial distribution of pharmaceuticals near point sources in
lakes.
The temporal variations of micropollutants also depend on a variety of factors, which may
explain the differences in reported seasonal trends. Though a number of studies found
higher concentrations during winter and spring, this was not always the case. Higher
concentrations observed in winter/spring were often attributed to cold-water temperatures,
which may enhance the recalcitrance of given compounds during WW treatment, as well
as their persistence in the natural environment42–44. Certain compounds, such as the anti-
epileptic carbamazepine, displayed no signiﬁcant variation by season40,42. Seasonal variability
may also be the effect of varying ﬂow conditions, precipitations and consumption patterns of
pharmaceuticals (e.g. antibiotics are more frequently prescribed in winter45)40,43,46.
Human metabolites were not only detected in wastewaters, but also in the receiving
environment, though data remains scarce. Various authors report the presence of metabolites
in streams receiving wastewater efﬂuent, in drinking water (the main metabolite of carba-
mazepine) and even in bottled water (an N-acetylated metabolite of sulfamethazine)29,30,47.
For pesticides, the ﬁrst reports of surface water contamination date back to 1960’s. Both diffuse
surface runoff and point source input of urban pesticides from WWTPs contribute to pesticide
pollution worldwide. Resulting concentrations in surface waters vary with compound and
may reach the low μg·L−1 range. Several consecutive reviews reported that more than 95% of
samples collected from streams across the United States contained at least one pesticide48,49.
Frequently detected pesticides in the European environment include atrazine, mecoprop
and isopropanol50–52. In comparison to pharmaceuticals, spatial and temporal patterns
have been more extensively studied. This may be explained by both the earlier discovery in
environmental waters and the intrinsic seasonal and spatial aspects of pesticide application.
As expected, detected concentrations showed a strong seasonality and were linked to rainfall
events, with highest concentrations detected during ﬁeld application periods50,52,53.
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The monitoring of pesticides in Lake Geneva was initiated in 2001, whereas
pharmaceutical occurrence data exist since 2005. Samples, taken two times a year
at various depths above the deepest point of the lake (309 m) were analysed for an
entire suite of pesticides (306 in 2010) and pharmaceuticals (109 in 2010). Though
not peer-reviewed, the latest report conﬁrmed the presence over 50 pesticides 10 and
pharmaceuticals. In 2010, the sum of all pesticides ranged between 0.1 and 0.2 μg·L−1
and has been stable since 2008. Note that the sum of pesticides detected in the Venoge
river on the eastern limit of the Bay was over 0.4 μg·L−1 in November 2009 and May
2010. For pharmaceuticals, the highest concentrations were observed for the anti-
eplieptics carbamazepine (62 ng·L−1) and gabapentine (24 ng·L−1), and the anti-diabetic
metformin (320 ng·L−1).
To date, regulations in Switzerland limiting the concentrations of pharmaceuticals in
environmental waters remain vague. The water protection ordonnance (OEaux, 814.201)
stipulates that surface waters must not contain synthetic substances that may be persistent
and/or have adverse effects on biota. However, there are no numeric requirements for
pharmaceuticals. Conversely, ﬁxed limits are given for individual organic pesticides, for
which concentrations must remain below 0.1 μg·L−1.
1.2.6 Occurrence in drinking water
Trace levels of several compounds have even been detected in ﬁnished drinking water.
Commonly studied pharmaceuticals such as paracetamol, diclofenac, and carbamazepine
were detected in drinking water across Europe and in North America14,39,54. Moreover,
concentrations detected in Berlin tap water were found to be correlated to the proportion
of groundwater recharge used as drinking water source (54 and references therein). Car-
bamazepine and gemﬁbrocil were found in the drinking water of four Canadian cities that
all used advanced water treatment, such as ozone or granular activated carbon, indicating
that certain substances may pass through modern and advanced water treatment facilities.
Nevertheless, the overall detection frequency remains low, and to date the contamination of
drinking water does not pose an known appreciable risk to human health (54,55 and references
therein).
A recent news report on Swiss TV revealed the systematic presence of up to 10
micropollutants in tap water sampled around Lake Geneva, with the notable presence
of the atrazine (pesticide), benzotriazole (corrosion inhibitor) and carbamazepine (anti-
epileptic) (ABE (RTS), 30 October, 2012).
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1.2.7 Potential effects on the aquatic environment
Pharmaceutical compounds are originally designed to be biologically active and inﬂuence
speciﬁc metabolic pathways in humans and animals. Though measured concentrations in
water are considerably lower than those producing targeted physiological effects, the continu-
ous exposure of aquatic fauna and ﬂora to low-levels of biologically active pharmaceuticals
and pesticides is concerning. The potential effects of pharmaceuticals still remain largely
unknown. Effects are commonly predicted from acute (short-term) and chronic (long-term)
laboratory tests performed on species such as algae, crustaceans and ﬁsh, yielding threshold
concentrations such as the EC50 (effect concentration 50% 1) or NOEC (no-observed effect
concentration).
Adverse effects of exposure to trace concentrations of individual pharmaceuticals and more
complex mixtures have been revealed by a growing number of studies (54,56,57 and references
therein). One typical example is the feminization of male ﬁsh due to the endocrine disrupting
effects of estrogens58. A recent critical review reported that 10–15%of pharmaceuticals present
acute or chronic toxicity for certain biological endpoints57. However, it is relevant to note
that ecotoxicological data is available for less than 15% of pharmaceuticals detected in the
environment.
Most research to date has focused on acute effects of single compounds59. Available data
show that acute effect concentrations are 2–3 orders of magnitude above actual environmental
concentrations, suggesting that there is little risk of acute toxicity57,60. Yet, in the environment,
organisms are exposed to an entire cocktail of substances over their entire life-time.It has been
found that such mixtures can exhibit different and more harmful effects on growth, fertility,
sex ratios or reproductive behavior of aquatic organisms than single compounds14,54,56. As to
long-term effects, the common approach of deriving chronic ecotoxicity data from acute tests
by means of applying a safety factor (or assessment factor) has been proven invalid for several
compounds59,61. Overall, experts agree that there is a general lack of information regarding
long-term effects of environmentally relevant mixtures. Moreover, available data on chronic
effects often don’t concern the key targets, nor consider different organisms60. Recent studies
focus on the speciﬁc modes of action of pharmaceuticals to better identify the most sensitive
trophic groups and measure pertinent biological endpoints57.
Metabolites are generally expected to have an equal or lower toxicity than the parent
compound62, but may still lead to adverse effects on aquatic organisms. Norﬂuoxetine, the
main metabolite of ﬂuoxetine, was found to be 50% more toxic than the parent compound36.
Several other metabolites, such as those of cloﬁbric acid or propranolol, were determined to
be at least as toxic as their parent compound36,63. As for the majority of pharmaceuticals, the
ecotoxicological risks of metabolites are still to be determined, but a precautionary principle
should be applied by also considering excreted metabolites in risk assessments.
1concentration at which 50% of the tested organism shows the targeted endpoint, generally mortality
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Another area of concern is the spread of antibiotic-resistant bacterial strains. Efﬂuent
wastewater has been identiﬁed as a major source of antibiotic resistant bacteria (ARB) in
surface waters64,65, and the continual input of ARB and their resistance genes may ultimately
lead to an increase of infections with resistant pathogens. ARB were detected in diverse
aquatic environments54,56. In addition, trace concentrations of antimicrobials play a role in
promoting resistance among environmental strains. Recent work showed that even extremely
low antibiotic concentrations, similar to the concentrations found in natural environments,
can select for resistant bacteria66. The question if the direct input of already resistant bacteria
or low levels of antibiotics in surface waters represents a more important source of ARB in the
environment was highlighted in a recent review56. To date, available data points toward the
direct input of ARB as the most important source of resistance in the environment.
1.2.8 Environmental risk assessment of micropollutants
The increasing concern regarding the presence and effects of micropollutants in surface waters
has led European and North American countries to propose water quality criteria (WQC)
for micropollutants in surface waters (67 and references therein). EU guidelines often use
predicted no-effect concentrations (PNEC) as WQC68. PNECs represent concentrations below
which an unacceptable effect will most likely not occur. PNECs are classically determined
using ecotoxicity data (preferably chronic data, e.g NOEC) of three trophic levels. The PNEC
for each substance is calculated by dividing the EC50 or NOEC of the most sensitive trophic
level by a safety factor (SF), typically 100 or 1000. The safety factor expresses the degree of
uncertainty in the extrapolation from the test data on a limited number of species to the actual
environment and as mentioned earlier, will be higher if using results from acute tests. When
enough ecotoxicity data is available (e.g. for many pesticides), the hazardous concentration 5
(HC5), a more robust WQC, can be derived from species sensitivity distribution curves (SSD).
The HC5 represents the concentration that protects 95% of all aquatic species67, and a PNEC
equivalent can be calculated by dividing HC5 by a factor of 568.
The environmental risk is generally characterized by comparing the measured environmental
concentrations (MEC) with speciﬁc WQCs (PNECs). The resulting risk quotient (RQ) for each
individual substance i , shown in equation 1.1, must remain below one to ensure an acceptable
risk to the environment67.
RQi =
MECi
PNECi
(1.1)
However, in the aquatic environment, all substances are present contiguously, thus a realistic
ecotoxicological risk assessment should consider the effect of all chemicals present.
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Latest research recommends applying a concentration addition (CA) model as a conservative
worst case estimation of mixture toxicity69,70. Explicitly, the risk of a chemical mixture, RQm ,
is the sum of the RQ of all n substances present in the mixture, RQi (equation 1.2):
RQm =
n∑
i=1
MECi
PNECi
(1.2)
The CA model by deﬁnition assumes all substances exhibit a similar mode of action, an
assumption that is often not fulﬁlled in environmentally realistic mixtures70. Nevertheless,
the concept of CA is recommended for a precautious risk assessment, and has been shown to
provide excellent predictions of mixture toxicities71,72.
1.2.9 Natural elimination in the environment
Organic micropollutants are subject to various removal processes which affect their concen-
tration in environmental systems. These processes are largely inﬂuenced by the intrinsic
physical and chemical properties of the compound, but also the environmental conditions
and the surrounding matrix. The main removal processes in surface waters are biodegradation,
sorption and photodegradation.
We can expect a minor importance of biodegradation for those micropollutants that
showed incomplete removal during biological wastewater treatment and are released to
the environment60. Moreover, the lower bacterial density and diversity in surface waters
likely implies slower biodegradation than in sewage56. For example, a recent review reported
that over 20 important antibiotics were not found to biodegrade readily in batch reactors
(closed-bottle tests)56,73.
Given the polar and hydrophilic nature of the large majority of pharmaceuticals (low octanol-
water partition coefﬁcient), removal through sorption processes is expected to be small.
However, sorption is also affected by pH, stereochemical structure and chemical nature of
the sorbent and sorbed compound56. This is well illustrated with the antibiotic ciproﬂoxacin,
which, despite its low log KOW (0.28, physprop database), was found to sorb to particulate
organic matter71, showing that ionic interactions between ionized groups of a pharmaceutical
can also act as binding mechanisms to particles or dissolved organic matter. Planar aromatic
structures may also favor sorption by intercalation in layers of some clay minerals56.
Nevertheless, for those chemicals that do not undergo sorption to sludge nor biodegradation
in WWTPs, photodegradation can be expected to be a major environmental removal process.
Photolysis has been identiﬁed as an key degradation mechanism of many pharmaceuticals
and other micropollutants in the environment74–76. Many compounds feature aromatic rings,
heteroatoms and other functional groups capable of absorbing solar radiation and making
them susceptible to transformation by the sun75.
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Compounds which do not directly absorb incident radiation may nonetheless undergo
indirect transformation mechanisms via reaction with other photo-excited species such as
various water constituents11. Direct and indirect photoprocesses yield various intermediate
species, which in turn can trigger the other degradation mechanisms described above.
Indeed photoproducts and intermediates are more polar and hydrophilic than their parent
compounds, and may undergo further biodegradation and hydrolysis77,78.
Important principles of direct and indirect photolysis will be described next, followed by a
review of relevant literature regarding photodegradation in aquatic environments in section
1.3.
Direct Photolysis
Direct photolysis can occur when an organic pollutant directly absorbs incoming radiation.
Light absorption implies an overlap of the sunlight emission spectrum with the absorbance
spectrum of the given compound; however, not all absorbed light yields a photochemical
transformation. Light absorption leads to the promotion of the compound to an excited
state, namely the short-lived singlet-state. At this point the excited compound may convert to
triplet state via intersystem crossing. The triplet excited state has lower energy than the singlet
excited state, but a longer lifetime. Both excited states may, through physical processes, return
to their ground state (no transformation), or undergo chemical reactions which involve the
transformation of the compound.
Physical processes which return the excited molecule to the ground energy state include19:
Internal conversion: vibrational energy loss yielding heat
Luminescence: energy loss by light emission (e.g. ﬂuorescence and phosphorescence)
Photosensitization: energy transfer to another molecule
Yet, we are more interested in potential chemical reactions, as these have environmental
implications. Possible phototransformation reactions include cleavage, dimerization, electron
transfer, hydrogen atom abstraction, intramolecular rearrangement and isomerization are
listed below and some are depicted in ﬁgure 1.419.
The efﬁciency of a phototransformation reaction is given by the reaction quantum yield,Φ(λ).
For a given wavelength (λ), it is deﬁned as the ratio of the number of molecules transformed
by photolysis to the number of photons absorbed:
Φ(λ) = number ofmolecules transformed by photolysis
number of photons absorbed
(1.3)
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Figure 1.4: Examples of phototransformation reactions (adapted from79,80).
Quantum yields cannot be predicted (yet) on basis of the chemical structure of the compound,
so they must be determined experimentally. Equation 1.3 evokes a wavelength dependence of
the quantum yield. However in many cases the quantum yield can be assumed wavelength
independent, except for compounds absorbing over a large wavelength range with several
light absorption peaks19.
As light absorption is a prerequisite for all photoprocesses, it is important to deﬁne
necessary concepts of light absorption which will serve as a basis for calculating important
photodegradation quantities, such as the quantum yield or the light screening factor. For a
complete derivation of the equations, interested readers are referred to textbooks19.
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Two important absorption processes must be considered:
a) Light absorption by the bulk solution.
Light attenuation by the totality of chromophoric substances in solution impacts the amount
of radiation available for photodegradation processes. The Beer-lambert law describes the
absorbance of light by a solution by relating the amount of light emerging from the solution
I (λ) to the incident light intensity I0(λ):
I (λ) = I0 ·10−[α(λ)+εi (λ)·Ci ]·l (1.4)
where α(λ) is the attenuation coefﬁcient of the solution in cm−1, Ci is the concentration of
the compound i under consideration, l the pathlength of light through the solution and εi (λ)
the decadic molar absorption coefﬁcient of i , which describes the ability of the compound to
absorb light at a particular wavelength.
The absorbance of the solution A(λ) is then given by:
A(λ) = I0(λ)
I (λ)
= [α(λ)+εi (λ) ·Ci ] · l (1.5)
In natural systems, the trace concentrations of micropollutants have little inﬂuence on the
total amount of light absorbed by a body of water, but other factors such backscattering and
reﬂection of light come into play. In this case, εi (λ) ·Ci is negligible, αD (λ) replaces α(λ) to
account for backscattering and reﬂection, and the pathlength l becomes zmix :
A(λ) = αD (λ) · zmix = 1.2 ·α(λ) · zmix (1.6)
where αD (λ) is the diffuse attenuation coefﬁcient and zmix the depth of the mixed water
column. αD (λ) can be approximated by 1.2·α(λ) for non-turbidwaters and temperate
latitudes19. Hence, the more light absorbed by the solution (large α(λ) due e.g. to presence
of dissolved organic matter and/or deeper mixing depth), the less light will be available for
absorption by the compound.
b)Light absorption by the compound itself
This quantity determines the amount of light absorbed by a compound of interest within
a solution containing several chromophores. The speciﬁc rate of light absorption, ka(λ),
expresses the amount of light absorbed per unit time per mole of compound I in a given system
(characterized by αD (λ) and zmix). It is determined by the intersection of the absorbance
spectrum of the compound i of interest (εi (λ)) , and the irradiance spectrum of the light (I (λ)).
ka(λ) = I (λ) ·εi · (1−10
−α(λ)·zmix )
zmix ·α(λ)
(1.7)
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In the case of very little light absorption by the water column (i.e. shallow, near-surface
conditions), the following approximation is valid:
1−10−α(λ)·zmix = 2.303 ·α(λ) · zmix (1.8)
The near-surface speciﬁc rate of light absorption at a given wavelength is then:
k0a(λ) = 2.303 · I (λ) ·εi (λ) (1.9)
This quantity is integrated over the wavelength range over which the compound absorbs
k0a = 2.303 ·
∫
λ
k0a(λ) dλ
∼= 2.303 ·
∑
k0a(λ)Δλ = 2.303 ·
∑
I (λ) ·εi (λ)Δλ (1.10)
Finally the reaction quantum yield (assuming independance of wavelength) can be related to
the direct photolysis rate constant and the speciﬁc rate of light absorption by:
Φ = number ofmolecules transformed by photolysis
number of photons absorbed
= kphotolysis
k0a
(1.11)
Where kphotolysis is the experimentally determined photolysis rate constant in the system
under consideration.
A light screening factor describes the fraction of light absorbed by the water column, and
is used to correct measurable parameters such as the observed photolysis rate constant, to
account for the fact that not all incident light is available for photoprocesses, resulting in slower
photodegradation. Note that it is the simpliﬁed ratio of ka (equation 1.7) and near-surface k0a
(equation 1.9):
SF(λ) = ka(λ)
k0a(λ)
= 1−10
−α(λ)·zmix
2.303 ·α(λ) · zmix
(1.12)
Direct photolysis of organic compounds is only possible when there is overlap between the
absorption spectrum of the compound and the solar spectrum. Therefore, compounds that do
not absorb light above 290 nm are resistant to direct photodegradation. Nonetheless, they may
be transformed by reaction with other excited species, through indirect photodegradation
processes.
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Figure 1.5: Formation of several reactive intermediates from irradiation of DOM and subsequent indirect
photolysis of an organic compound i. Dotted arrows represent radiationless transition (adapted from19).
Indirect photolysis
Indirect photolysis involves an additional species capable of light absorption, which after
excitation transfers this energy to or reacts with the compound . These excited species, known
as sensitizers, are for instance formed after light absorption by natural water constituents
(dissolved organic matter (DOM), nitrate and nitrite) or other organic contaminants.
DOM is present in all natural waters. It is one of the most highly absorbing compounds in
the aqueous phase and therefore plays a major role in the photoprocesses of surface waters.
The fraction of DOM which absorbs light is commonly refered to as chromophoric dissolved
organic matter (CDOM). Light absorption promotes it to the singlet excited state, which, due
to its short life-time, rapidly yields triplet excited state CDOM (3CDOM). Figure 1.5 shows
various reactive species generated from excited CDOM, which in turn may react with the
compound. Molecular oxygen is the main quencher of excited CDOM, leading to formation of
reactive singlet oxygen 1O2. Other reactive species formed are for example superoxide anion
(•O−2 ), oxyl- and peroxl radicals (RO
•, ROO•), hydrogen peroxide (H2O2), hydroxyl radical
(HO•) (though DOM is more sink than source) and solvated electrons (e−aq ). The relevance of
each of these reactive species in natural water chemistry is inﬂuenced by several factors such
as their formation rate, lifetime and the speciﬁc reactions with organic compounds. More
details pertaining to important reactive species, namely 3CDOM, 1O2 and •OH, in addition to
other factors which have been found to inﬂuence the fate of micropollutants in surface waters
are given in the following section 1.3.
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1.3 Stateof researchonenvironmental photolysis ofmicropollutants
In the objective of understanding the fate of micropollutants in natural waters, a substantial
number of studies have focused on determining the propensity of these compounds to
undergo photolysis. These experiments commonly investigate the direct and/or indirect
photolysis kinetics via laboratory experiments using artiﬁcial light (lamp or solar simulator),
or by exposing test beakers to natural sunlight. The photodegradation of pharmaceuticals can
vary signiﬁcantly from compound to compound and strongly depends on the characteristics
of each individual substance (absorption spectrum, reaction quantum yield), as well as
many environmental factors (season, latitude, pH, turbidity, water depth, temperature)
and on the water constituents (presence of DOM and/or nitrate). Several reviews have
noted the large variance in experimental set-ups: different light sources, reactor geometry,
solution composition, initial compound concentration, actinometric methods, etc.37,75. These
disparities may render the direct comparison between results difﬁcult.
The following paragraphs highlight some examples from literature with the objective of
showing how compound structure and water composition can inﬂuence the fate of a
pharmaceutical in water.
1.3.1 Chemical structure of the pharmaceutical
The propensity of pharmaceuticals to undergo photodegradation can sometimes be predicted
based on structural similarities to other compounds for which the photodegradation behavior
has been investigated. For example, certain pesticides containing structural moieties, such
as phenol, nitro, and napthoxyl groups are known to undergo direct photolysis. Therefore,
pharmaceuticals containing these moieties can be expected to exhibit similar degradation
behavior. This fact is well illustrated on the example of pesticides carbaryl and napropamide,
which show fast photolysis and contain the napthoxyl chromophore, a moiety also found in
the pharmaceuticals propanolol and naproxen (Figure 1.6a). Consequently, propanolol and
naproxen were also found to be photolabile75.
Indeed, propranolol rapidly undergoes direct photolysis through ring oxidation. In contrast,
beta blockers atenolol and metoprolol, which are structurally different beta blockers (Figure
1.6b), with only one ring, showed much slower direct photolysis81.
However, structural similarities are not always a sufﬁcient indicator for photodegradation
behavior. For example, although ﬁve-membered sulfadrugs have a fairly similar structure
and differ only in their ﬁve-membered N-bond substituent, they possess relatively different
direct photodegradation rate constants82, suggesting that the ﬁve-membered ring governs
photochemical behavior of such compounds. Figure 1.7 shows the potential direct photolysis
cleavage sites. The main products reported by this and other studies result from cleavage at δ
and γ site.
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Figure 1.6: a) Structural similarities between the pesticides carbaryl and napropamide and the
pharmaceuticals propranolol and naproxen, which all contain the napthoxyl chromophore (emphasized
in blue) (adapted from75). b) Chemical stucture of betablockers atenolol and metoprolol with only one
ring.
On the other hand, a signiﬁcantly different photochemical behavior was observed for 6-
membered sulfa drugs. These showed similar direct photolysis rate constants, however, unlike
5-membered sulfa drugs, which degrade mainly through direct photolysis, they also undergo
indirect photolysis with triplet excited state dissolved organic matter, presumably by electron
transfer or hydrogen atom abstraction83. However, the major products of six-membered
sulfonamides were not the cleavage products expected based on their analogy with the ﬁve-
membered structures, but resulted from of SO2 extrusion (Figure 1.7, bottom).
This example shows that a slight change in structure may alter the extent and routes of
photolysis, and though structure may at times aid to predict the propensity of a compound to
photodegrade, a case-by-case study remains necessary.
1.3.2 Water composition
The generation of reactive species by natural water components is an important process for
the removal of certain compounds, namely those persistent to direct photolysis. Surface
waters with high levels of dissolved organic matter, nutrients and reactive transients have been
shown to increase the overall degradation rates through photosensitizing effects. Such effects
have been observed among others on carbamazepine, cloﬁbric acid, diclofenac, ibuprofene,
sulfonamides and several beta blockers78,83–86. DOM, singlet oxygen and hydroxyl radicals are
the most studied and most relevant reactants for indirect transformations of compounds in a
natural water system. The following paragraphs summarize their modes of action with several
examples from literature.
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Figure 1.7: Top: Structures of selected 5-membered sulfadrugs, potential direct photolysis cleavage
sites andmajor products generated through d-cleavage82. Bottom: structures of selected 6-membered
sulfadrugs and major products resulting from SO2 extrusion83.
Dissolved organic matter
Dissolved organic matter, though still ill-deﬁned, is known to contain a variety of chro-
mophores capable of light absorption. Triplet excited state CDOM (3CDOM) can then be
generated after light absorption by CDOM. As presented in ﬁgure 1.5, an entire suite of
reactive species are formed by reaction with 3CDOM, namely 1O2, RO•, ROO•, •O−2 , H2O2 and
HO•. 3CDOM may also undergo direct reactions with pharmaceuticals by energy, electron-
or hydrogen-transfer19. Electron or hydrogen transfer reactions typically occur with easily
oxidizable compounds such as electron-rich phenols87,88. Tertiary amines and anilines are
also expected to be readily oxdized by triplet states of CDOM-derived photooxidants, as
illustrated earlier for six-membered sulfadrugs which degraded up to 2.8 times faster in river
water compared to dionized water83. Moreover, a positive correlation was found between the
dissolved organic carbon (DOC) content in water and degradation kinetics of betablockers
atenolol, metoprolol, and propranolol, which presumably react via oxidation of their electron-
rich ring structures78. Typical concentrations of DOC in natural waters range from 0.1-50
mg·L−1 89.
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But increasing concentrations of CDOM may on the contrary act as an inner ﬁlter through
competitive light absorption of incident radiation, and thus yield decreased photodegradation
rate constants84. Other inhibitory mechanisms of CDOM include scavenging of reactive
oxidants (hydroxyl or carbonate radicals) by CDOM, and transformation of reaction inter-
mediates back to the reduced parent compound. For example, Canonica et al. showed
that increasing amounts of CDOM has an inhibitory effect on photodegradation of (among
others) sulfamethoxazole, trimethoprim and propranolol due to backreduction of the oxidized
photoproducts90. This particular inhibitory effect was also found to depend on the CDOM
type; CDOM with high allochthonous (soil-derived) content (greater aromaticity) generally
showed greater inhibition capacity91.
Singlet oxygen
Singlet oxygen (1O2) denotes the ﬁrst electronic excited state of molecular oxygen and is
mainly formed by energy transfer from 3CDOM to molecular oxygen (3O2). In natural waters,
the life-time of 1O2 (and steady-state environmental concentration) is essentially controlled
by physical deactivation by water92. Other processes such as physical quenching by organic
substrates, reaction with contaminants or radiative decay back to ground state are minor in
environmental conditions, though quenching by DOM can become important for DOC levels
above 20 mg C ·L−1 (19 and references therein). Typical steady state concentrations of 1O2 in
surface waters range from 10−13–10−14 M93, and can be up to three orders of magnitude larger
within the DOM94. The efﬁciency of 1O2 formation from CDOM was found depend on the
type of the CDOM (aquatic or terrestrial) and the season93,95. However, several studies have
shown that certain CDOM parameters, namely absorbance at 300 nm or DOC, can be used to
estimate the environmental steady state concentrations of singlet oxygen within a factor of
four96.
Singlet oxygen is a selective oxidant, and reacts mainly with compounds exhibiting structural
moieties (dienes) capable of [4+2] reactions (cycloaddition), compounds containing electron-
rich double bonds (for example double bonds that are substituted with electron-donating
groups), and with easily oxidizable moieties (e.g. sulﬁdes, anilines, and phenols).
The reactivity of speciﬁc chemical structures and organic chemicals with 1O2 has been
extensively studied97,98. However, singlet oxygen being a rather selective oxidant, it is expected
to play an important role in the environmental fate of only a few types of compounds, in
particular those with high reaction rate constants (>108 M−1·s−1)99. These predictions seem
validated by the sparse research reporting reaction between pharmaceuticals or pesticides
with singlet oxygen. Even though some pharmaceuticals such as cimetidine, naproxen and
atorvastatin were found to react with singlet oxygen, this process was considered important
in natural waters only for cimetidine85,100,101. Other compounds such as the antibiotics
sulfamethoxazole and trimethoprim were found to generate singlet oxygen, via their triplet
excited state, but the self-generated singlet oxygen did not affect their degradation82,102,103.
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OH radical
Of all the reactive intermediates mentioned, hydroxyl radical is the most reactive and
non-selective, and consequently reacts with many organic compounds at nearly diffusion
controlled rates104,105.
The hydroxyl radical can be produced by several processes such as the photolysis of hydrogen
peroxide, nitrate, nitrite, DOM, FeOH2+ and by reaction of H2O2 with Fe2+ (Fenton reaction).
Yet, the major sources of hydroxyl radical in surface waters appear to be the photolysis of NO−3
and NO−2 by the following reactions
19:
NO3+hν−−→NO−∗3 −−→NO2+O•−
H2O−−−→HO• +HO− (1.13)
NO−2 +hν−−→NO−∗2 −−→NO+O•−
H2O−−−→HO• +HO− (1.14)
The consumption of hydroxyl radicals is controlled by natural scavengers, namely carbonate,
DOM and bromide in seawater, which in turn may give rise to longer-lived, selective
radicals such as the carbonate radical (CO•−3 ) and the bromine radical (Br
•). Steady-state
concentrations of hydroxyl radical in surface waters thus strongly depend on the chemical
composition of water. Commonly reported concentrations range from 10−14–10−18 M106.
Moreover, hydroxyl radical formation and its scavenging can be related to the nitrate and DOM
and bicarbonate content, respectively of a given water, allowing for a reasonable estimation of
its concentration in various surface waters based on these parameters106.
Typical reactions involve electrophilic addition to a double bond or an aromatic system and
hydrogen atom abstraction (Figure 1.8). Compounds exhibiting aromatic rings and/or carbon-
carbon double bonds with electron-donating substituents, as well as those with aliphatic
groups from which an H-atom can be easily abstracted react at near diffusion controlled
rates19. These speciﬁc reaction pathways have been useful in distinguishing degradation
products from direct and indirect photolysis107. Conversely, hydroxyl radical was found least
reactive with aliphatic polyhalogenated substances19.
Figure 1.8: Reactions with hydroxyl radical: electrophilic addition to a double bond or an aromatic
system (above) or hydrogen atom abstraction from a carbon atom (below)19.
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Figure 1.9: Effect of nitrate and humic acids on the phototransformation of the antibiotic oﬂoxacin
in bi-distilled water during exposure to spring sunlight at 25 ◦C. [Oﬂoxacin]= 1·10−5 mol·L−1(•: only
oﬂoxacin;: with humic acids (5·10−3 g·L−1);: with humic acids (5·10−3 g·L−1) and nitrate (1·10−2
g·L−1);: with nitrate (1·10−2 g·L−1)) (from74).
Owing to their non-selective nature, hydroxyl radicals are expected to play a signiﬁcant role
in limiting the persistence of many organic micropollutants. Numerous studies have indeed
conﬁrmed both the role of nitrate in enhancing photolysis through hydroxyl radical generation
and the important contribution of these radicals to the overall fate of contaminants in surface
waters74,85,103,106,108,109. This is well illustrated by the enhanced degradation of the antibiotic
oﬂoxacin in presence of DOM and/or nitrate (Figure 1.9).
1.3.3 Other parameters inﬂuencing photodegradation rates
pH inﬂuences the protonation state of the compound, and consequently its absorption
spectrum (shape and/or maximal absorbance). Accordingly, though higher absorbance is not
necessarily correlated with higher degradation rate constants, varying pH may inﬂuence direct
photolysis rate constants. Five-membered sulfadrugs showed varying degradation kinetics
at different pH-values; for example, sulfamethoxazole rapidly undergoes direct photolysis in
its neutral state (at pH values below pKa,2=5.7), whereas the anionic component present at
environmentally relevant pH ranges photolyzes more slowly82. Similar pH-dependancies were
observed for ciproﬂoxacin or propranolol, among others78,110–113. Changes in protonation
state furthermore alters the electron density of a molecule, which may consequently also affect
indirect photolysis processes via more speciﬁc transient species such as singlet oxygen19,99.
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Figure 1.10: Half-lives (in days) for the direct photolysis of selected pharmaceuticals at different seasons
and latitudes. (1) spring; (2) summer; (3) fall; (4) winter. •: 20 ◦N,: 30 ◦N;: 40 ◦N; : 50 ◦N (from74).
Another water component which may inﬂuence photolysis of certain compounds is iron.
Indeed, the macrolide antibiotic clarithromycin was only found to photodegrade efﬁciently
when complexed by Fe(III). Generally, macrolide antibiotics do not absorb at wavelengths
above 290 nm, yet complexed to iron(III) they become photochemically active114.
Irradiation being the prerequisite for all photoprocesses, variations in the solar irradiation
spectrum and intensity will clearly affect photodegradation rates. Hence season and/or
latitude may have a large inﬂuence on the environmental fate of micropollutants. At temperate
latitudes of 40◦N, predicted pharmaceutical half-lives were up to 5 times longer in winter than
during the summer season and the seasonal effect increases with increasing latitude, as shown
in ﬁgure 1.1074. Using similar model predictions, various studies show a signiﬁcant decrease
of photolysis rates in winter months82,115,116. Actual accumulation of pharmaceuticals,
in winter months or at lower depths was also conﬁrmed by environmentally measured
concentrations42,117,118.
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1.4 Research objectives and approach
From the large scale of the Vidy Bay to the molecular level of an antibiotic, the following
chapters intend to ﬁll some research gaps identiﬁed throughout the literature review. The
objectives and content of these chapters is described brieﬂy as follows:
Chapter 2 Only scarce data is available concerning the environmental fate of pharmaceuticals
and other micropollutants directly discharged from WWTPs into lakes. Moreover,
the spatial and temporal distribution of pharmaceuticals in lakes has rarely been
studied. By means of monthly sampling at various depths and locations across the
Vidy Bay, this chapter aims to understand the impact of the wastewater outfall on the
spatial distribution of 39 micropollutants in the Vidy Bay. The spatial occurrence of
contaminants discharged from the wastewater outfall (pharmaceuticals) are compared
to those typically entering the lake from streams or runoff from land, such as pesticides.
Moreover, the seasonal variability of micropollutant concentrations and their proﬁles
throughout the water column are examined, both of which may be impacted by summer
stratiﬁcation.
Chapter 3 The limitations of punctual water sampling in evaluating the spatial extent of
pollution sources is readily understood. In such cases, modelling physical and chemical
processes has been proven successful. This chapter describes a model developped to
predict the spreading of wastewater-derived micropollutants arising from the WWTP
outfall in Vidy Bay. The overall goal is to spatially and temporally deﬁne the area of
potential ecotoxicological risk in Vidy Bay. Both hydrodynamics, from a ﬂow model, and
direct and indirect photolysis processes, determined experimentally, are coupled in a
model that predicts the concentrations of micropollutants under typical wind scenarios
and seasons relevant to Vidy Bay.
Chapter 4 To date, there is very little information on the environmental occurrence of
human metabolites of pharmaceuticals. However, evidence of their potential capacity
to transform back to the parent compound, along with the knowledge that some
metabolites retain biological activity, are inciting reasons to include metabolites in
the study of presence, fate and effects of micropollutants. This chapter is a continuation
of the ﬁrst chapter with regard to human metabolites. The goal is to determine the
presence of a selection of human metabolites in Lake Geneva, to assess their fate with
respect to degradation over time and space, and to evaluate their contribution to the
overall ecotoxicological risk.
Chapter 5 The identiﬁcation of phototransformation products was highlighted as an im-
portant research need. This ﬁnal research chapter investigates the direct photolysis
products of an antibiotic, sulfamethoxazole (SMX) and four of its human metabolites,
with the objective of understanding the inﬂuence of the small structural differences
between SMX and its metabolites on photolysis rates and pathways. In addition, the
possibility of photolytic back-transformation of a metabolite to SMX is assessed for the
ﬁrst time.
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2 Spatial and temporal presence of a
wastewater-derived micropollutant plume
in Lake Geneva
2.1 Introduction
The occurrence and potential adverse effects of micropollutants in the environ-ment have
been the object of many recent studies. A wide variety of pesticides and, more recently,
pharmaceuticals have been detected in the ng-μg·L−1 range in various aquatic environments
throughout the planet14. Human pharmaceuticals enter the environment mainly via the
discharge of wastewater efﬂuent to surface waters. Only a fraction of the pharmaceuticals
consumed are metabolized by the human body, whereas the remainder is excreted into
the sewer system, and transported to the wastewater treatment plant (WWTP). Studies
have shown that many pharmaceuticals are removed by less than 50% during wastewater
treatment. Therefore, sewage treatment plant efﬂuents represent an important point source
of micropollutants into fresh water systems18 . Moreover, during high rain events, when the
WWTP capacity is surpassed, or due to leaking sewers, untreated wastewater may be directly
discharged into aquatic environments119. Pesticides, in contrast, can enter surface waters by
several diffuse mechanisms, such as runoff from land9,120.
To date, most research on environmental occurrence and fate of pharmaceuticals has focused
on the presence of these compounds in rivers and streams, often at sites close to discharges of
WWTP efﬂuent. These studies have reported higher concentrations of several pharmaceuticals
downstream of WWTP efﬂuent discharges compared to upstream, as well as decreasing
concentrations with increasing downstream distance from the efﬂuent discharge point23,121.
This decrease was for the most part attributed to dilution with receiving waters, and natural
degradation processes, mainly photolysis42,118.
A modiﬁed version of this chapter was published as: F. Bonvin, R. Rutler, J. Halder, N. Chevre and T. Kohn,
Environmental Science & Technology, vol. 45, 2011
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Only scarce data exist, however, concerning the environmental fate of pharmaceuticals and
other micropollutants directly discharged from WWTPs into lakes. A study conducted in the
Great Lakes region observed the highest concentrations of most pharmaceuticals nearest
to the WWTP discharges; however no depth proﬁles were acquired and only surface water
samples were considered122. Another study on corrosion inhibitors in Swiss rivers and lakes
found maximal concentrations at the surface and at -10 m water depth in Lake Zürich and
Lake Geneva123. The authors speculated that the peak at -10 m was caused by WWTP efﬂuent
discharged directly into the lakes; however this hypothesis was never pursued.
When wastewater is discharged into a large body of water, it may not fully mix with the
surrounding water mass, but instead stratify as a distinct layer (plume) at a point where
its density corresponds to that of the surrounding water mass124. Several authors have
investigated the dispersion and dilution of sewage outfall. Common wastewater plume tracers
aremicrobiological, physical and chemical indicators, such as bacteria, salinity or conductivity,
which can be associated with the outfall-plume125–127. Plumes can also be traced directly
by added tracers such as ﬂuorescent dyes or radioisotopes128. No data exist, however, on
micropollutant concentrations in these plumes.
In this study, we aim to determine whether wastewater plumes represent a reservoir of
micropollutants in lakes. Our study location, Lake Geneva, represents one of the largest
potable water resources of Western Europe and is the main drinking water source to more than
700’000 people. Several WWTPs along the shoreline discharge efﬂuent wastewater directly
into the lake. The centralized Lausanne WWTP, which collects the wastewater of 220’000
inhabitant equivalents, discharges more than 100’000 m3 of treated wastewater per day into
Lake Geneva’s Vidy Bay at -30 m depth. Previous work has shown that the wastewater efﬂuent
contains pharmaceuticals and other micropollutants in the 0.1-1 μg·L−1 range24. To date no
research has investigated the 4-dimensional variations (space and time) of a large selection of
micropollutant concentrations in a lake, in particular near a wastewater efﬂuent discharged
directly into the lake. The objectives of the present study were to determine the impact of
the wastewater outfall on the spatial distribution of 39 micropollutants in the Vidy Bay. The
spatial occurrence of contaminants discharged from the wastewater outfall (pharmaceuticals)
was compared to those typically entering the lake from streams or runoff from land, such
as pesticides. Moreover, the seasonal variability of micropollutant concentrations and their
proﬁles throughout the water column were examined, both of which may be impacted by
summer stratiﬁcation. Finally, we assessed the potential ecotoxicological risks of elevated
concentrations of micropollutants observed in the wastewater plume.
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2.2.1 Site description and sampling strategy
The study area, Vidy Bay, lies on the northern shore of Lake Geneva, and represents 0.3% of
the lake’s total volume (Figure 2.1)129. Aside from lake currents, a major input of water to Vidy
Bay is discharge from Lausanne’s wastewater treatment plant 700 m from shore at -30 m depth.
During rain events the WWTP capacity is rapidly exceeded, and untreated wastewater ﬂows
directly into the lake130. Other sources of water to the Bay are the Chamberonne River and
the Flon stormwater outlet. On the western limit of the bay, 3.1 km downstream of the WWTP
outfall, the St. Sulpice drinking water plant (sand ﬁltration) withdraws ca. 100’000 m3 of raw
drinking water per day.
Monthly water samples were collected at various depths and locations in Vidy Bay between
April 2010 and January 2011. The central sampling location (”WWTP outfall”) was above the
discharge point of efﬂuent wastewater. The two other sampling sites were located ca. 1.5
km upstream (”REF up”) and downstream (”REF down”) of the discharge point (Figure 2.1).
Between 5 and 9 depths were sampled at each site. Samples were taken from the R/V “La
Licorne” (Forel Institut, Geneva) equipped with a crane and a rosetta water sampler (1018
Rosette Sampling System, General Oceanics Inc.). The rosetta consisted of 11 Niskin bottles
(1.7 L), coupled to a CTD device (OCEAN SEVEN 316Plus CTD, IDRONAUT Srl) which were
externally powered via a sea cable and yielded instantaneous information on temperature and
electrical conductivity. Temperature and electrical conductivity were processed with REDAS-5
Release 5.40 (IDRONAUT Srl). For selected months, the WWTP efﬂuent was sampled in the
WWTP pipeline before discharge into the lake. 24 h composite samples were taken on the
same day as the lake campaign using an automatic sampler (full-size portable sampler ISCO
6712, Teledyne Isco, Inc.) located at the entrance of the pipeline.
Figure 2.1: Map of the Vidy Bay with sampling sites ”WWTP pipeline”, ”WWTP outfall”, ”REF up”, and
”REF down”. Coordinates are in Swiss Grid system with datum CH1903.
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The pipe receives treated wastewater combined with excess wastewater, which bypassed the
WWTP. Although water samples could not be acidiﬁed during the automatic sampling, tests
showed that even the most biodegradable compound of our selection of micropollutants
(paracetamol) remained stable during the 24h sampling period.
2.2.2 Choice of substances
Previous studies identiﬁed priority micropollutants for the Lake Geneva region, based on
consumption loads, the degree of human metabolism, removal in the WWTP, and – if known –
ecotoxicological relevance2. After a preliminary sampling campaign to identify the substances
present at detectable concentrations, a total of 39 micropollutants were retained as priority
pollutants for this study, including 27 pharmaceuticals (analgesics, antibiotics, antilipemic
agents, beta-blockers), and 12 other micropollutants (corrosion inhibitors, pesticides). A
detailed list of the selected micropollutants and their applications is presented hereafter in
table 2.1. The chemical structures, pKa and logKOW are given in Appendix A
Chemicals and reagents. All chemicals and reagents used have been listed previously24.
2.2.3 Sample manipulation
1 L water samples were collected in Niskin bottles and transferred into amber glass bottles,
immediately acidiﬁed to pH 2 (with concentrated HCl) to inhibit all biological activity, and
transported to the laboratory within 4 hours of sampling, where they were directly ﬁltered
through <1μm glass ﬁber ﬁlters (Whatman). Test experiments showed no signiﬁcant difference
between acidiﬁcation before or after ﬁltration, indicating that the partitioning of our selection
of micropollutants between water and suspended matter was not inﬂuenced by acidiﬁcation.
Before further treatment, all ﬁltrates were spiked with a set of 20 deuterated standards (ﬁnal
concentration 120 ng·L−1) to account for losses during extraction, as described previously24.
All glassware used for samples was immersed for 24h in a Contrad bath, machine-washed and
ﬁnally rinsed with methanol and sample water before use.
2.2.4 Analytical method
A previously developed analytical method for the monitoring of various micropollutants
involving solid-phase extraction (SPE) and ultra-performance liquid chromatography coupled
to a tandem mass spectrometer (UPLC-MS/MS) (Acquity UPLC system, Waters) was adapted
and applied to the lakewater samples24. Brieﬂy, the target compoundswere extracted on hand-
assembled 6 mL cartridges using an automated SPE system (GX-274 ASPEC, Gilson), eluted
and evaporated to 200 μL and ﬁnally stored at -20◦C until UPLC-MS/MS analysis. Within
two weeks of sampling, stored extracts were diluted 1:1 with UPLC eluent and analyzed twice
by UPLC-MS/MS. Reported values represent the average of the two separate measurements.
UPLC-MS/MS parameters are described as Method 1 in Morasch et al.24. A set of 10 to 13
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standards with concentrations between 1 and 700 μg·L−1 were analyzed in duplicate along
with the samples. The analytical limit of quantiﬁcation (LOQ) was deﬁned as the concentration
of the lowest standard with a signal-to-noise ratio > 10. Micropollutant concentrations in the
sample concentrates were calculated based on calibration curves using at least 6 calibration
points closest to the sample concentration. Correlation coefﬁcients for the calibration curves
were typically > 0.990. The few compounds with unreliable calibrations and high detection
limits (Table 2.1) were not included in the spatio-temporal analysis described below. Extraction
recoveries for each sampling day were determined for each of the 20 deuterated surrogates by
averaging the recoveries in the individual samples. Compounds lacking deuterated surrogates
were assigned one based on retention time in the liquid chromatography (see Appendix A,
Table A.1). The concentrations in the original lake water samples were determined taking
into account the extraction efﬁciencies of the associated deuterated standards and the exact
sample masses weighed during sample preparation. The uncertainty associated with the
sample concentrations, calculated as the relative standard deviation, was <30% for the large
majority of the compounds. Details regarding the calculation of this uncertainty are given in
Appendix A.
2.2.5 Statistical analyses
Statistical analyses and correlations were performed in Matlab (2009b, The Mathworks, Natick,
MA).
2.2.6 Ecotoxicological risk assessment
The increasing concern regarding the presence and effects of micropollutants in surface
waters has led European and North American countries to propose water quality criteria
(WQC) for micropollutants in surface waters (67 and references therein). EU guidelines often
use predicted no-effect concentrations (PNEC) as WQC68. PNECs represent concentrations
below which an unacceptable effect will most likely not occur. In the present study, the
ecotoxicological risk was assessed by comparing the measured concentrations with speciﬁc
WQCs deﬁned for individual substances. The resulting risk quotient (RQ), which is the ratio of
the environmental concentration and the WQC (PNECs), must remain below one to ensure an
acceptable risk to the environment67.
PNECs are classically calculated by dividing the effect concentration 50% (EC50) or no-
observed effect concentration (NOEC) by a safety factor, typically 100 or 1000. When enough
ecotoxicity data is available (e.g. for many pesticides), the hazardous concentration 5 (HC5), a
more robust WQC, can be derived from species sensitivity distribution curves (SSD). The HC5
represents the concentration that protects 95% of all aquatic species67, and a PNEC equivalent
can be calculated by dividing HC5 by a factor of 568. PNECs for the individual micropollutants,
calculation methods and references are listed in Appendix A (Tables A.3, A.4 and A.5).
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Table 2.1: List of targetedmicropollutants, their applications and average limit of quantiﬁcation (LOQ) of
the analytical method. *: Compounds not considered in spatio-temporal analysis due to poor calibration
or lack of data
Compound Name Application CAS LOQ [ng·L−1]
atenolol beta blocker 29122-68-7 1.3
atrazin pesticide (herbicide) 1912-24-9 1.3
azithromycin antibiotic 83905-01-5 1.3
benzotriazol corrosion inhibitor 95-14-7 6.6
bezaﬁbrat anticholesterol 41859-67-0 1.0
carbamazepin antiepileptic 298-46-4 1.3
carbendazim pesticide (fungicide) 10605-21-7 1.8
chloridazon pesticide (herbicide) 82869-32-7 0.7
ciproﬂoxacin antibiotic 85721-33-1 2.1
clarithromycin antibiotic 81103-11-9 0.6
clindamycin antibiotic 18323-44-9 1.1
cloﬁbric acid* antilipemic 637-07-0 5.0
diclofenac analgesic (NSAID) 15307-86-5 1.8
diuron* pesticide (herbicide, algicide) 330-54-1 8.4
gabapentin antiepileptic 60142-96-3 2.2
gemﬁbrozil anticholesterol 25812-30-0 2.2
iopamidol* X-ray contrast media 62883-00-5 288.2
iopromid* X-ray contrast media 73334-07-3 735.9
IPBC* pesticide (fungicide) 85045-09-6 1.5
irgarol pesticide (herbicide, algicide) 28159-98-0 1.6
isoproturon* pesticide (herbicide, fungicide) 34123-59-6 2.0
ketoprofen analgesic (NSAID) 22071-15-4 2.0
mecoprop pesticide (herbicide) 93-65-2 2.1
mefenamic acid* analgesic (NSAID) 61-68-7 17.6
methylbenzotriazol corrosion inhibitor 29385-43-1 1.3
metoprolol beta blocker 37350-58-6 0.7
metronidazol antibiotic 443-48-1 1.4
naproxen* analgesic (NSAID) 22204-53-1 3.6
norﬂoxacin antibiotic 70458-96-7 1.9
oﬂoxacin antibiotic 82419-36-1 1.4
paracetamol analgesic 103-90-2 3.6
primidon antiepileptic 125-33-7 2.0
propiconazol pesticide (fungicide) 60207-90-1 0.7
propranolol beta blocker 525-66-6 0.9
simvastatin anticholesterol 79902-63-9 1.2
sotalol beta blocker 3930-20-9 1.3
sulfamethoxazol antibiotic 723-46-6 1.1
terbutryn pesticide (herbicide, algicide) 886-50-0 1.2
trimethoprim antibiotic 738-70-5 1.1
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2.3 Results and Discussion
2.3.1 Occurrence of micropollutants in the Vidy Bay
Over the 10-month sampling period, almost 200 water samples were taken at different depths
and locations in the Vidy Bay as well as in the outlet pipeline of the Lausanne WWTP. The
majority of the compounds investigated were detected in more than 70% of the water samples.
The frequency of detection was slightly higher above the WWTP outfall than in the other
lake sampling sites. The highest concentrations were observed for the corrosion inhibitors
benzotriazol and methylbenzotriazol, as well as the analgesic paracetamol. However, most
of the targeted micropollutants showed concentration ranges below 20 ng·L−1 (Figure 2.2).
Highest concentrations of pharmaceuticals were observed above the WWTP outfall, whereas
this was not the case for all pesticides.
2.3.2 Presenceof awastewaterplumewith elevatedmicropollutant concentrations
The presence of efﬂuent wastewater discharged into the lake was evident from conductivity
depth proﬁles taken above the wastewater discharge point. During the warmer months,
elevated conductivities (a common indirect plume tracer126), arising from high ion concentra-
tions (e.g., Na+, Cl-) in wastewater (see Figure A.1, Appendix A ) could be observed at variable
depth in the water column, indicating the presence of a wastewater plume. Corresponding
water samples taken within this plume exhibited elevated concentrations of a large fraction of
the targeted micropollutants.
In these samples, pharmaceutical concentrations were up to 70-fold higher than those
detected in the surrounding water column (Figure 2.3 a). Such micropollutant hotspots
were consistently observed during the warmer seasons for substances entering the bay with
efﬂuent wastewater (i.e. most pharmaceuticals, as well as corrosion inhibitors), whereas no
such feature was detected for most pesticides (Figure 2.3 d,e). The absence of a pesticide
plume conﬁrms that these substances mainly enter the Bay through runoff from land or with
streams, but not via the WWTP outlet.
The wastewater plume and associated elevated micropollutant concentrations was initially
detected at a depth of -10 m during the April sampling campaign. The plume depth decreased
over the following months and ﬁnally was detected near the lake bottom at -25 m in October,
as shown by the conductivity proﬁles in Figure 2.4. The formation and depth of these
micropollutant hotspots can be explained by thermal lake stratiﬁcation which occurs during
the warmer months when the upper water layer is heated by the sun, leaving colder, denser
water below. Stratiﬁcation inhibits vertical transport from the lake bottom to the surface.
Discharged wastewater, characterized by a speciﬁc temperature and conductivity, will stabilize
at a level where its density corresponds to that of the surrounding water column.
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Figure 2.2: Detected concentration ranges of micropollutants in the water column above WWTP outfall
(above) and at the reference points (below). Boxes represent 25th percentile, median and 75th percentile.
The whiskers are determined by the 5th and 95th percentiles. Stars, upward-, and downward-facing
triangles show the mean, maximum andminimum values, respectively.
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Under stratiﬁed conditions, wastewater generally rose through the water column, but its
density did not allow it to mix with the less dense, warmer water masses above the thermocline.
The wastewater thus accumulated below the warmer upper layer, creating the micropollutant
hotspots (plume) detected from April to October.
During the cold season, the temperature proﬁles straightened (Figure 2.4), and allowed
mixing of the water column. Explicitly, this phenomenon caused the disappearance of
the micropollutant hotspots above the WWTP outfall, and led to a homogeneous vertical
concentration proﬁle for all of the targeted substances. In November, the density of the
unstratiﬁed water column appeared to be slightly higher than that of wastewater, allowing
wastewater to rise and form a diluted, yet measurable concentration peak between -3 and
-5 m (Figure 2.3 c).
Carvalho et al.128 reported similar plume dynamics using dye tracers added to wastewater.
Under stratiﬁed conditions the plume was trapped below the thermocline with low dilution by
surrounding water (35-fold), yet when unstratiﬁed, the plume surfaced and the dilution
increased (100-fold). The thermocline barrier effect was also observed in Vidy Bay in a
previous phage tracer study, when bacteriophages injected at -30 m depth only surfaced
under unstratiﬁed conditions131.
In the present study, the measured dilutions of micropollutants from the wastewater efﬂuent
to the plume increased from 20-fold during thermal stratiﬁcation up to 100-fold under
homogenous water column conditions. Seasonal comparisons of plume concentrations
are difﬁcult to make because it was not known if the minimal dilution was captured on each
sampling occasion. Several authors have acknowledged the challenge of plume tracing given
the highly complex and patchy structure of plumes131,132.
The full horizontal extent of the plume remains unknown, but past and present data provide
evidence that the wastewater plume is not merely a local issue above the WWTP outfall. On
one occasion, during the April sampling campaign, the plume was detected as far as the
reference point 1.5 km downstream of the WWTP discharge (Figure A.3, Appendix A). Though
such a large spreading was not observed in any of the following campaigns, previous research
in the Vidy Bay also veriﬁed a similar horizontal extension. Tracer-phages added to the WWTP
outfall were detected up to 1.8 km away131. More recent ﬁeld studies in the Bay (summer
2010) also noted higher conductivity values above the WWTP outfall, with a patchy, horizontal
extension of at least 400 m in all directions (Matthieu Masson, personal communication).
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Figure 2.3: Conductivity, temperature and concentration proﬁles of a selection of pharmaceuticals
(a,b,c) and non-pharmaceuticals (d,e,f) relative to the concentration detected at the bottom. Shown
proﬁles were taken above the WWTP outfall in May (a,d), August (b,e) and November (c,f)
2010. EC:electrical conductivity, T:temperature, Atn:atenolol, Cbz:carbamazepin, Cip:ciproﬂoxacin,
Dfc:diclofenac, Gbp:gabapentin, Met:metoprolol, Nor:norﬂoxacin, Par:paracetamol, Sot:sotalol,
Smx:sulfamethoxazol, Tri:trimetoprim, Atr:atrazin, Ben:benzotriazol, Car:carbendazim, Irg:irgarol,
Iso:isoproturon, Mec:mecoprop, Mbz:methylbenzotriazol, Pro: propiconazol, Ter: terbutryn.
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Figure 2.4: Chronology of temperature and electrical conductivity proﬁles above theWWTP outfall. Peaks
in conductivity indicate the location and depth of the wastewater plume. Round symbols indicate depth
at which highest concentrations (plume) of micropollutants were detected in the water sample proﬁle.
Conductivity proﬁles coincide with the sampling cast, whereas temperature proﬁles were taken in the
surrounding water column.
2.3.3 Conductivity as an indicator for elevated micropollutant concentrations
Micropollutant hotspots could be identiﬁed by elevated conductivities. Further analyses
showed that there exists a linear correlation between conductivity and the concentrations of
wastewater-derived micropollutants in the plume, with correlation coefﬁcients generally > 0.8
(Figure 2.5, blue bars). Given this strong correlation, it will be possible in the future to track the
plume and estimate its wastewater-derived micropollutant concentrations using conductivity
measurements alone. Pesticides, in contrast, exhibited a different trend, with insigniﬁcant
or low correlation coefﬁcients (between 0.2 and 0.6) (Figure 2.5, green bars), conﬁrming the
notion that their main input into the Vidy Bay is not associated with the WWTP efﬂuent.
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Some noteworthy exceptions to the observed trends (Figure 2.5, orange bars) include the
anti-epileptic carbamazepin, which is known to be highly recalcitrant during wastewater
treatment and has frequently been detected in wastewater efﬂuent28. The poorly discernable
plume peak (Figure 2.3 a,b), combined with the markedly lower correlation with conductivity
(R=0.68), indicate that this pharmaceutical shows pesticide-like input trends. Carbamazepin
is produced by several pharmaceutical industries in the Rhône Valley that discharge their
efﬂuents to the main tributary of Lake Geneva, the Rhône River. This induces a non-negligible
source of carbamazepin into the lake. In fact, it has been estimated that >90% of carbamazepin
in Lake Geneva is of industrial origin (Nathalie Chèvre, personal communication). Periodically
high carbamazepin concentrations (1 μg·L−1) have been observed in the Rhône River shortly
before it reaches Lake Geneva133. Therefore, background carbamazepin concentrations are
high enough to dominate the concentrations above the WWTP outfall.
The contrary was observed for two corrosion inhibitors and the fungicide carbendazim,
which show the plume feature, similar to pharmaceuticals. Yet, this ﬁnding is in agreement
with past research. The corrosion inhibitors benzotriazol and methylbenzotriazol are widely
used in dish-washing detergents and have frequently been detected in WWTP efﬂuent123.
Carbendazim is applied for ﬁlm preservation in paints and facade coatings, and considerable
input of carbendazim to the aquatic environment through wastewater was observed in
several Swiss rivers. Constant inﬂuent loads, rather than peaks during rain events from
leaching facades, led to the hypothesis of an additional unknown source of carbendazim from
households134.
The pesticide mecoprop shows, as expected, no strong linear relation to conductivity (R=0.28)
yet a small plume peak can be observed (Figure 2.3 d,e). Considered a classic urban pesticide9,
which is used as a herbicide on lawns and roadsides and as a protection agent for roofs,
mecoprop may be washed out from these sources and directly enter the Bay via runoff, or
leach to the sewage system and enter the Bay via the WWTP outfall. This dual source may lead
to a reduced linear correlation, while maintaining a measurable peak in the plume.
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Figure 2.5: Above: relation between electrical conductivity (EC) and concentration, computed for
EC values above background levels for the antiepileptic gabapentin (left) and the pesticide atrazin
(right). R=correlation coefﬁcient. Below: Correlation coefﬁcient between EC and concentration for all
micropollutants. Blue: pharmaceuticals, orange: exceptions (see text), green: pesticides.
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2.3.4 Dilution and degradation of WWTP-derived micropollutants throughout
the Vidy Bay
To determine the inﬂuence of the micropollutant plume on the overall water quality of
the Vidy Bay, the spatial variations of micropollutant concentrations were examined. The
concentrations measured above the WWTP outfall were compared to those detected at the
reference points by means of a percentile analysis, in which uncharacteristic compounds,
namely carbamazepin, benzotriazol, methylbenzotriazol and carbendazim, were removed for
the analysis (Figure A.2, Appendix A). For all targeted pharmaceuticals except carbamazepin,
the maximal concentrations in the Vidy Bay were observed above the WWTP discharge point.
In contrast, as expected given their diffuse input, the observed concentrations of pesticides at
WWTP and the reference points were similar.
Changes in concentrations with distance from the WWTP were particularly evident for
antibiotics norﬂoxacin and oﬂoxacin, which were rarely detected at the reference points.
Similarly, 75% of all concentrations of azithromycin and ciproﬂoxacin (antibiotics), diclofenac
and paracetamol (anti-inﬂammatories) detected at the reference points were below the
median values detected above the WWTP outfall. This difference was less perceptible in winter
(November-January), which may be explained by enhanced mixing of the water masses due to
stronger winds and the absence of stratiﬁcation during this period. Other pharmaceuticals,
such as gabapentin, primidon, sulfamethoxazol or trimetoprim showed smaller differences
between sampling locations.
The observed decrease in micropollutant concentrations with distance from the WWTP
discharge point can arise from both dilution and degradation processes. To assess the extent
of micropollutant degradation occurring in the Vidy Bay, concentrations of all compounds at
a given location and depth were normalized to the gabapentine concentration at this location,
to remove the effect of dilution. Gabapentine hereby served as a conservative tracer, owing to
its persistence in WWTPs and surface waters24,135. Given that dilution affects all compounds
equally, and assuming generally constant ratios of the targeted compounds to gabapentine in
efﬂuent wastewater, this normalization eliminates the effect of dilution, and differences in
normalized concentrations therefore indicate degradation processes or additional sources of
the compound in question.
Normalized concentrations of the majority of pharmaceuticals showed a gradual decrease
from the WWTP pipeline, to the plume and ﬁnally to the reference points (average value over
entire water column). This indicates the occurrence of natural elimination processes during
the passage of water through the Vidy Bay (Figure 2.6). The extent of degradation was variable,
but typically ranged from 40 to > 90% between the WWTP efﬂuent and the average water
column concentration at the reference points.
Paracetamol, which is well-known to readily biodegrade, showed the greatest decrease from
efﬂuent wastewater to the reference point. An important removal was also observed for
atenolol, bezaﬁbrat and norﬂoxacin.
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Figure 2.6: Degradation of a representative selection of micropollutants (fromWWTP efﬂuent, to plume,
surface above WWTP outfall and reference points up-and downstream). Detected concentrations are
normalized by gabapentine and are shown relative to the concentration in the WWTP efﬂuent (for better
comparison between compounds).
In contrast, less degradation occurred for the antibiotics sulfamethoxazol and trimetoprim,
which is consistent with the small concentration differences observed between sampling
locations and seasons. Moreover, these observations are in agreement with previous work
reporting the conservative nature of sulfamethoxazol and trimetoprim in surface waters127.
As the compounds investigated are known to neither hydrolyze, adsorb to particles, nor —
with the exception of paracetamol – biodegrade very readily2, the observed elimination
can tentatively be attributed to photodegradation processes. Photodegradation as the
main elimination mechanism is also consistent with the ﬁnding that the decrease in
the concentrations of wastewater-derived compounds between the WWTP efﬂuent and
the reference points was greatest in the summer and smallest during winter (Figure A.2,
Appendix A). The temporal variations of the ratio of photodegradation products to parent
compound would be the best conﬁrmation of this hypothesis. However, the identiﬁcation and
environmental detection of products of photolysis goes beyond the scope of the present study,
but will be addressed in future work.
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Non-wastewater-derived substances, mainly pesticides and carbamazepine, showed the
opposite behavior, with a gradual increase of normalized concentration from the efﬂuent to
the reference points. Once more, this supports the assumption that the Lausanne WWTP does
not represent the main source of pesticides and carbamazepin to the Vidy Bay.
2.3.5 Environmental signiﬁcance
The wind regimes in the Vidy Bay lead to a predominantly circular current that retains both
water and sediments within the Bay136. Coupled with the constant input of wastewater into
the relatively shallow bay, this situation raises concerns regarding the ecotoxicological hazards
associated with wastewater-derived micropollutants. Despite variable weather and wind
conditions and changing seasons throughout the sampling campaign, a wastewater plume
was consistently observed above the WWTP discharge point from April to October. The high
concentrations of pharmaceuticals detected in the wastewater plume, along with the plume’s
extension over several hundred meters, may present a risk to the ecosystem. An individual
risk (RQ>1) was observed for several pharmaceuticals in the plume, namely the antibiotics
azithromycin, ciproﬂoxacin and sulfamethoxazol (Figure 2.7) and the pesticide irgarol.
Figure 2.7: Time course of risk quotient (RQ) for azithromycin, ciproﬂoxacin, and sulfamethoxazol for
concentrations detected in the plume (left) and average water column concentrations detected at REF
down (right). RQ>1 (red line) indicates a potential ecotoxicological risk.
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RQ of ciproﬂoxacin remained critical for the greater part of the campaign, whereas the critical
RQ was surpassed only in May, June and August for azithromycin and sulfamethoxazol.
However, it is uncertain that the minimal dilution of the plume was captured on any occasion
by the water samples, thus the RQ may have been exceeded for these compounds during the
other months as well. Of the remaining compounds, diclofenac, carbendazim, propranolol
and terbutryn consistently came within an order of magnitude of an RQ of 1 (Figure A.4,
Appendix A).
Average monthly concentrations detected at the reference point 1.5 km downstream of WWTP
outlet were always lower than recommended WQC, except for the pesticide irgarol, which
exceeded the RQ on ﬁve occasions. With the exception of this compound, the ecotoxicological
risk posed by micropollutants in the Vidy Bay can be considered acceptable, except in the
vicinity of the WWTP outlet. However, this localized risk should not be neglected, in particular
owing to the unknown extent of spreading of efﬂuent wastewater around the outlet. Moreover,
though many substances have an RQ <1, the effect of mixtures of substances with a similar
mode of action is not considered in the individual RQ. However, assessing the risk of mixtures,
especially in the case of substances with very different mechanism of action goes beyond the
scope of this study and will be the matter of a future publication.
Overall, the presence of micropollutant plumes and associated ecotoxicological risks should
be considered when discharging wastewater directly into lakes. However, further research is
needed to depict a more accurate picture of the spatio-temporal evolution of the wastewater
plume, and to better assess the ecotoxicological risk posed by the micropollutant mixture.
In the case of the Lausanne WWTP, current pilot projects are testing advanced wastewater
treatment to further decrease the discharged micropollutant load in the near future.
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3 Micropollutant dynamics in Vidy Bay-
coupled hydrodynamic-photolysis model to
assess the spatial extent of ecotoxicological
risk
3.1 Introduction
The direct discharge of wastewater efﬂuent into the Vidy Bay of Lake Geneva results in the
seasonal formation of an efﬂuent plume, presenting locally high concentrations of wastewater-
derived micropollutants. A 10-month sampling campaign showed that the plume depth
followed the thermocline, which moved to deeper depths over the course of the seasons. In
absence of thermal stratiﬁcation, between November and January, the plume surfaced or was
not detected due to enhanced mixing of the water column. The locally elevated concentrations
of micropollutants near the wastewater (WW) outfall present a potential ecotoxicological risk.
Although the high concentrations of micropollutants were observed as far as 1.5 km from the
outfall on one occasion, the spatial extent of this risk zone remains unclear. Nevertheless,
a sampling approach to determine the risk zone represents a costly, tedious and unrealistic
task. In this sense, models are increasingly used in the ﬁeld of environmental risk assessment
of organic micropollutants to overcome the limitations of sampling or to augment punctual
environmental measurements.
In Vidy Bay, factors that contribute to the dispersion of the wastewater-derived micropollutant
plume and the associated risk zone are multiple. On the one hand physical mixing
processes contribute to dilution of micropollutants by surrounding water masses and are
largely inﬂuenced by the hydrodynamics of currents in the Bay. On the other, biotic and
abiotic degradation and removal processes will affect the fate micropollutants and their
concentrations within the Bay.
The hydrodynamics of water masses in Vidy Bay have been the object of a recent study
investigating the effect of dominant meteorological conditions on the currents in the Bay137.
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In this study water ﬂow in Lake Geneva was modeled using a 3D ﬁnite-difference hydrody-
namic model (Delft3D-FLOW), forced by high resolution meteorological data (COSMO-2). The
simulations revealed that the main currents in the Bay were highly affected by overlying wind
conditions and were generally parallel to shore (eastward and westward) above the wastewater
outfall. Moreover, certain wind conditions were found to result in the formation of a gyre.
Such circular currents retaining water and sediments within the Bay have also been reported
previously136.
Aside from dilution, several mechanisms, such as photolysis, biodegradation or sorption
may inﬂuence the concentration of micropollutants in water. The compounds of interest
for this study were selected in part due to their low removal efﬁciencies during wastewater
treatment; accordingly, these compounds are likely not very susceptible to biodegradation
and/or sorption to settling particles31,75,78. Therefore, photodegradation is expected to be
their main elimination mechanism in surface waters. This assumption is consistent with
a number of studies, which acknowledge the importance of direct and indirect photolysis
processes for micropollutants in various aquatic environments74–76.
Both lake hydrodynamics and photolysis processes are highly affected by season. Warm
summer temperatures induce thermal lake stratiﬁcation, preventing mixing of the top and
bottom layers of the water column. In addition, the increased solar irradiance leads to faster
photolysis kinetics in the summer19. Conversely, during the cold season, solar irradiance is
reduced, but homogeneous temperature proﬁles lead to enhanced mixing throughout the
entire water column.
A number of models integrating both physical mixing processes and degradation mechanisms
have been developed to determine the fate of micropollutants in aquatic environments.
Commonly applied models include river catchment models (GREAT-ER or PhATE™) and
2D lake models (e.g. AQUASIM). A number of studies report the use of such models which
incorporate photodegradation kinetics to predict concentrations of pharmaceuticals in rivers
and lakes116,117,138,139, but none relate 3D dynamics with depth-dependent processes in lakes.
In hydrodynamics, particle tracking is often used for plume studies as it is designed to describe
the detailed spatial pattern of water parcels ("particles") over the mid-ﬁeld range (<15 km).
Hence, particle-tracking represented the ideal method to combine 3D plume spreading and
depth-dependent photolysis processes.
This work aims to couple water hydrodynamics and photodegradation of micropollutants in
the vicinity of the efﬂuent wastewater outfall to estimate the concentration of micropollutants
under typical wind scenarios and seasons relevant in Vidy Bay. Speciﬁcally, we determined
the direct and indirect photolysis rate constants for 24 wastewater-derived micropollutants,
and implemented this data into a hydrodynamic ﬂow model, which tracked the movement
of water parcels from the WW outfall through the Vidy Bay. Modeling results were validated
with monthly ﬁeld data collected in 2010. The ultimate goal of this study was to spatially and
temporally deﬁne the area of potential ecotoxicological risk in Vidy Bay.
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3.2 Material and methods
3.2.1 Site description, water sampling strategy and analysis of micropollutants
The Vidy Bay, lies on the northern shore of LakeGeneva, by the city of Lausanne, and represents
0.3% of the lake’s total volume129. Aside from lake currents, the main input to Vidy Bay is
discharge from Lausanne’s wastewater treatment plant. Between one and three m3·sec−1
of treated wastewater is released 700 m from shore at -30 m depth. Other minor sources
of water to the Bay are the Chamberonne River and the Flon stormwater outlet. Three
locations were sampled on a monthly basis at various depths between April 2010 and January
2011, namely ”WWTP outfall”, directly above the discharge point of efﬂuent wastewater and
two references sites ”REF-up” and ”REF-down”, respectively 1.5 km east and west of the
WWTP outfall sampling site (Figure 3.1). Samples were analyzed within 24 h to determine the
concentrations of 35 micropollutants (pharmaceuticals, pesticides, corrosion inhibitors). Of
these, most pharmaceuticals as well as the corrosion inhibitors were found to be wastewater-
derived, whereas the majority of pesticides entered the lake via diffuse sources. The analysis
proceeded through solid phase extraction followed by detection via ultra-performance liquid
chromatography coupled to a tandem mass spectrometer. Details regarding sampling strategy,
choice of substances, and the analytical method have been described previously24,140.
Figure 3.1: Situation and map of the Vidy Bay showing the sampling locations WWTP outfall (Swiss
coordinates : 534’672/ 151’540), REF-up (Swiss coordinates : 536’000/151’000) and REF down (Swiss
coordinates : 533’048/150’920). Coordinates are in the Swiss Grid system with datum CH1903. Arrows
show the predominant current directions which are generally parallel-to-shore137.
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3.2.2 Particle tracking to model spreading of the plume
The hydrodynamic spreading of the wastewater plume in Vidy Bay was simulated using
a particle tracking model (Delft3D-PART), a module of Delft3D which considers both
advection and dispersion processes. The transport of particles in Delft3D-PART was driven by
current velocity ﬁelds from a 3D ﬁnite-difference hydrodynamic ﬂow model (Delft3D-FLOW),
validated for Lake Geneva137.
Particles tracks were computed for four scenarios, with differing wind and lake stratiﬁcation
conditions. The dominant winds regimes affecting Lake Geneva and more speciﬁcally Vidy
Bay are the ”Bise” (north wind), the ”Vent” (west wind). Thus, the four chosen scenarios
comprise moderate Bise (10◦, 3 m·s−1) and Vent (240◦, 3 m·s−1) both in stratiﬁed (summer)
and unstratiﬁed (winter) conditions. As the particle tracking module does not model the
initial spreading and mixing (near-ﬁeld) of discharged water from an outfall, the dynamics
of release near the outfall were modeled by starting the simulation from a circular plume
with an estimated radius of 10 m for the Vidy Bay outfall situation. The release depth was
chosen to be the depth of the thermocline (14–16 m) for stratiﬁed scenarios and the surface
(0–1 m) for unstratiﬁed conditions, based on ﬁeld observations and theoretical concepts. An
instananeous release of 5’000 particles at the given depth above the WWTP outfall location was
simulated for each scenario. Simulations using 2’000 and 3’000 particles showed no signiﬁcant
differences with release of 5’000 particles. The simulation yields the position (x-y-z(depth)) of
each particle at each timestep (15 min), which was used as the input for the photodegradation
model described below. Details concerning the parameters used for each simulation are
available in the SI and described thoroughly by Razmi et al.141.
The particle tracking model was validated using measured concentrations of conservative
micropollutants (e.g. gabapentine) in the Bay. Explicitly, currents in Lake Geneva were
modelled using 2010 meteorological data using Delft3D-FLOW137. Thereafter, simulations
were computed using Delft3D-PART for ﬁeld sampling days of 2010 and results compared
nicely to actual measured concentrations141.
3.2.3 Photolysis experiments and photodegradation in surface waters
The direct and indirect photolysis kinetics of target micropollutants necessary for the
photodegradation model were determined experimentally under a solar simulator.
Chemicals. The commercial origin of the selected micropollutants has been listed previ-
ously24. Stock solutions were made in HPLC grade methanol. All other solvents used were
of analytical grade quality. All aqueous solutions were made using Nanopure water. Further
chemicals used in the photodegradation experiments were p-nitroanisole (Sigma-Aldrich),
pyridine (Acros), sodium bicarbonate (Fluka) and sodium nitrate (Fluka).
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Direct photolysis experiments. Solutions of a mixture of up to nine micropollutants, with
individual concentrations ranging between 15 and 80 μg·L−1 in 1 mM bicarbonate-buffered
Nanopure water (pH 8.4) were irradiated between 2 and 76 h by a Sun 2000 Solar Simulator
(ABET Technologies, Milford, Connecticut) equipped with a 1000 W Xe lamp and an AM1.5
ﬁlter. The starting concentration of each compound corresponded to 10-times its limit of
detection (LOD). As such, we monitored a 90% decay, while minimizing light screening by the
target compounds. The compounds were grouped into mixtures based on their susceptibility
to direct photolysis determined in preliminary experiments.
The irradiance of the solar simulator was determined spectroradiometrically (Model ILT-900-R,
International Light) before and after each experiment. The absolute irradiance was calibrated
using chemical actinometry (p-nitroanisole (pNA)) and was 76 W·m−2 between 280 and 430
nmand showed no day-to-day variation (lamp spectrum shown in SI, Figure xx). The irradiated
solutions (400 mL) in amber glass beakers were continuously stirred , and their temperature
was maintained at ca. 19◦C using a water-ﬁlled tray, connected to a recirculation cooler (F240
Recirculating Cooler, Julabo). Identical solutions were left in the dark during each experiment
to serve as dark controls. Moreover, mixtures containing double the starting concentration of
each compound (between 30 and 160 μg·L−1) were photolyzed concurrently, to determine if
second-order reactions between compounds in the mixture were contributing to the observed
degradation. At selected time points (minimum 7), 1.2 mL samples were collected to monitor
the parent compound concentration decrease over time. The samples were transferred to
amber glass vials, were maintained at 4◦C after collection and were analyzed within 48 h
by ultra-performance liquid chromatography (Acquity UPLC system, Waters) coupled to a
tandem mass spectrometer (MS/MS, XEVO, Waters). The experiments were repeated three
times. Data acquisition and processing was performed using Masslynx. In parallel, absorbance
spectra for all solutions were collected with a UV-vis 2550 Spectrophotometer (Shimadzu
Scientiﬁc Instruments) at various irradiation time points to assess the change in absorbance
over time and wavelength. Time-averaged values were used to correct for light screening. The
chromatographic conditions and analytical methods were described previously24,140.
Indirect photolysis experiments. To determine the contribution of indirect photolysis, two
sets of experiments were conducted: in the ﬁrst set, micropollutants were irradiated as
described above, but water from Lake Geneva was used as the matrix. These experiments
were used to determine the importance of transient species (e.g., singlet oxygen, triplet state
organic matter) formed during irradiation of this particular lake water. These experiments,
however, contained <0.4% methanol arising from the micropollutant stock solutions. Because
methanol is an efﬁcient hydroxyl radical quencher, the contribution of hydroxyl radicals
to micropollutant degradation could therefore not be assessed. Instead, a second set of
experiments were conducted in 1 mM bicarbonate buffer amended with nitrate (15 mg·L−1)
as a sensitizer for hydroxyl radicals. For these experiments, the compounds were added to the
buffer from stock solutions of the individual compounds prepared in methanol-free Nanopure
water.
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Quantum yield calculations. The degradation of all compounds followed ﬁrst order kinetics
and degradation rate constants (kdirect ,i ) were calculated using the slope of ln(At/A0) plotted
against time, where At refers to the peak area of chromatograms at time t, and A0, the initial
peak area. A light-screening factor was used to account for the fact that in some solutions the
average light intensity in the beaker was lower than in optically dilute solutions, due to self-
screening by the compounds in solution or transformation products forming. The observed
direct photolysis degradation rate constant, kdirect ,i , for each compound i was corrected
to yield a photolysis rate constant representative of an optically dilute system, k0direct ,i . The
direct photolysis quantum yield(Φi ) was determined for each compound (i ). It represents the
efﬁciency of direct photolysis and was calculated as follows:
Φi =
k0direct ,i
k0abs,i
(3.1)
where k0abs,i is the speciﬁc rate of light absorbtion, a measure of the spectral overlap of light
irradiance and compound absorbance.
Details regarding light screening corrections, quantum yield calculations and calibration of
light intensity by chemical actinometry and error calculations are described in Appendix C.
Contribution of indirect photolysis. The reaction rate constant (k0tot ,i ) determined in the
indirect photolysis experiments encompasses both direct and indirect photolysis processes.
The importance of indirect photolysis by reaction with hydroxyl radical (k ′•OH ,i ) generated
through nitrate photolysis was assessed after subtracting the direct photolysis rate constant
from the total observed rate constant. Second order reaction rate constants (k•OH ,i ) between
hydroxyl radical and each target compound were then determined from equation 3.2:
k0tot ,i −k0direct ,i = k ′•OH ,i = [•OH ]ss ·k•OH ,i (3.2)
where [•OH ]ss represents the steady state concentration of OH-radicals in solution. This
quantity was determined from the decay of one of the compounds within the micropollutant
mixtures for which k•OH ,i was known (see Appendix B). The importance of other transient
species was determined analogously by comparing the total degradation rate constants (k0tot ,i )
in the lake water experiment to the direct photolysis rate constant, k0direct ,i , determined in
buffered Nanopure water.
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Extrapolation to environmental conditions. The direct photolysis quantum yields deter-
mined experimentally, Φi , were used to calculate the environmental direct photolysis rate
constants, kenv,direct ,i , for the different scenarios following equation 3.3.
kenv,direct ,i (z) = Φi ·k0abs,sun,i ·SFl ake (z) (3.3)
where k0abs,sun,i is the speciﬁc rate of light absorption of the pollutant under solar irradiation,
a quantity which depends on the substance itself, as well as on the intensity of solar irradiance.
A theoretical solar irradiation was computed (SMARTS), at 47◦N latitude, for the 21st of
June (stratiﬁed scenario) and 21st of December (unstratiﬁed scenario), assuming clear sky
conditions. The reduced photolysis rate due to light absorption by the lake water is accounted
for in the lake water screening factor, SFl ake ,and is a function of depth z. Explicitly, the near-
surface speciﬁc rate of light absorption for a given substance i , can be calculated as follows
over the relevant wavelength absorption range:
k0abs,sun,i = 2.303 ·
λrange∑
280nm
εi (λ) · Isun(λ) (3.4)
εi denotes the decadic molar extinction coefﬁcient for substance i and was determined at
pH 8.3 using a UV-vis 2550 Spectrophotometer (Shimadzu Scientiﬁc Instruments). Isun(λ)
represents the computed solar irradiance for the chosen scenario (summer or winter).
The lake water screening factor for a given depth z is the ratio of the speciﬁc rate of light
absorption at that depth, kzabs,sun,i , and the near-surface speciﬁc rate of light absorption,
k0abs,sun,i :
SFl ake (z) =
kzabs,sun,i
k0abs,sun,i
= Isun(λ) ·εi · (1−10
−z·αD (λ))
Isun(λ) ·εi ·2.303 · z ·αD (λ)
= 1−10
−z·αD (λ)
2.303 · z ·αD (λ)
(3.5)
Where αD (λ) denotes the diffuse attenuation coefﬁcient of lake water. It can be approximated
by19:
αD (λ) = 1.2 ·αl ake (λ) (3.6)
Though wavelength-dependent, it can be approximated by using the value from a single
wavelength where kabs is maximal, which in the case of nitrate and most of the targeted
compounds is near 320 nm. For Lake Geneva water, an average lake water absorbance at
320 nm, αl ake(320 nm), of 0.02 cm
−1 was measured. The absorbance values did not vary
signiﬁcantly over the entire sampling period.
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Indirect photolysis processes are particularly relevant for compounds resistant to direct
photodegradation. The importance of reaction with 1O2 or excited triplet state organic matter
were found negligible for Lake Geneva water (see Results section); therefore the environmental
indirect photolysis rate constant, kenv,indir,i , considers only reaction with hydroxyl radical:
kenv,indir,i (z) = k•OH ,i · [•OH ]ss,l ake ·SFl ake (z) (3.7)
The steady state concentration of hydroxyl radicals in Lake Geneva, [•OH ]ss,l ake , was
calculated based on average measured levels of nitrate (0.029 mM) and scavenging species,
such as HCO−3 , CO
2−
3 and dissolved organic carbon content (see Appendix B). The estimation
of the steady state concentration of hydroxyl radicals extrapolated to 24 h on a sunny day yields
maximal values of 1.7 ·10−17 and 3·10−18 M for the summer and winter scenarios respectively.
The SF in equation 3.7 accounts for the reduction in hydroxyl radical production with depth,
as less light becomes available for the photolysis of nitrate. Finally, the total environmental
photolysis rate constant for each pollutant (assuming midday irradiance) can be written as:
knoonenv,tot ,i (z) = kenv,direct ,i (z)+kenv,indir,i (z) (3.8)
The midday rate constant can be extrapolated to the average irradiance over 24 hours by a
factor of 0.419:
k24henv,tot ,i (z) = 0.4 ·knoonenv,tot ,i (z) (3.9)
The photolysis component of the proposed model is based on well-acknowledged theoretical
concepts. The equations above have been derived previously and more details are given in
Schwarzenbach et al.19.
The photodegradation equations used herein have been repeatedly applied for simple
estimation of photodegradation half-lives of micropollutants in water (e.g.74,82), in ”back
of the envelope”-type calculations, to assess the importance of photolysis compared to other
removal mechanisms117, and in more complex models which modeled photolysis rates
in rivers as a function of the distance of single ”particles” from the surface116. Moreover,
several studies compared predicted environmental direct photolysis rate constants (calculated
from laboratory-determined quantum yields (i.e. equation 3.3 above)) to experimental
rate constants (measured in natural sunlight) and found similar results for a variety of
compounds82,138
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3.2.4 Mixture toxicity assessment
Recent work revealed a potential ecotoxicological risk for individual micropollutants above
the outfall140. The individual risk of pollutants is commonly estimated using the risk quotient
(RQ), which is the ratio of the measured or predicted environmental concentration (MEC
or PEC) to the predicted no effect concentration (PNEC)70. A potential risk exists when RQ
surpasses one. The PNEC-values of the selected micropollutants were compiled previously140.
RQi =
PECi
PNECi
(3.10)
In the aquatic environment, all substances are present contiguously, thus a realistic
ecotoxicological risk assessment should consider the effect of all chemicals present. Latest
research recommends applying a concentration addition (CA) model as a conservative worst
case estimation of mixture toxicity69,70. Explicitly, the risk of a chemical mixture, RQm , is the
sum of the RQ of each substance present in the mixture, RQi (equation 3.10):
RQm =
∑
i
RQi (3.11)
Though the CA model by deﬁnition assumes all substances exhibit a similar mode of action,
which is often unveriﬁed in environmentally realistic mixtures70, it is nevertheless suggested
for a precautious risk assessment, and has been proven to provide excellent predictions of
mixture toxicities71,72.
3.2.5 Coupling photodegradation and hydrodynamics
The spatial distribution of environmental concentrations near the outfall was estimated by
combining particle tracking (section 3.2.2) and photolysis kinetics (section 3.2.3). Themodeled
area of the Bay (4 km by 3 km, starting at the north-eastern coordinate 532’600/152’450, Swiss
coordinate system) was discretized into a 50-by-50 m grid, over layers of 2 m depth. The
hydrodynamic model yielded the 3D position pn,t , j of each parcel of water n (total of 5’000
parcels (”particles”) released), for each timestep t (15 min intervals=Δ(t))), up to 3 days
following the time of release.
pn,t , j = j th component of the position for particle n at time t (3.12)
with j = 1: x coordinate, j = 2: y coordinate and j = 3: depth z (in m)
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The number of particles in each cell of the grid (x, y,z) at each timestep t is then given by:
Nx,y,z,t =
∑
n
δpn,t ,1,x ·δpn,t ,2,y ·δpn,t ,3,z with x = 1,2, ...,300 (3.13)
z = 1,2, ...,25
y = 1,2, ...,200
and with δ the Kronecker delta : δα,β =
⎧⎨
⎩
1 if α = β,
0 if α = β.
(3.14)
Thereafter, the concentration of each substance in every cell of the grid was determined
separately, for each timestep. To do so, all n particles were attributed a hypothetical mass
Mi0 at the time of release (t = 0). Mi0 is compound-dependent, and chosen such that the sum
of all particle masses in the release volume match the concentration of a given compound
(i ) that was actually observed during the 2010 sampling campaign (i.e. the concentrations
measured in the surface plume in November 2010 were used for the unstratiﬁed scenario and
those detected in June 2010 for the stratiﬁed scenario). Assuming no degradation, the mass of
each particle is constant in time, and the concentration of compound i in a given cell (x, y,z)
at a speciﬁc timepoint t is given by:
Cconser vati ve,ix,y,z,t =
Nx,y,z,t ·Mi0
V
(3.15)
where V is the cell volume (50 × 50 × 2 m). In this conservative case, only dilution due to
currents affects the concentration in each cell of the modelled area.
However, most compounds being susceptible to photodegradation, each of the 5’000 particles
released undergoes a depth-dependent degradation. Hence, the mass of each particle evolves
over time according to its relative distance from the surface, following a 1st order degradation:
Min,t = Mi0 ·e
−Δt ·
t−1∑
t˜=0
ki
n,t˜
(3.16)
with Δt = 15 min, and ki
n,t˜
the depth-dependent degradation rate constant of particle n for
a given micropollutant i . ki
n,t˜
was calulated according to equation 3.9 and is a function of
the propensity of compound i to undergo photolysis, the incoming irradiance, Isun (summer
or winter), and the depth. Due to the ﬁnite resolution, we used the average depth between
timesteps (pn,t˜ ,3+pn,t˜−1,3/2):
kin,t˜ = f (i ,pn,t˜ ,3,pn,t˜−1,3, Isun) (3.17)
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When both dilution and photolysis processes are considered, the concentration of compound
i in a given cell at time t is:
Cphoto,ix,y,z,t =
∑
n
δpn,t ,1,x ·δpn,t ,2,y ·δpn,t ,3,z ·Min,t
V
(3.18)
Finally, to reﬂect the actual conditions of efﬂuent WW discharge in Vidy Bay, which is
continuous and not instantaneous, a continuous release situation was mimicked by addition
of the concentrations in each cell over all timesteps, until reaching steady state conditions.
Accordingly the steady state predicted environmental concentration (PEC) in a given cell
assuming only dilution processes (cloudy skies) is given by:
PECconser vati ve,i ,ssx,y,z =
∑
t
Cconser vati ve,ix,y,z,t (3.19)
When both dilution and photodegradation are occurring, the predicted environmental
concentration becomes:
PECphoto,i ,ssx,y,z =
∑
t
Cphoto,ix,y,z,t (3.20)
Ultimately, the ecotoxicological risk of the plume was calculated following equation 3.11, con-
sidering 24 wastewater-derived substances and the predicted environmental concentrations
from the coupled hydrodynamic-photolysis model. All computations were performed using
Matlab R2011b.
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3.3 Results and discussion
3.3.1 Photolysis experiments
The direct photolysis rate constants measured under the solar simulator, corresponding
quantum yields and calculated environmental half-lives are listed in Table 3.1. The data span
a wide range of values, from the photolabile substances such as ketoprofen and diclofenac
with direct photolysis rate constants between 0.4 and 9 h−1, to the compounds which were
more recalcitrant to direct photodegradation, with rate constants on the order of 0–0.1 h−1.
The calculated quantum yields also spanned a large range from 1.4·10−4 to 0.75. The quantum
yields determined in the present study were compared to literature values (often single-
wavelength Φ), when available. The values obtained herein compared relatively well to
literature, with values between 1.1 and 9 times those reported in previous studies.
The total photolysis rate constants determined in the experiments conducted in Lake Geneva
water showed no signiﬁcant difference with experiments buffered Nanopure water(k0tot ,i were
within 20% of k0direct ,i ). This indicates that indirect processes via triplet state organic matter
or singlet oxygen are negligible for this particular lake water. Note that these experiments
contained methanol from the compound stock solution, hence hydroxyl radical reactions
were suppressed. On the other hand, for a large number of compounds signiﬁcantly faster
degradation was observed in experiments (without traces of methanol) amended with 15
mg·L−1 nitrate, a hydroxyl radical sensitizer. These radicals being very reactive and non-
selective, they are known to react with many organic compounds at nearly diffusion controlled
rates104,105. Accordingly, the bimolecular rate constants with hydroxyl radical determined
in the present study or from literature vary from 1–22·109 M−1·s−1 (Table 3.1). Though the
actual nitrate levels in Lake Geneva are typically well below the experimental concentrations
(ca. 1-2.5 mg·L−1 142), hydroxyl radicals nevertheless play an important role in the overall
degradation of a number of compounds (see ”contribution of indirect to total photolysis” in
Table 3.1) , namely those that are not susceptible to direct photolysis.
Based on their environmental half-lives, calculated according to equations 3.8 and 3.9, the
targeted wastewater-derived micropollutants were classiﬁed in 4 groups; 5 degraded very
rapidly (τsummer < 1h) in near-surface, summer conditions, 5 degraded fast (τsummer < 1 day),
2 fall into the moderately persistent category (1 day < τsummer < 50 days), and the remainder
(12 compounds) were classiﬁed as persistent (τsummer > 50 days ). Note that all compounds
relying mainly on indirect phototransformation processes (contribution of indirect to total
photolysis > 70 %) fall in the persistent category, indicating that for the compounds targeted
in this study, direct photolysis still represents the most efﬁcient removal process for the given
lake parameters.
Diclofenac, sulfamethoxazole and gabapentine were chosen as representative compounds
for the ”very fast”, ”fast” and ”persistent” categories. They will be considered below for the
analysis of the spatial extent of elevated concentrations around the wastewater outfall.
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3.3.2 Predicted plume extension for representative compounds
During the colder months when the lake temperature is homogeneous throughout the water
column, the warmer wastewater discharged at -30 m depth rises through the colder, denser
water to the lake surface. Figure 3.2 shows the subsequent distribution and attenuation of
diclofenac, sulfamethoxazole and gabapentine in the surface water (0–2 m depth) surrounding
the wastewater outfall. In order to show the area impacted by discharged WW containing
elevated concentrations of micropollutants, the individual concentration plumes are shown
down to 0.5 ng·L−1, regardless of background concentrations measured in the lake. Values
measured in the surface plume in November 2010 were used as the concentration at the outfall
(after initial near-ﬁeld mixing of the plume)140. Two weather conditions were distinguished:
the left column illustrates the predicted concentrations based on only dilution by lake currents.
This situation represents the plume dynamics on a cloudy day. In the right column, both
dilution and photodegradation are considered, representing a sunny day (averaged over
24 h). If only dilution is considered, the area impacted by efﬂuent wastewater varies from
compound to compound, due to the different initial concentrations at the source. Among
the compounds considered, gabapentin shows the largest area of elevated concentrations,
followed by diclofenac. If photolysis is taken into account, however, the spatial extent of the
diclofenac plume is signiﬁcantly reduced. On the other hand, photolysis only slightly reduces
the area of the sulfamethoxazole plume. Though this antibiotic degrades rather fast at the
water surface in summer sunlight, the estimated winter half-life is over 80 h (Table 3.1). As the
timescale of dilution (ca. 12 h travel time until reaching concentrations <1 ng·L−1, see Figure
B.1, Appendix B) is considerably smaller than that of photolysis processes, only little reduction
of the concentration due to photolysis is observable in Figure 3.2. Finally, gabapentine, owing
to its persistent nature, relies exclusively on dilution for the attenuation of its concentration.
The presence of sunlight therefore does not inﬂuence the extent of its plume.
3.3.3 Predicted extent of the diclofenac-plume near the WW outfall for different
wind and stratiﬁcation scenarios
Given the important inﬂuence of sunlight on the spatial extent of diclofenac discharged from
the WWTP, the footprint of the diclofenac plume was considered for each scenario (Bise and
Vent; stratiﬁed and well-mixed) and weather condition (cloudy (only dilution) and sunny
(dilution and photolysis)). In sunny weather conditions (Figure 3.3, right panel), results from
the coupled hydrodynamic-photolysis model showed a larger extension of the diclofenac
plume in stratiﬁed conditions compared to mixed ones, owing to decreased photodegradation
due to entrapment of the WW plume below the thermocline. The largest extent of the plume
under stratiﬁed conditions was observed for the Bise scenario (Figure 3.3 d). The smaller
extent of the plume in the stratiﬁed-Vent scenarios can be attributed to the stronger dilution
of particles, which are pushed against the shore, experience a return ﬂow along the lake bed
and are thus distributed to deeper depths compared to the Bise conditions137 (Figure 3.4 (F)
and Figure B.2 in Appendix B )
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Figure 3.2: Predicted concentrations in the surface layer (0–2 m depth) of diclofenac (top),
sulfamethoxazole (middle) and gabapentine (bottom) around the wastewater outfall, assuming a small
surface plume in unstratiﬁed conditions, under the inﬂuence of Bise (arrow shows wind direction). The
concentrations are shown down to 0.5 ng·L−1, under cloudy (only dilution, left panel) and sunny weather
conditions (dilution & photolysis, right panel). The size of the sun differentiates winter (small sun) and
summer (large sun) irradiance. Axes show the latitudinal and longitudinal coordinates (Swiss Grid
system with datum CH1903).
In the absence of sunlight (Figure 3.3, left panel) similar plume extensions were observed
for stratiﬁed and unstratiﬁed conditions when the Bise is blowing (ca. 1 km). However,
the largest plume extension of all weather conditions (sunny vs cloudy) and scenarios was
observed for the combination of an unstratiﬁed lake and Vent. This may be explained by
higher current velocities under these conditions. Indeed, the magnitude of currents induced
by friction between air and underlying water is proportional to the the maximal distance an
air mass travels across a lake, the fetch. The long fetch associated with Vent (20 km) leads
to the formation of large gyres in the lake, which in turn generate high along-shore current
velocities and in consequence a higher dispersion of the plume when it is at the surface. In
contrast, owing to land topography and wind direction, the fetch of Bise in the Vidy Bay is
understandably smaller. Accordingly, surface current velocities and plume dispersion are
smaller as well.
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Figure 3.3: Predicted concentrations of diclofenac around the WW outfall for different scenarios. a)
Vent-unstratiﬁed b) Vent-stratiﬁed c) Bise-unstratiﬁed d) Bise-stratiﬁed, under cloudy (only dilution,
left panel) and sunny (dilution & photodegradation, right panel) weather conditions. Depth proﬁles
are given in Figure 3.4 for the blue crosses and the reference points (green dots). Arrows indicate the
wind direction. Maps show the layer of particle release: 0–2 m in unstratiﬁed conditions and 14–16 m in
stratiﬁed conditions. Axes show the latitudinal and longitudinal coordinates (Swiss Grid system with
datum CH1903).
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Figure 3.4: Modeled concentration depth proﬁles for diclofenac under unstratiﬁed Vent (top), and
stratiﬁed Vent (bottom) for the locations A-F marked by blue crosses in Figure 3.3.
The previous ﬁgures delineate the WW plume assuming pristine surrounding waters (microp-
ollutant concentrations <0.5 ng·L−1). However, actual measured background concentrations
of diclofenac in the lake are approximately 1.5 ng·L−1 140.
The actual spatial extent of the zone with concentration greater than the background
concentration is depicted in ﬁgure 3.5 for the case of diclofenac. Similar extents were
predicted for other wastewater-derived micropollutants. The maximal extension observed
under stratiﬁed Bise conditions extends 300 m away from the outfall. In contrast, in
unstratiﬁed conditions, the footprint of the wastewater plume is barely discernible from
the background concentrations, owing to the enhanced near-ﬁeld mixing of up-welling
wastewater. Accordingly, during the cold season the chances of detecting a plume at the
surface are diminished. Indeed, during the 10-month sampling campaign, a surface plume
was detected only on one occasion, whereas it was regularly detected when the lake was
stratiﬁed.
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Figure 3.5: Spatial extent of the diclofenac concentration which exceeds the lake background
concentration (1.5 ng·L−1) for the different wind conditions: Bise (left panel) and Vent (right panel);
and climatic scenarios: well-mixed cloudy conditions (top), well-mixed sunny conditions (middle) and
stratiﬁed sunny conditions (bottom).Axes show the latitudinal and longitudinal coordinates (Swiss Grid
system with datum CH1903)
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3.3.4 Extent of the ecotoxicological risk zone around the WWTP outfall
The ecotoxicological risk exerted the wastewater plume, comprising a entire suite microp-
ollutants, cannot be determined based on the behavior of individual substances alone. For
a realistic ecotoxicological risk assessment, the entirety of micropollutants present in the
mixture, which differ in concentration, susceptibility to photolysis, and ecotoxicological
relevance should be considered.
Herein, the overall ecotoxicological risk of the 24 targeted micropollutants was determined
based on the combination of the individual risk of each substance according to equation
3.11. The zone with RQm >1 was deﬁned as the zone with a potential ecotoxicological risk. It
should be noted, however, that possible mixture effects at low doses, well below the NOEC
(no-observed effect concentration) remain a major ecotoxicological concern151. Furthermore,
inclusion of additional compounds in the study would likely induce an even larger RQm . To
account for these uncertainties, the area with RQm values between 0.1 and 1 is was additionally
deﬁned as a precautionary risk zone for the purpose of this study.
Calibrated with measured concentrations in the plume at the level of the thermocline, a
maximal value of RQm=12.9 was obtained at the WW outfall location. Through dilution and
degradation processes, this extremely high RQ rapidly decreased with distance from the
outfall. Model results showed that the risk zone (red in Figure 3.6) was generally larger under
stratiﬁed (summer) conditions (Figure 3.6 b,d) than under well-mixed (winter) conditions
(Figure 3.6 a,c). The risk zone was largest during stratiﬁed Bise, in the thermocline layer
(Figure 3.6 b). Indeed, for these conditions we predicted a horizontal spread of over 300 m.
The precautionary risk zone was also largest for this scenario, with a westward expansion of >1
km. The area of potential adverse effects was signiﬁcantly smaller in well-mixed conditions.
Under Vent conditions, the zone affected by RQm >1 area was slightly smaller. Nevertheless,
the precautionary risk zone (orange in Figure 3.6) almost matched the Bise extension (ca. 700
m) and extended to deeper depths mainly to the east (upstream) of the WW outfall (Figure
3.7).
The mixture toxicity near the outfall was dominated by ﬁve substances, namely, in order
of the importance of their contribution, the antibiotics ciproﬂoxacin, sulfamethoxazole,
and azithromycin, carbendazim, an urban pesticide and diclofenac, an anti-inﬂammatory
drug. With increasing distance from the source, we observe a shift in the compounds that
dominate the overall risk, owing to photodegradation processes. For instance, in unstratiﬁed
conditions, 1 km from the outfall, sulfamethoxazole, azithromycin and carbendazim still
contributed signiﬁcantly to RQm , but other compounds such as paracetamol, propranolol and
carbamazepine became increasingly relevant.
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Figure 3.6: Delineation of the risk zone (RQm>1, red) and precautionary risk zone (0.1<RQm<1, orange)
for the four scenarios and 2 weather conditions (cloudy: left panel and sunny: right panel) in the layer of
release (0–2 m for unstratiﬁed conditions and 14–16 m for stratiﬁed conditions). a) Vent-unstratiﬁed; b)
Vent-stratifed; c) Bise-unstratiﬁed; d) Bise-stratiﬁed. The size of the sun differentiates winter (small sun)
and summer (large sun) irradiance. Arrows indicate the wind direction and axes show the latitudinal
and longitudinal coordinates (Swiss Grid system with datum CH1903).
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Figure 3.7: 3D extension of the risk quotient for stratiﬁed vent scenario. The highest risk is observed in
the release layer (14–16 m), but the precautionary risk zone extends further at lower depths (20–22 m).
Arrows indicate the wind direction and axes show the latitudinal and longitudinal coordinates (Swiss
Grid system with datum CH1903).
Note that area of potential ecotoxicological risk determined here only accounts for wastewater-
derived micropollutants targeted in this study. However, an entire suite of organic chemicals
have been detected in Lake Geneva, which undoubtedly affect the overall risk. For example,
the additional risk that can be attributed to measured background concentrations of a small
selection of non-wastewater derived substances (i.e pesticides also measured during the 2010
sampling campaign140), adds up to 0.1.
3.3.5 Comparison of measured and predicted concentrations
The coupled hydrodynamic photolysis model predicts the extent of a micropollutant plume
discharged from a point-source. The location of this source was chosen to be not the actual
WW outfall at -30 m depth, but rather the depth to which the plume rises before it spreads.
Under stratiﬁed conditions, this corresponds to the level of the thermocline (14–16 m) and
for the well-mixed, winter scenario to the surface layer (0–2 m). The release of particles
was assumed to be continuous at these depths. In reality, the thermocline depth will vary
slightly on a daily, even hourly basis, along with the WWTP discharge ﬂow. In addition, the
hydrodynamic driving force (wind speed and direction), which was assumed constant for each
of the 4 scenarios, also ﬂuctuates at times on an hourly scale137.
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A recent campaign depicted the near-ﬁeld (<300 m) spatial and temporal variability of the
wastewater plume via dense measurements of conductivity proﬁles around the outfall152.
Results showed that within 100 m of the outfall, the number and depth of elevated conductivity
peaks varied with sampling site around the outfall, but no relation was found with respect
to the distance or direction of the sampling location from the outfall. Moreover, day to
day variations were observed. These results conﬁrm the complex current dynamics within
the Bay, due in part to the variability of the parameters discussed above, and illustrate the
near-ﬁeld heterogeneity of the wastewater plume. Nevertheless, though the wind ﬁeld may
be remarkably variable, Bise and Vent are the two wind directions which occur regularly
over the lake153. Therefore with this model we do not claim to give an exact picture of the
micropollutant plume, yet to depict the worst-case extent of the plume on a larger scale
(mid-ﬁeld) under typical wind conditions and solar irradiation.
Exact validation of the coupled hydrodynamic-photolysis model is delicate due to the lack of
sampling points between the source and the reference points, which were generally beyond
the plume. Nevertheless, the plume was captured on one occasion at REF-down at -10 m
depth, which allowed for the validation of the hydrodynamic component of the model, as
phototransformation processes are not relevant at this depth.
When comparing results of the coupled model with actual measurements, it is important
to note that sampling observations capture both the plume signal as well as background
concentrations. On the other hand, the hydrodynamic-photolysis model assumes the unique
source of micropollutants is above the wastewater outfall at the level of the thermocline (or
the surface). The importance of photolysis processes, seasonality and distance from the
outfall is well depicted in Figure 3.8 which shows the measured concentration ranges in the
near-surface (0–3 m) and near-bottom (17–30 m) layers of the Bay in stratiﬁed (June–August)
and unstratiﬁed (November–January) conditions. Firstly, under stratiﬁed conditions average
concentrations in the surface layers (orange boxes) are generally smaller than below the
thermocline (blue boxes) at both the outfall sampling location and at REF-down. Lower surface
concentrations may be attributed to enhanced photolysis of micropollutants in the surface
layers as well as their entrapment beneath the thermocline. Correspondingly, differences
are more pronounced for compounds that photolyze relatively fast (diclofenac, atenolol and
benzotriazole), than for the persistent compounds (gabapentine). From the model results it is
evident that the large majority of the particles released at the thermocline effectively remain
below the thermal boundary, where photolysis is reduced, leading to increased concentrations
in the summer (Figure 3.4, bottom). On the other hand, under well-mixed conditions, the
measured concentrations did not differ signiﬁcantly in the top and bottom layers of the water
column. This corresponds well to the modeled depth proﬁles (Figure 3.4, top), which show
that background concentrations are rapidly reached under unstratiﬁed conditions.
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Figure 3.8: Range of concentrations measured at WWTP outfall and the reference points during the
2010 sampling campaign in the near-surface (0–3 m, orange box) and near-bottom (17–30 m, blue box)
layers of the Bay in stratiﬁed (June–August) and unstratiﬁed (November–January) conditions. Boxes
represent the 25th percentile, mean and 75th percentile. The whiskers are determined by the 5th and 95th
percentiles.
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3.4 Conclusions
This work illustrates the importance of photolysis as well as the key factors affecting the
fate of organic contaminants in aquatic environments; namely solar irradiance (inﬂuencing
photolysis rates and lake stratiﬁcation), water absorbance (inﬂuencing photolysis kinetics)
and mixing processes (inﬂuencing relative distance of the contaminant from the surface).
These factors were also found crucial in determining the extent of the WW plume in Vidy Bay.
Similarly, past research in UK and US rivers found that direct photolysis signiﬁcantly reduced
the predicted environment concentrations of the beta-blocker propranolol in the water
phase116. The highest reductions were predicted in summer, for long rivers with low turbidity
and low ﬂow conditions. Likewise, direct photolysis was also identiﬁed as the main elimination
process of diclofenac and triclosan in a small Swiss lake117,138. In the latter study, Tixier et
al. successfully matched ﬁeld data with (2D) modeled concentrations in the water column of
the lake. Photolysis was found to take place only in the upmost 50 cm of this particular lake,
where 95% of sunlight is absorbed138.
In the ﬁeld of environmental risk assessment of organic micropollutants, models are
increasingly used to overcome the limitations of sampling or as complimentary information
to augment punctual environmental measurements. The coupled hydrodynamic-photolysis
model allowed for the identiﬁcation of critical scenarios. Simulations show that owing to
the thermal stratiﬁcation, the zone of ecotoxicological risk is largest in summer and extends
horizontally over 300 m from the WW outfall. Finally, modeling the ecotoxicological risk
helped to pin-point priority substances which contribute signiﬁcantly to increasing the zone
of potential adverse effects. Several antibiotics showed an important contribution to the total
ecotoxicological risk. Antibiotics thus exhibit a dual problematic role in the environment: not
only do they cause the well-acknowledged problematic of promoting antibiotic resistance, but
they are also among themost relevant compoundswith respect to detrimental ecotoxicological
effects. Clearly, these are the substances that should be the focus of future monitoring
campaigns and pollution mitigation strategies.
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4 Pharmaceuticals and their human
metabolites in Lake Geneva: occurrence,
fate and ecotoxicological relevance
4.1 Introduction
4.1.1 Micropollutants in the aquatic environment
Over the past two decades, an increasing number of studies have documented the presence
of low concentrations (ng·L−1 range) of various anthropogenic organic substances, or
micropollutants, in surface and groundwaters1,10,14,154,155. Anthropogenic micropollutants
include pharmaceuticals, personal care products, pesticides, xenoestrogens, biocides and
other substances of human origin. These substances can enter the aquatic environment via
runoff from agriculture and urban landscapes, atmospheric deposition, and industrial and
municipal wastewater streams. Despite the abundance of occurrence data, less is known about
the fate of micropollutants once they reach the environment. Main degradation pathways
in surface waters are believed to include photolytic degradation or biodegradation75,156, but
knowledge of the corresponding transformation rates and products is incomplete. Information
is even scarcer regarding the effects that these individual substances or their mixtures exert on
the ecosystem. Some studies report shifts in microbial populations157, feminization of ﬁsh158
or of frogs159. However, much remains to be understood regarding the mechanisms of action
underlying these effects. As such, micropollutants in the environment have emerged as one of
the preeminent research ﬁelds in water quality.
A modiﬁed version of this chapter was published as: F. Bonvin, R. Rutler, N. Chevre and T. Kohn, Archives des
Sciences, vol. 65, 2012
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4.1.2 Micropollutants in Lake Geneva
In Europe, approximately 50 new substances are authorized for use in commercial and
industrial markets every year, adding to the 100’000 of compounds already in use160. Through
point-source and disperse pollution sources, many of these compounds are expected to
enter rivers and lakes. In Lake Geneva, a large selection of micropollutants has effectively
been detected on a regular basis throughout the water column, within the framework of
the International Commission for the Protection of Lake Geneva161–163, as well as in other
studies24,140. The range of detected compounds includes a suite of pesticides and biocides,
several classes of pharmaceuticals, X-ray contrast media, corrosion inhibitors and endocrine
disruptors. Pesticides mainly originated from diffuse sources, such as runoff from land.
The presence of some pharmaceuticals could be related to industrial discharge into the
Rhône River, the main tributary of Lake Geneva. However, most pharmaceuticals, corrosion
inhibitors and selected biocides were found to be associated with wastewater discharge
into the lake. Recent work has shown that during the summer stratiﬁcation period of the
lake, the discharged wastewater does not readily mix with the surrounding water column,
but instead forms a plume of signiﬁcant spatial extent below the thermocline140. Within
this plume, the concentrations of several micropollutants exceeded the predicted no-effect
concentrations (PNEC), indicating a potential ecotoxicological risk to the environment. Thus,
the practice of direct discharge of wastewater into the lake is of particular concern with respect
to ecotoxicological effects of micropollutants.
4.1.3 Pharmaceuticals and their human metabolites
Among the different micropollutant classes detected in Lake Geneva and worldwide, pharma-
ceuticals are of exceptional interest. Because they are designed to fulﬁll a speciﬁc biological
function, they are prone to exert undesired biological effects in the environment. In particular
antibiotics have been a priority, as they may not only exert ecotoxicologial effects, but may
also promote antibiotic resistance in the environment56.
An important route of pharmaceuticals into the environment is the ingestion by humans and
subsequent excretion into the sewage system4. After intake by humans, pharmaceuticals are
metabolized to various extents. Thus, a variable fraction of the active pharmaceutical, along
with its metabolites, is released via urine and feces into raw wastewater. Due to incomplete
removal during wastewater treatment18, many pharmaceuticals are ultimately discharged
into receiving waters. Therefore, centralized sewage treatment plants represent an important
point source for pharmaceuticals and their metabolites into the aquatic environment.
The presence of metabolites in the environment has received little attention to date.
Nevertheless, available data shows that metabolites are present in wastewater efﬂuent in
concentrations comparable to or higher than their parent compound27–31,33,164.
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Leclercq et al. found 2–5 times higher concentrations of themainmetabolite of carbamazepine
(10,11-dihydro-10,11-trans-dihydroxycarbamazepine) in wastewater of three different treat-
ment plants, in addition to other metabolites of this antiepileptic drug25. Hilton reported high
concentrations of N4-acetylsulfamethoxazole, a metabolite of sulfamethoxazole, in treated
sewage26. Human metabolites were not only detected in wastewaters, but also in the receiving
environment, though data remains scarce. Trace concentrations of human metabolites were
found in streams receiving wastewater efﬂuent, in drinking water (the main metabolite of
carbamazepine) and even in bottled water29,30.
Human metabolites of pharmaceuticals are generally more polar and less biologically
active than their parent substance, though some metabolites are known to retain biological
function165,166. Furthermore, human metabolites have been found to back-transform to
the parent substance via both biotic167 and abiotic processes168,169. Human metabolites
could thus present a source of pharmaceuticals to the environment. Finally, despite
their increased polarity, some human metabolites have been found to be more persistent
to typical environmental degradation processes, such as photolysis, compared to their
parent substance168,170. Combined, these arguments make a compelling case that human
metabolites should be included in the study of presence, fate and effects of micropollutants.
The goal of this study was to determine the presence of a selection of human metabolites
in Lake Geneva, to assess their fate with respect to degradation over time and space, and to
evaluate their contribution to the overall ecotoxicological risk. We have focused our work on
the Vidy Bay, as this area was found to exhibit high micropollutant concentrations, likely due
to the discharge of efﬂuent wastewater from the Vidy treatment plant.In the present study, we
focus on the humanmetabolites of a selection of pharmaceuticals. Speciﬁcally, we investigated
human metabolites of three antibiotics (clarithromycin, norﬂoxacin and sulfamethoxazole),
one analgesic (diclofenac) and an anti-epileptic (carbamazepine). The spatio-temporal
distribution of the parent compounds was already examined in a previous study; the ﬁrst four
were found to originate primarily from wastewater efﬂuent, and were previously reported in
concentrations close to or beyond the PNEC. Conversely, carbamazepine, though also present
in wastewater efﬂuent, mainly enters the lake from industrial inputs into the Rhône River.
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4.2 Materials and Methods
4.2.1 Site description and sampling strategy
The study area, Vidy Bay, lies on the northern shore of Lake Geneva, and represents 0.3% of the
lake’s total volume (Figure 4.1)129. Aside from lake currents, 100’000 m3 of wastewater efﬂuent
are discharged per day into Vidy Bay from Lausanne’s wastewater treatment plant (WWTP).
The WWTP outfall is located 700 m from shore at -30 m depth. During rain events the WWTP
capacity is rapidly exceeded, and untreated wastewater is released directly into the lake130.
Other sources of water to the Bay are the Chamberonne River and the Flon stormwater outlet.
Monthly water samples were collected at various depths and locations in Vidy Bay between
April 2010 and January 2011, as described in an earlier publication140. The central sampling
location (”WWTP outfall”) was above the discharge point of the efﬂuent wastewater. The two
other sampling sites were located ca. 1.5 km upstream (”REF-up”) and downstream (”REF-
down”) of the discharge point (Figure 4.1). They will be considered together and referred to
as reference sites or REF. Between 5 and 9 depths were sampled at each site. Samples were
taken from the R/V “La Licorne” (Forel Institut, Geneva) equipped with a crane and a rosetta
water sampler (1018 Rosette Sampling System, General Oceanics Inc.). The rosetta consisted
of 11 Niskin bottles (1.7 L), coupled to a CTD device (OCEAN SEVEN 316Plus CTD, IDRONAUT
Srl) which were externally powered via a sea cable and yielded instantaneous information
on temperature and electrical conductivity. Temperature and electrical conductivity were
processed with REDAS-5 Release 5.40 (IDRONAUT Srl).
Figure 4.1: Situation and map of the Vidy Bay showing the sampling locations WWTP outfall (Swiss
coordinates : 534’672/ 151’540), REF-up (Swiss coordinates : 536’000/151’000) and REF down (Swiss
coordinates : 533’048/150’920). Coordinates are in Swiss Grid system with datum CH1903.
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4.2.2 Choice of substances
Previous research in Vidy Bay retained a selection of 27 pharmaceuticals as priority pollutants
for this area based on consumption loads, the degree of human metabolism, removal in the
WWTP, previous detection in the Vidy bay, and – if known – ecotoxicological relevance2,140.
A subset of these chemicals, namely carbamazepine (CBZ), clarithromycin (CLA), diclofenac
(DCF), norﬂoxacin (NOR) and sulfamethoxazole (SMX), were chosen herein for analysis of
their human metabolites. Deciding factors included their ecotoxicological impact in Vidy Bay,
the commercial availability of their metabolites, and previous evidence for their presence in
wastewater or surface waters in literature. The targeted metabolites included: trans-10,11-
dihydro-10,11-dihydroxy carbamazepine (DiOH-CBZ), carbamazepine 10,11-epoxide (epoxy-
CBZ), 10,11-dihydro-10-hydroxy carbamazepine glucuronide (DiOH-CBZ-glu), N-desmethyl
clarithromycin (desm-CLA), 4’-hydroxy diclofenac (4-OH-DCF), N-acetyl norﬂoxacin (acetyl-
NOR), sulfmethoxazole β-D glucuronide (SMX-glu) and N-acetyl sulfamethoxazole (acetyl-
SMX). The structures of the selected micropollutants and their corresponding human
metabolites are shown in Figure 4.2.
4.2.3 Chemicals and reagents
Most human metabolites were purchased from Toronto Research Chemicals (Canada). N-
acetyl sulfamethoxazole was obtained from CHEMOS GmbH (Germany), and carbamazepine
10,11-epoxide from Sigma Aldrich (Switzerland). Other chemicals and reagents used in the
analytical procedure have been listed previously24.
4.2.4 Sample manipulation
1 L water samples were collected in Niskin bottles and transferred into amber glass bottles,
immediately acidiﬁed to pH 2 with concentrated HCl to inhibit biological activity, and
transported to the laboratory within 4 hours of sampling, where they were directly ﬁltered
through > 1 μm glass ﬁber ﬁlters (Whatman). Before further treatment, all ﬁltrates were
spiked with a set of deuterated standards (ﬁnal concentration 120 ng·L−1) to account for
losses of the parent compound during extraction, as described previously24. As deuterated
standards of the metabolites were not available for spiking at the time of sampling, their losses
during extraction were determined in experiments using spiked lake water, as described in the
following paragraph. All glassware used for samples was immersed for 24 h in a Contrad bath,
machine-washed and ﬁnally rinsed with methanol and sample water before use
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Figure 4.2: Structures of the targeted pharmaceuticals (blue box) and their selected humanmetabolites.
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4.2.5 Analytical method
The concentrations of the parent compounds in lake water samples were analyzed following a
previously developed analytical method involving solid-phase extraction (SPE) and ultra-
performance liquid chromatography coupled to a tandem mass spectrometer (UPLC-
MS/MS)24,140. Additionally, an analytical method for the detection of human metabolites was
developed. Brieﬂy, the target compounds were extracted on hand-assembled 6mL cartridges
using an automated SPE system, eluted and evaporated, under a ﬂux of nitrogen, at 40◦C, to
200 μL and ﬁnally stored at -20◦C until UPLC-MS/MS analysis. Analytical details regarding the
determination of the parent compound concentration have been described previously140. For
analysis of targeted metabolites, the stored extracts were diluted 1:6 with UPLC eluent (A) and
analyzed twice by UPLC-MS/MS. Reported values represent the average of the two separate
measurements. Compounds were separated on a Waters ACQUITY UPLC HSS T3 1.8 μm
column. The mobile phases were (A) 95% H2O; 5% MeOH; 1% formic acid; 5 mM ammonium
formate and (B) 95% MeOH; 5% H2O; 1% formic acid; 5 mM ammonium formate. The ﬁrst
minute the fraction of mobile phase A decreased from 90 to 60%, followed by a linear gradient
for 7 min to 5% A. Thereafter the initial conditions were restored and held for 3 minutes. The
injection volume was 10 μL, and the ﬂow rate 0.3 mL·min−1. UPLC-MS/MS parameters for
our selection of human metabolites are listed in Table 4.1; a positive ionization potential
(ESI-mode) was applied for all compounds. A set of 10 to 13 standards with concentrations
between 1 and 700 μg·L−1 were analyzed in duplicate along with the samples. The analytical
limit of quantiﬁcation (LOQ; Table 4.1) was deﬁned as the concentration of the lowest standard
with a signal-to-noise ratio > 10.
Table 4.1: Details of the analytical method for MS/MS analysis of targeted human metabolites and PNEC
used in risk assessment.
Name Precursor Fragment Cone Collision Retention LOQ1 Extraction PNEC2
ion [m/z] ions [m/z] [V] [V] time [min] [ng/L] efﬁciency [ng/L]
epoxy-CBZ 253.27
167.15 22 36
3.8 <1 0.3 ± 0.08 2500179.7 22 22
DiOH-CBZ 271.33
210.18 22 14
3.5 <1 1.8 ± 0.23 2500
236.18 22 12
acetyl-SMX 296.22
65.01 34 36
3.1 <1 1.39 ± 0.19 28
134.12 34 28
4-OH-DCF 312.22
230.14 20 36
6.1 1.1 1.12 ± 0.19 100
266.15 20 12
acetyl-NOR 362.43
231.15 58 38
4.6 <1 0.7 ± 0.08 40100
274.24 54 34
SMX-glu 430.3
156.08 26 30
2.1 1 0.99 ± 0.11 28
254.16 26 14
DiOH-CBZ-glu 431.29
194.18 24 34
3.3 19 n.d. 2500
237.14 24 12
desm-CLA 734.8
83.14 30 54
6.3 <1 0.62 ± 0.04 60
144.18 30 24
1LOQ: limit of quantiﬁcation
2PNEC (predicted no-effect concentration). PNEC of the corresponding parent compound was used for human
metabolite PNEC (see text for details).
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Human metabolite concentrations in the sample concentrates were calculated based on
calibration curves using at least 6 calibration points closest to the sample concentration.
Correlation coefﬁcients for the calibration curves were typically > 0.990. Extraction recoveries
(Table 4.1) and repeatability were determined by a method reproducibility test, in which
6 replicates of lake water spiked with all metabolites to 50 ng·L−1 were processed by the
entire sample workup procedure. The concentrations in the original lake water samples
were determined taking into account the extraction efﬁciencies determined by this test. The
reproducibility of the entire method was high, resulting in a relative standard deviation of less
than 25% of the calculated concentration.
4.2.6 Risk assessment
For a single compound i , the risk for aquatic organisms is normally evaluated by comparing
the measured environmental concentration (MEC) in the aquatic system under consideration
to either the predicted no-effect concentration (PNEC68) or the hazardous concentration
(HC171). In this study, we calculated the risk based on the PNEC, as not enough data was
available for the compounds under consideration to determine a HC The ratio of MECi to
PNECi (RQi , equation 4.1) must be smaller than one to ensure that a given chemical i presents
an acceptable risk to the environment.
RQi =
MECi
PNECi
< 1 (4.1)
For mixtures of compounds exhibiting a similar mode of action, the mixture effect can
be predicted by the concept of concentration addition (CA)171. As no ecotoxicological
information was available for the metabolites, we assumed that the mode of action of a
metabolite is similar to that of its parent compound, and therefore deﬁned the PNEC of
metabolites as equivalent to the PNEC of the parent compound. This assumption will be
discussed in the Results and Discussion section. The risk quotient for mixtures (RQm) of a
parent compound and its metabolites thus corresponds to the sum of the individual RQi
(Equation 4.2). The RQm must remain smaller than one to ensure that a mixture of chemicals
presents an acceptable risk to the environment:
RQm =
n∑
i=1
RQi =
n∑
i=1
MECi
PNECi
< 1 (4.2)
PNECs of the individual parent compounds (and hence of their metabolites; Table 4.1) that
were used to calculate RQ have been determined in a previous study (140 and references
therein).
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4.3 Results and discussion
4.3.1 Occurrence of human metabolites in Lake Geneva
Over 140 lake water samples were analyzed for the presence of ﬁve pharmaceuticals along
with a selection of their human metabolites. The frequency of detection and the observed
concentrations varied with time and compound. Two metabolites, namely CBZ-glucuronide
and N-acetyl NOR, were never detected over the entire sampling period. SMX-glucuronide
and 4-OH-DCF showed a relatively low overall frequency of detection of 9 and 21% respectively.
These compoundsweremainly detected at theWWTPoutfall sampling site. Higher frequencies
of detection were observed for DiOH-CBZ, desm-CLA, acetyl-SMX and epoxy-CBZ, which
were detected in 96, 89, 50 and 43% of all samples, respectively. Some difﬁculties were
encountered with the detection of epoxy-CBZ which was unstable during analysis; thus the
reported detection frequencies and concentrations for this compound may underestimate the
actual occurrence.
Generally, the detected concentrations of human metabolites were in the same range or
below those of their parent compound (Figure 4.3). The absolute range of concentrations was
compound speciﬁc: CBZ and its metabolite epoxy-CBZ showed the highest concentrations
with a median of 20 ng·L−1. The concentrations of all the other compounds and metabolites
were generally below 10 ng·L−1. In a few samples, namely those obtained in close vicinity to
the wastewater outfall, signiﬁcantly higher concentrations of up to > 100 ng·L−1 were detected.
Though numerous human metabolites have been identiﬁed for CBZ, the major metabolic
route involves transformation to epoxy-CBZ, which is subsequently hydrated to DiOH-CBZ.
In addition, DiOH-CBZ can be conjugated with a glucuronide. Therefore DiOH-CBZ and
the corresponding glucuronide are the main metabolites of CBZ172. Several studies have
effectively detected DiOH-CBZ in inﬂuent and efﬂuent wastewater samples, as well as in
surface waters in concentrations up to three times those of the parent compound CBZ25,28,173.
Conversely, the present study found signiﬁcantly lower concentrations of DiOH-CBZ than
its parent. This was attributed to the industrial sources of CBZ to Lake Geneva140, which
maintain relatively high and stable concentrations of the parent compound throughout the
water column. Accordingly, signiﬁcant differences of detected concentrations were observed
between the WWTP outfall and the reference point only for the human metabolites and
not CBZ. The other major metabolite, CBZ-glucuronide has never been reported to date in
environmental samples, however there is evidence for cleavage of the glucuronide acid moiety
in wastewater treatment plants (25 and references therein). The CBZ-glucuronide standard
was highly unstable in aqueous and organic solutions; hence its absence in lake water samples
is not surprising.
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Figure 4.3: Range of concentrations detected at all sampling sites over the entire sampling period of the
parent compounds (shaded box) and their corresponding humanmetabolites. The frequency of detection
(f) is given for each compound. Boxes represent 25th percentile, median and 75th percentile. The whiskers
are determined by the 5th and 95th percentiles. Stars show the mean value.
Concentrations of clarithromycinwere relatively low (<5 ng·L−1) and correspondingmetabolite
concentrations were signiﬁcantly lower. Though the desmethylated metabolite of clar-
ithromycin was detected in many samples, the detected concentrations were frequently
below the limit of quantiﬁcation. To our knowledge, this is the ﬁrst report of the occurrence of
a human metabolite of clarithromycin in wastewater or surface water samples.
Up to 50% of ingested diclofenac is excreted as the hydroxylated metabolite 4-OH-DCF and
its corresponding glucuronide, while less than 10% remains unaltered174. Thus the presence
of the major metabolites in untreated sewage is to be expected. Indeed, various studies have
found 4-OH-DCF in both inﬂuent and efﬂuent wastewater, with only partial removal (<50%)
via various wastewater treatment processes32,33. The concentrations were sometimes as
elevated as those of the parent compound in efﬂuent samples. Averaged over all samples
(Figure 4.3), the present study found similar concentration ranges of 4-OH-DCF and its parent
in the Vidy Bay. More detailed analysis of individual sample concentrations, however, show
generally higher concentrations of themetabolite above theWWTPoutfall, whereas the inverse
is observed at the reference sites.
Approximately 14% of ingested sulfamethoxazole is excreted unchanged; the remaining
fraction is metabolized mainly to acetyl-SMX (47%) and SMX-glucuronide (10%)175. Acetyl-
SMX has been detected in wastewater efﬂuent27 as well as surface waters at concentrations
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comparable to its parent compound121. For SMX-glucuronide, in contrast, this is the ﬁrst
evidence of its occurrence in surface waters. Its low frequency of detection (15%) was expected
given the unstable nature of the glucuronide bond, which can be microbially cleaved167. The
overall concentrations of acetyl-SMX detected in this study were signiﬁcantly lower than those
of SMX. As for DCF, however, a sample-by-sample analysis revealed that in samples taken
above the WWTP outfall, the metabolite concentration was signiﬁcantly higher than that of
the parent compound.
4.3.2 Peak metabolite concentrations in wastewater plume
The presence of a wastewater plume originating from the direct discharge of treated (and
during high rain events, also untreated) wastewater into the Vidy Bay was reported in a recent
study140. Locally high concentrations of pharmaceuticals were observed above the WWTP
outfall site. The plume depth followed the thermocline during thermal lake stratiﬁcation,
which moved to lower depths over the course of the warm seasons. Additionally, a strong
linear correlation between electrical conductivity and concentrations of wastewater-derived
micropollutantswas identiﬁed. In absence of thermal stratiﬁcation, fromNovember to January,
no plume was observed.
Figure 4.4: Depth proﬁles of relative concentrations of the targeted humanmetabolites (full lines) and
their corresponding parent compound (dashed lines) for a) April, b) August, c) October and d) December
2010. Temp: temperature; EC: electrical conductivity.
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The presence of human metabolites of pharmaceuticals in wastewater has been well-
established25,27,32; hence the latter should logically show the plume feature. Indeed, notably
higher concentrations of our targeted human metabolites were observed in vicinity to the
WWTP outfall in April (Figure 4.4 a) and August (Figure 4.4 b). These high concentrations
coincided with an elevated conductivity, which is indicative of wastewater. A slight plume
feature could still be observed at -26 m depth in October (Figure 4.4 c); whereas homogenous
concentrations are established in December (Figure 4.4 d) when complete mixing of the
water column was restored. In general, the relative peak concentrations of the metabolites
were more pronounced than their associated precursor. This could either be due to faster
degradation of the metabolite with regard to its parent, or to high background concentrations
of the parent, which may diminish the peak amplitude. For example, carbamazepine, which
enters the lake with the Rhône River, showed little to no peak feature in the wastewater plume.
Conversely, its human metabolite, DiOH-CBZ, showed evident concentration peaks above the
WWTP outfall, in accordance with the hypothesis that its main source is wastewater.
The unstable nature of SMX-glucuronide mentioned earlier was conﬁrmed by a low detection
frequency in the water column. However, it was detected in the plume in April and August, as
well as in other months (not shown), displaying a strong plume feature.
4.3.3 Spatio-temporal variations of metabolite concentrations in Vidy Bay
During thermal stratiﬁcation, the locally high concentrations of human metabolites associated
with the wastewater plume led to notably elevated median concentrations at the WWTP outfall
site (Figure 4.5). Additionally, the 25-75% quantile ranges were large due to this plume feature.
Conversely, after mixing of the wastewater with the surrounding water mass and travel to the
reference sites, the water column concentrations of the targeted human metabolites were
lower and more homogeneous. These homogeneous conditions, depicted by a narrow 25-
75% quantile range in ﬁgure 4.5, were also observed during the cold months (November to
January) at the WWTP outfall site. This can be explained by enhanced mixing throughout the
water column, as temperature proﬁles straighten during the winter. Generally, metabolite
concentration trends at the reference sites closely tracked those of the wastewater plume.
Among the metabolites considered, only acetyl-SMX exhibited noticeable concentration
differences at the reference sites between the warm and cold seasons, consistent with the
higher concentrations in the plume during the same period. Notably, however, all metabolites
appeared to decrease in concentration during the month of August.
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Figure 4.5: Temporal and spatial variation of detected concentrations of DiOH-CBZ (left), 4-OH-DCF
(middle) and acetyl-SMX (right). The solid line shows the median concentration and shaded area the
25-75% quantile range.
4.3.4 Degradation within the Vidy Bay
After discharge from the WWTP, and upon dispersion of the wastewater plume, wastewater-
derived micropollutant concentrations decrease with distance from the WWTP outlet due to
dilution with surrounding water masses. In addition, environmental degradation processes,
such as biodegradation or photolysis, can decrease micropollutant concentrations in the
water column. The substances studied herein have previously been reported to undergo
various extents of degradation in the Vidy Bay24,140: The concentrations of CLA and DCF were
found to readily diminish, whereas SMX was more recalcitrant. As CBZ’s main source was
not the WWTP, no apparent decrease in concentration was found throughout the Vidy Bay.
Furthermore, CBZ is known to be particularly recalcitrant to environmental degradation117.
Compared to their parent compounds, human metabolites may be more susceptible to
environmental degradation processes. For example, in a laboratory batch reactor, 4-OH-
DCF was found more susceptible to biodegradation than its parent32. However, incomplete
removal of this compound during wastewater treatment32,33 indicates that biodegradation
proceeds at a slow rate. Furthermore, both acetyl-SMX and SMX-glucuronide were reported to
undergo biodegradation back to SMX during wastewater treatment35 and in sediment tests167.
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Figure 4.6: Seasonal and spatial (WWTP-plume vs reference sites) variation of the metabolite/parent
compound ratio.
Finally, SMX-glucuronide has recently been found to be more photolabile than SMX, whereas
acetyl-SMX was slightly more photostable168.
To assess if human metabolites undergo environmental degradation in the Vidy Bay, and to
determine the relative extent of degradation compared to the parent substance, we calculated
the ratio of metabolite/parent concentration close to the wastewater outfall, as well as at the
reference points located 1.5 km up- or downstream (Figure 4.6). Both metabolites and parents
are equally affected by dilution; consequently, the difference in ratio between the wastewater
discharge and the reference indicates the relative propensity of the metabolite to undergo
environmental degradation during passage through the Vidy Bay. This analysis could only be
conducted for those substances for which both parent and metabolites concentrations were
detected at a high frequency.
As can be seen in ﬁgure 4.6, the metabolite/parent ratio was generally greater for samples
taken near the wastewater outlet than in the corresponding reference samples. The difference
was most drastic in April, where the wastewater sample captured a particularly pronounced
plume feature, and thus consisted of poorly diluted wastewater (Figure 4.4). Correspondingly,
metabolites were present at concentrations up to 4.5-fold greater than their parent compound,
consistent with the notion that pharmaceuticals are mainly excreted into sewage in their
metabolized form. In both April and August, the metabolite/parent ratio dropped off steeply
between the plume and the reference points, indicating that metabolites underwent more
rapid environmental degradation than their parent compounds.
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During the months of October and December, the difference in ratio was less pronounced.
This could be due to enhanced mixing of the discharged wastewater with the surrounding
water column during the colder months (Figure 4.4). Furthermore, both biodegradation and
photolysis processes are less efﬁcient in fall and winter. Compared to dilution, the degradation
of metabolites may thus play a smaller role during the cold period.
Overall, it can be stated that the metabolites considered herein are less recalcitrant in the
environment than their parent compounds. As it is not fully clariﬁed which products are
formed during environmental degradation, however, it cannot be concluded that metabolites
therefore are of lesser ecotoxicological concern. In particular for those metabolites which can
be back-transformed to their parent compound, environmental degradation may lead to an
increase in ecotoxicological risk.
4.3.5 Ecotoxicological risk assessment
Given the presence of metabolites in Lake Geneva, the important question arises whether
these compounds are of ecotoxicologial relevance. Explicitly, our ﬁnal goal was to determine
if metabolites make a signiﬁcant contribution to the ecotoxicological risk presented by
the parent compounds. As was determined previously, DCF and SMX both presented an
ecotoxicological risk (i.e., RQ > 1) in several plume samples140. In contrast, the detected
concentrations of CLA and CBZ were always below the corresponding PNEC.
Even if metabolites are taken into account, a negligible risk is estimated for all mixtures of
parent compound and metabolites at the reference point (Figure 4.7, right). At the plume,
however, a risk is highlighted for DCF and metabolites in June and for SMX and metabolites in
April and June (Figure 4.7, left). Taking into account metabolites leads to both a more frequent
excess of the RQ of 1, as well as to higher overall RQs. For SMX, the RQ reaches a value of 3.3
in June, compared to 2.4 taking into account only the parent compound, suggesting that this
pharmaceutical may be of environmental concern. Similarly, for DCF in June, the RQ only
exceeded 1 if metabolites were considered, whereas it amounted to 0.56 for the parent alone.
Similarly, other studies have reported that the combination of several xenoestrogens led
to ecotoxicological effects, even if each individual compound was present at no effect
concentrations176. This highlights the importance of taking into account not only individual
substances, but classes of compounds with the same mechanisms of action.
To our knowledge, no ecotoxicological information is available to date on human metabolites
of pharmaceuticals; therefore it is not possible to determine accurate PNECs. In this study, we
therefore assumed the PNEC of the metabolites to be similar to those of the parent compound.
This assumption is supported by the study of Boxall et al.170, who showed that 81% of the
degradates are less or similarly toxic as the parent compound. However, one has to note that
19% of the metabolites are more toxic that the parent compound. We can therefore not exclude
that we underestimated the toxicity of any given metabolite.
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Figure 4.7: Time course of mixture
risk quotient (RQm) for the sum of
pharmaceuticals carbamazepine (CBZ),
clarithromycin (CLA), diclofenac (DCF)
and sulfamethoxazole (SMX) and their
associated metabolites for concentra-
tions detected in the plume (left) and
average water column concentrations
detected at REF down (right). RQ
> 1 (red line) indicates a potential
ecotoxicological risk.
Furthermore, by applying the concentration addition model we assumed that the metabolites
have the same mode of action as the parent compound. To our knowledge, this was never
evaluated in environmental organisms. From a pharmacological point of view, i.e. in humans,
this assumption is correct for many, but not all metabolites. For example, the mode of action
of 4-hydroxy-tamoxifen is similar to its parent compound, the anti-cancer drug tamoxifen177.
In contrast, another metabolite of tamoxifen, endoxifen, has a different mode of action177.
Furthermore, even in humans, the mode of action of pharmaceuticals and metabolites are not
always well understood. The CA approach applied in this study is therefore used as a worst
case scenario, as proposed by Backhaus et al.171, when the mode of action of the chemicals in
a mixture are not known.
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4.4 Conclusion
Over a period of 10-months, the concentrations of ﬁve environmentally relevant pharmaceu-
ticals and eight of their human metabolites were monitored at several locations and depths
in Lake Geneva’s Vidy Bay. Among the targeted metabolites, six were detected with variable
frequency in the lake water samples. The highest concentrations were detected above the
WWTP outfall, supporting the assumption that wastewater efﬂuent represents the main source
of human metabolites to the lake. The concentration proﬁles at the WWTP discharge location
displayed a plume-like feature corresponding to the wastewater plume. On average, the
detected concentrations of human metabolites were similar to, or lower than, their associated
parent compound. Moreover, the metabolites targeted in this study were found to be less
recalcitrant to typical environmental degradation processes than their parent. Nevertheless,
their presence in the aquatic environment may still lead to an increase of the ecotoxicological
risk. Assuming a worst-case scenario, in which pharmaceuticals and their metabolites present
a similar ecotoxicological impact, we found a critical increase of the environmental risk for
two compounds with their metabolites, namely SMX and DCF. The actual PNECs of human
metabolites are still to be determined for a more precise evaluation of the environmental
risk. However, the precautionary principle and the results of the present study underline the
importance of including human metabolites of pharmaceuticals in environmental studies.
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5 Direct photolysis of human metabolites of
the antibiotic sulfamethoxazole: Evidence for
abiotic back-transformation
5.1 Introduction
Antibiotics are now well-acknowledged contaminants of natural aquatic systems. The chronic
exposure of bacteria and other aquatic organisms to trace concentrations of antibiotics
raises concerns regarding their ecotoxicological effects, but also their potential to induce
bacterial resistance. Among the target compounds measured, the antibiotic sulfamethoxazole
(SMX) has regularly been detected in wastewaters and natural aquatic environments with
median concentrations between 60 and 150 ng·L−1 140,155. Moreover, the PNEC (predicted no
effect concentration) of SMX, a level which should not be surpassed to ensure an acceptable
risk to the environment, has been repeatedly exceeded. The frequent detection of this
antibiotic in surface waters can be explained by its extensive use in both human and veterinary
medicine35, its poor elimination in conventional wastewater treatment plants18,24,178,179 and
its relative persistence in the environment39. Much effort has been spent on investigating the
presence and fate of SMX in the aquatic environment155,180. Photodegradation was identiﬁed
as the major degradation pathway for SMX in surface waters75, thus direct and indirect
photodegradation kinetics of SMX have been extensively studied74,82,102,103,107. More recently,
research interests have shifted towards identifying photolysis products of pharmaceuticals,
as well as the presence and fate of their human metabolites, as both may present a risk to
the aquatic ecosystem. Selected photoproducts have been shown to be more persistent than
the corresponding parent compound and to retain biological activity166,181. Similarly, though
human metabolites are generally more polar than the parent compounds, they are not always
less toxic36,175. Only 14% of ingested SMX is excreted in its original form, yielding a large
fraction of metabolites175 (Figure 1, right panel). The most prominent metabolite is N-acetyl
sulfamethoxazole (Ac-SMX), which represents 50% of the excreted administered dose.
A modiﬁed version of this chapter was published as: F. Bonvin, J. Omlin, R. Rutler, W. B. Schweizer, P. Alaimo, T.
Strathmann, K. McNeill and T. Kohn. Environmental Science & Technology, 2013.
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Other metabolites include sulfamethoxazole β–D-glucuronide (SMX-glucuronide) (9%), N-
hydroxy sulfamethoxazole (OH-SMX) (2.2%), and minor fractions of 4-nitroso sulfamethoxa-
zole (NO-SMX) and 4-nitro sulfamethoxazole (NO2-SMX)175.
The presence and fate of these metabolites in wastewater and receiving waters has received
little scrutiny to date. NO-SMX was determined to be even more cytotoxic than SMX itself182,
but has never been reported in environmental studies. Acetyl-SMX has been detected in
wastewater efﬂuent27 as well as surface waters at concentrations comparable to its parent
compound121. In addition, there is evidence that Ac-SMX may be transformed back to the
parent compound during wastewater treatment35. Biological back-transformation was also
reported for both Ac-SMX and SMX-glucuronide in water sediment tests167 Moreover, a
potential abiotic back-transformation of NO2-SMX, was recently revealed under strongly
reducing conditions169. Photolytic back-transformation, however, has not been investigated
to our knowledge.
Understanding the photochemical fate of SMX metabolites and their photoproducts is
essential to fully evaluate the risk associated with SMX in the environment. Therefore,
the present study aims to investigate the photolysis kinetics and products of a selection
of SMX metabolites, namely the ones most abundantly found in urine175, Ac-SMX and SMX-
glucuronide, as well as OH-SMX, NO-SMX and NO2-SMX. The possibility of photolytic back-
transformation to SMX was assessed, and the inﬂuence of the small structural differences
between SMX and its metabolites on photolysis rates and pathways was investigated. Finally,
the inﬂuence of the photolability of metabolites on their fate and expected distribution in
surface waters is discussed and compared to actual concentrations measured in Lake Geneva
near a wastewater treatment plant efﬂuent discharge point.
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5.2 Materials and methods
5.2.1 Chemicals
SMX, Ac-SMX, OH-SMX, NO-SMX (>90%), NO2-SMX, SMX-glucuronide were obtained from
Toronto ResearchChemicals. 4-(Acetylamino)benzensulfonic acid, 3-amino-5-methylisoxazole,
4-nitrobenzenesulfonamide, N-phenylacetamide, aniline and sulfanilic acid were all analytical
grade from Sigma-Aldrich. (5-Methylisoxazol-3-yl)sulfamate was synthesized via sodium (5-
methylisoxazol-3-yl)sulfamate using an adaptation of a procedure by Spillane et al.183. Details
regarding this synthesis and conﬁrmation of the product are available in Appendix C. All
solutions were made using Nanopure water from either a Millipore Synergy UV or a Barnstead
NANOpure Diamond Water Puriﬁcation System (resistivity >18.2 MΩ cm). Stock solutions
were made in HPLC grade methanol and other solvents used were all analytical grade quality.
Further chemicals were used in buffer solutions and eluents, namely ammonium acetate
(Sigma-Aldrich), acetic acid (Fluka), disodium tetra borate decahydrate (Merck), sodium
bicarbonate (Fluka), pyridine (Acros), p-nitroanisole (Sigma-Aldrich).
Figure 5.1: Left panel: structure of parent compound sulfamethoxazole (SMX), protonation states and
main cleavage sites of SMX photolysis. Right panel: major humanmetabolites of sulfamethoxazole.
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5.2.2 Spectrophotometric titration for pKa,2 determination
The absorbance spectra of aqueous solutions (Nanopure water) of each individual metabolite
(5 mg·L−1) were measured with a 2550 Spectrophotometer (Shimadzu Scientiﬁc Instruments)
in the pH range from 2 to 11. pH was adjusted using HCl and NaOH. pKa,2 values were
determined by a least square ﬁt of absorbance versus pH data at a single wavelength, with
the inﬂection point representing the pKa,2 value (Figure C.2, Appendix C).pKa,1 values of
sulfa-drugs are generally below pH 2 and thus not relevant to natural water systems.
5.2.3 Direct photolysis experiments
The direct photolysis kinetics of SMX and metabolites were measured utilizing two different
setups.
Solar simulator setup.
In the solar simulator setup, solutions of individual target compounds (1 mg·L−1) in
buffered Nanopure water were irradiated between 1 and 24 h from above by a Sun 2000
Solar Simulator (ABET Technologies, Milford, Connecticut) equipped with a 1000 W Xe
lamp and an AM1.5 ﬁlter to mimic solar radiation. The irradiance for this setup was
determined spectroradiometrically (Model ILT-900-R, International Light) before and after
each experiment. The absolute irradiance was calibrated using chemical actinometry (p-
nitroanisole (pNA)) and was 76 W·m−2 between 265 and 430 nm and showed no day-to-day
variation (lamp spectrum is shown in Appendix C, Figure C.1). The irradiated solutions
(400 mL) in amber glass beakers were kept homogenous by stirring, and their temperature
was maintained at ca. 19◦C using a water-ﬁlled tray, connected to a recirculation cooler (F240
Recirculating Cooler, Julabo). Identical solutions were left in the dark during each experiment
to serve as dark controls. 1.2 mL samples were collected at selected time points (min. 10) to
monitor the parent compound concentration decrease over irradiation time. The samples in
amber glass vials were maintained at 4◦C after collection and analyzed within 48 h by ultra-
performance liquid chromatography (Acquity UPLC system, Waters) coupled to a tandem
mass spectrometer (MS/MS, Acquity TQD, Waters). Each experiment was conducted at least
twice. Data acquisition and processing was performed using Masslynx. In parallel, absorbance
spectra for all solutions were collected with a UV-vis 2550 Spectrophotometer (Shimadzu
Scientiﬁc Instruments) at various irradiation time points to assess the change in absorbance
over time and wavelength. Averaged values were used to correct for light screening. As pH
can affect the protonation state and thus the photolysis kinetics of organic compounds82,
direct photolysis experiments were conducted under acidic (pH 3.2) and mildly basic (pH
8.4) conditions. The various buffers, chromatographic conditions and analytical methods are
described in Appendix C.
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Rayonet setup.
The second setup used a turn-table apparatus inside a photochemical reactor (Rayonet)
equipped with six 300 nm bulbs (Southern New England Ultraviolet Co. RPR-3500 A˚). The bulb
spectrum is shown in Appendix C (Figure C.1). The irradiation intensity, also calibrated with
a chemical actinometer (pNA) from 265 to 430 nm, was 44.4 W·m−2. In this setup, solutions
containing 12–30 mg·L−1 of the target compound in borate-buffered (pH 9) Nanopure water
were irradiated in borosilicate glass test tubes for 1 to 24 h. Higher concentrations were used to
facilitate and enhance photo-product identiﬁcation. Two 150 μL aliquots were taken at various
time points, and analyzed in parallel via two complementary methods: the ﬁrst used a HPLC
(Dionex) equipped with a UV detector to obtain quantitative kinetic data; the second allowed
for high resolution mass determination of photoproducts by UPLC separation of compounds
(NanoAcquity, Waters) and detection on a high-resolution mass spectrometer (HRMS, Thermo
Exactive Orbitrap) (details below). Dark controls of the experimental solutions were monitored
for parent compound decay over the duration of the photolysis experiments. Data acquisition
and processing was done using Chromeleon (HPLC-UV) or Excalibur and Toxid (UPLC-HRMS).
Again, to account for light screening, the absorbance (200–600 nm) of the solutions was
monitored over time using a Cary 100 Bio (Varian) UV/Visible spectrophotometer. Solutions
of a chemical actinometer pNA with pyridine184 were photolyzed concurrently with SMX
and metabolites as a measure of the effective light seen by the compounds in solution. The
analytical methods are described thoroughly in Appendix C.
5.2.4 Product identiﬁcation
Samples were directly analyzed by UPLC-HRMS and MS data was recorded scanning from
m/z 90 to m/z 600 in both positive and negative ESI mode. Full mass spectra in both
modes were explored for appearance of peaks with increasing irradiation time. Chemical
formulas with theoretical exact masses within 5 ppm of the detected mass were considered as
possible products. Thereafter, formulas which made the most chemical sense with respect
to the starting material were investigated further. In absence of MS/MS fragmentation, no
structural elucidation per se was possible. However the presence of fragments appearing at
the same retention time due to in source fragmentation aided the structural elucidation. The
identity of a selection of photoproducts could be fully conﬁrmed by matching exact mass and
retention time to authentic standards (commercially available or synthesized). Identiﬁcation
of HPLC-UV peaks was achieved through fractionation of concentrated photolysate. Explicitly,
after reduction of the photolyzed experimental solution to ca. 1 mL via evaporation, the
concentrated solution was fractionated by HPLC and the fractions directly injected on the
HRMS to determine the exact mass of the peak captured in the fraction.
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5.2.5 Direct photolysis calculations
The direct photolysis rate constants were determined under various conditions (pH, light
source and concentration). The degradation of all metabolites followed ﬁrst order kinetics
(Figure C.4 a, Appendix C) and the observed degradation rate constants for each compound
i , kobs,i , were calculated using the slope of ln(At/A0) plotted against time, where At refers to
the peak area of chromatograms at time t, and A0, the initial peak area. For experiments with
relatively high concentrations of target compound and/or large volumes, a light-screening
factorwas used to account for the fact that the average light intensity in the tubewas lower than
in optically dilute solutions, due to self-screening by the compound itself or transformation
products forming. The observed degradation rate constant, kobs,i , was corrected to yield a
photolysis rate constant representative of an optically dilute system, k0obs,i .
The direct photolysis quantum yield(Φi ) was determined for each compound (i ). It represents
the efﬁciency of direct photolysis and was calculated as follows:
Φi =
k0obs,i
k0abs,i
(5.1)
where k0abs,i is the speciﬁc rate of light absorbtion, a measure of the spectral overlap of light
irradiance and compound absorbance (see Appendix C, Figure C.5). Details regarding light
screening corrections, quantum yield calculations, calibration of light intensity by chemical
actinometry and error calculations are given in Appendix C.
Finally, knowledge of the quantum yield and solar irradiance allows for the estimation of
environmental half-lives. Accordingly, these were calculated by multiplying the quantum yield
by the speciﬁc rate of light absorption of each compound under a theoretical solar irradiation
(SMARTS), at 47◦N latitude, on the 21st of June (summer scenario) and 21st of December
(winter scenario), assuming continuous exposure, half-light attenuation and omitting indirect
photolysis processes.
5.2.6 Surface water concentrations
The presence of Ac-SMX and SMX-glucuronide along with the parent compound SMX was
investigated in water samples collected on a monthly basis at various depths of two sampling
sites (reference sites) in the Vidy Bay of Lake Geneva between April 2010 and January 2011.
Sampling strategy, sample preparation, extraction and analyticalmethods have been described
previously140,185.
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5.3 Results and discussion
5.3.1 Acid-base speciation of SMX metabolites
SMX is a diprotonic acid (Figure 5.1, left panel), yet only the transition from the neutral
to the anionic form through deprotonation of the sulfonamide NH (pKa,2) is relevant for
natural waters. For SMX and its human metabolites, Ac-SMX, NO-SMX and NO2-SMX, pKa,2
values of 5.89±0.07, 5.07±0.08, 4.71±0.1 and 3.66±0.01, respectively, were obtained (Figure
C.2, Appendix C). Boreen et al. found a comparable pKa,2 for SMX of 5.782. No values were
determined herein for SMX-glucuronide or OH-SMX. SMX-glucuronide is missing this acidic
functionality and thus remains in its neutral form over the entire tested pH range (2-10).
OH-SMX was rapidly converted to NO-SMX in neutral and basic aerated solutions, and due to
this instability in experimental conditions, its pKa,2 was not determined, nor was it considered
for further experiments.
5.3.2 Direct photolysis kinetics, quantum yields and environmental half-lives
The protonation state of organic compounds affects their absorbance (Figure C.3, Appendix
C) resulting in differences in direct photolysis kinetics82. For this reason, direct photolysis
experiments were performed at different pH values and the resulting photolysis rate constants
of the predominantly neutral form (pH 3.2) and anionic form (8.4 and 9.2) are listed in Table
5.1. The pH dependence of the photolysis kinetics was evident, with faster reaction kinetics
in acidic conditions for most compounds. In accordance with previous research82,102, the
neutral form of SMX (prevalent at pH 3.2) was found to be more photolabile than the anionic
form. SMX metabolites also degraded faster under acidic conditions, showing up to 30-times
faster degradation kinetics of the neutral form. The accelerated direct photolysis in acidic
solution was not observed for SMX-glucuronide. This result was expected as SMX-glucuronide
is missing the sulfonamide NH acidic functionality; therefore, in contrast to SMX and the other
metabolites, it remains in its neutral and more photoreactive form at environmental pH. The
speciﬁc rate of light absorption of each compound (Table 5.1) in its neutral or anionic form
was compared to its corresponding reaction rate constant. Both SMX and Ac-SMX showed a
positive correlation between absorbed light and rate constant, with higher absorbance of the
neutral compounds leading to faster kinetics. In contrast, despite greater light absorption of
NO-SMX and NO2-SMX in their anionic form, the neutral form degraded more readily.
Among the target compounds at pH 3.2, the fastest degradation was observed for SMX.
The degradation of SMX-glucuronide and Ac-SMX were nearly as fast as SMX, whereas NO-
SMX and NO2-SMX were orders of magnitude slower. At pH 8.4 and 9.2, SMX-glucuronide
showed the fastest degradation kinetics of all investigated compounds followed by the parent
compound SMX. On the other hand, NO-SMX, Ac-SMX and NO2 SMX showed signiﬁcantly
lower rate constants (Table 5.1).
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5.3. Results and discussion
Finally, self-sensitization by the compound itself was ruled out, as experiments performed at
different concentrations showed no signiﬁcant differences in kinetics (Figure C.4 b, Appendix
C).
The majority of investigated compounds differ only in their aromatic-ring substituent, yet
large differences were observed within direct photolysis rate constants. Hence, the different
ring substituents inﬂuence the photochemical behavior of these compounds, as discussed in
detail below. Similarly, previous research found different direct photolysis behavior among
ﬁve sulfa drugs with varying ﬁve-membered heterocyclic substituents82. Direct photolysis is
thus clearly sensitive to both ring functionalities of the molecule, though differences in ﬁve-
membered ring substituents led to relatively small variations compared to the aromatic-ring
substituents investigated here.
Similar trends as for rate constants could be observed for quantum yields (Table 5.1). The
quantum yields of the neutral components (pH 3.2) were greater than of the anionic form
of the compound, except for SMX-glucuronide, which remained in its neutral form in all
experimental conditions. Furthermore, both SMX-glucuronide and SMX showed relatively
high quantum yields, compared to values 2–3 orders of magnitude lower for Ac-SMX, NO-SMX
and NO2-SMX.
Quantum yields determined in the solar simulator setup were systematically higher than those
determined using the Rayonet setup, with the exception of NO-SMX. A recent review reported
a wavelength speciﬁc quantum yield for SMX ofΦ = 0.038 ± 0.002105, which is comparable to
the one measured in the Rayonet setup (λmax=300 nm),ΦRayonet = 0.028 ± 0.005, but lower
than the quantum yield determined by Zhou and Moore,Φ257 = 0.084 ± 0.016 at pH 9102. The
latter found values closer to the quantum yields determined under natural sunlightΦsunli ght
= 0.09 ± 0.0182, which in turn match the ones determined here using the solar simulator setup
Φsol .sim = 0.074 ± 0.012.
The sensitive nature of quantum yield calculations has been reported186 and may explain
variance among different experimental setups. The molar absorptivity of all compounds at
pH 9.2 and 8.4 are identical and accordingly did not affect the quantum yields. In the present
case, however, owing to the small spectral overlap of molar absorptivity and solar simulator
irradiance for certain compounds (all but NO-SMX and NO2-SMX) (Figure C.5, Appendix C),
slight errors in their determination may largely inﬂuence the rate of light absorption,k0abs,i ,
and hence lead to differences in quantum yields. In contrast to the solar simulator irradiance
which begins at 280 nm, the Rayonet irradiance spans a wavelength range from 250 to 400 nm,
allowing for a larger spectral overlap with the target compounds (Figure C.5, Appendix C)
and leading to a likely more robust quantum yield. On the other hand, NO-SMX shows a
large spectral overlap in both experimental setups due to its absorption range up to 430 nm;
it is thus more robust with respect to small inaccuracies in the absorbance and irradiance
measurements. Correspondingly it is the only compound with comparable quantum yields in
both setups. Furthermore, quantum yields may be wavelength-dependent, which may also
97
Chapter 5. Direct photolysis of human metabolites of sulfamethoxazole
account for the observed differences with various light sources. Environmental half-lives were
computed using the Rayonet quantum yields, which we consider to be more robust.
The minimum environmental half-lives were computed for a sunny summer day (τsummer )at
47◦ N latitude (Geneva, Switzerland) and ranged from 1.3 hours for SMX-glucuronide
to 14 days for NO2-SMX. In the winter, the calculated half-lives (τwinter ) increased to
range from 6 h to 63 days (Table 5.1). In a lake environment, such as Lake Geneva,
summer stratiﬁcation constrains the mixing of the water column and consequently prevent
inﬂowing micropollutants entering below the thermocline to reach the surface and undergo
photolysis. Additionally, they may accumulate below the thermocline140. In winter months,
photodegradation is greatly reduced; however, the enhanced mixing of the water column
ensures a more homogeneous sunlight exposure throughout the water column. Therefore, the
reduced winter photolysis may not have a signiﬁcant impact on concentrations of SMX and its
metabolites in the lake.
5.3.3 Product identiﬁcation
Various studies have examined photoproducts arising from direct photolysis of SMX. The
majority of reported photoproducts arise from cleavage of the molecule at various positions
(Figure 5.1, left panel). Several authors have identiﬁed δ-cleavage, yielding sulfanilic acid, as
the prevailing mechanism82,166, though at least one study reported photoisomerization of the
ﬁve-member isoxazole as the main mechanism102.
The percent conversion was used to quantify the relative importance of conﬁrmed photo-
products of SMX and its metabolites. Explicitly, the conversion corresponds to the percentage
of irradiated target compound converted to a given ﬁrst-generation product; it is calculated
from the ratio of the initial rates of product concentration growth and target compound
concentration loss. The conversion of the target compounds to ﬁrst generation products could
only be calculated for products with available standards.
SMX
The concentrations of quantiﬁable photoproducts of SMX over time are depicted in ﬁgure
5.2a, and the corresponding structures and conversion rates are shown in ﬁgure 5.3. Similarly
to previous research, sulfanilic acid (m/z 172) was found to be the most important quantiﬁable
product of SMX photolysis, with a conversion of 20%. SMX also produced (5-methylisoxazol-
3-yl)sulfamate (m/z 176), a product which has not been reported to date and could be
conﬁrmed by matching exact mass, retention time and UV spectra with the synthesized
standard (validation of standard (NMR, crystal structure, IR, HRMS) given in Appendix C).
Generated through γ-cleavage, it accounts for 11% of degraded SMX. Further products that
could be conﬁrmed with authentic standards include aniline (5%, m/z 94) and 3-amino-5-
methylisoxazole (2%, m/z 99). Both have previously been reported as photoproducts of SMX,
and result respectively from γ- and δ-cleavage102,166.
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Figure 5.2: Photolysis (at pH 9.2) of SMX (a), Ac-SMX (b) and NO-SMX (c) over time with appearance
of quantiﬁable photoproducts and carbon mass balance. Left axis shows concentration of irradiated
substance (mg·L−1), ﬁrst right-axis the concentration of each quantiﬁable photoproduct (mg·L−1) and
second right-axis the carbon-mass balance (%). (d) Enlargement of (c) with concentration of SMX and
Ac-SMX (1st or 2nd generation products of NO-SMX) on the left axis (mg·L−1) and their corresponding
photoproducts on the right axis (mg·L−1). +: MS positive ionization mode, - : MS negative ionization
mode.
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As mentioned above, Zhou and co-workers reported an isomer of SMX, generated through
photo-rearrangment of the isoxazole ring, as the major product with a yield of 30%102. They
also identiﬁed a hydrated product of 2H-azirine, with mass [m-H]−= 270.0550102. Though
these have not systematically been observed in more recent studies82, the exact masses of
both an SMX isomer and hydrated 2H-azirine were observed in the present study. These,
however, could not be conﬁrmed, due to a lack of authentic standards or/and mass spectral
fragmentation data.
A number of additional products were formed during SMX photolysis. Their exact masses
in combination with mass spectral data, when available, were used to propose structures
(Table C.3, Appendix C). Among the proposed structures are hydroxylated products, such as
isomers of OH-SMX [m+H]+=270.0533 (at several retention times), the hydroxylated sulfamate
(4-hydroxy-5-methylisoxazole-3-yl)sulfamic acid ([m-H]−=192.9915), hydroxyaminobenzene
sulfonic acid ([m-H]−= 188.0013), hydroxysulfonic acid ([m-H]−=172.9906), and benzene
sulfonic acid (m-H]−= 156.9954. β-cleavage may also be occurring, with removal of the NH2
group, yielding [m+H]+=239.0478. A recent study onphotolysis of other sulfonamides and their
acetylated-metabolites found desulfonated products to be themost relevant photodegradation
products identiﬁed187. In our work, the exact mass signal corresponding to the SO2-extrusion
product of SMX was also weakly visible.
Ac-SMX
The degradation of Ac-SMX and the growth of conﬁrmed products over time are shown in
ﬁgure 5.2b. Total conversion was highest for Ac-SMX, which was mainly transformed to 4-
acetamidobenzenesulfonic acid (88%, m/z 214), the acetylated equivalent of sulfanilic acid,
generated through δ-cleavage. Other ﬁrst-generation products from direct irradiation of Ac-
SMX include N-phenylacetamide (13%, m/z 136) and (5-methylisoxazol-3-yl)sulfamate (2%,
m/z 176), both produced through γ-cleavage. The production of 3-amino-5-methylisoxazole
(m/z 99), already observed during SMX photolysis, was also conﬁrmed with an authentic
standard. The highest concentrations of most photoproducts were attained after 8h of
photolysis.
A further selection of products can be proposed on the basis of exact mass information. As
observed for SMX photolysis, [m+H]+=239.0485 is the proposed product of a β-cleavage.
[m+H]+=270.0536 could be observed at various retention times and may represent isomers of
hydroxy-SMX. In contrast to SMX, a mass likely corresponding to the SO2-extrusion product of
Ac-SMX ([m+H]+=232.1073) appeared after 1 h irradiation with a high intensity at a retention
time of 10.52 min. The exact masses of all conﬁrmed and proposed photoproducts are within
5 ppm of calculated masses of the proposed elemental composition and can be found Table
C.4, Appendix C.
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SMX-Glucuronide
SMX-glucuronide underwent δ-cleavage, yielding sulfanilic acid (m/z 172), which was,
with aniline (m/z 94), the only conﬁrmed photoproduct for this compound. Though
exact masses corresponding to glucopyranuric acid ([m+H]+=194.0659) and glucuronic acid
([M-H]−=193.0354) appeared with increasing irradiation-time, supporting cleavage of the
glucuronide, no production of the parent compound SMX was detected. The accurate mass
corresponding to the desulfonated product of SMX-glucuronide ([M+H]+=366.1294) was also
observed. Proposed structures are presented in Table C.5, Appendix C.
NO-SMX
NO-SMX showed the highest number of identiﬁed products, mainly due to the production of
SMX and Ac-SMX, which subsequently photolyzed to some of the above mentioned products.
This notable back-transformation of NO-SMX to SMX (m/z 254 in Figure 5.2c) is the ﬁrst
evidence for photolytic back-transformation of a metabolite to its parent compound. However,
the relative magnitude of this pathway remains small: the initial 18.6 mg·L−1 NO-SMX yielded
no more than 0.5 mg·L−1 of SMX, which rapidly degraded to form sulfanilic acid (m/z 172) and
aniline (m/z 94). Similarly, Ac-SMX (m/z 296) was observed right from the ﬁrst sampled time
point (0.3 h), but its maximum concentration remained below 0.5 mg·L−1. In accordance with
the slower photolysis kinetics of Ac-SMX, its respective photoproducts appeared with a slight
time shift relative to SMX photoproducts.
Direct reduction of NO-SMX to SMX and Ac-SMX is chemically improbable, therefore both
are likely at least second generation products of NO-SMX photolysis. The contribution of
buffer components to the unexpected observation of Ac-SMX could be ruled out, as Ac-SMX
was systematically observed with various types of buffers, only one containing an acetylated
derivative (acetic acid). Moreover, a second order reaction involving NO-SMX itself could
be excluded as doubling the initial concentration of NO-SMX did no more than double the
production of Ac-SMX.
The largest fraction of NO-SMX was transformed to the most stable metabolite, NO2-
SMX (m/z 282 in Figure 2c), with a conversion of 55%. It seems that the NO-substituent
favors modiﬁcations of the substituent (to NO2, NH2 and NHCOCH3) rather than cleavage
reactions, which predominated in SMX and Ac-SMX photolysis. As for SMX and Ac-SMX, (5-
methylisoxazol-3-yl)sulfamate (m/z 99) was detected after 0.66 h of irradiation. Its emergence
before SMX and Ac-SMX products (after 2 and 3 h respectively), yet with a slight delay on
NO-SMX degradation, leads us to believe it is not a 1st generation product; thus there is no
evidence that γ-cleavage occurs directly on NO-SMX.
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Figure 5.3: Photolyzed substances and structures of conﬁrmed photoproducts. Formulas are given for
proposed products which were not validated with authentic standards; proposed structures for these
formulas are given in tables C.3–C.6 in Appendix C.
Apart from the new products discussed above and previously mentioned products from SMX
and Ac-SMX, three new structures can be proposed, and supported by in-source fragmentation
information: the nitro-derived products, nitro-benzenesulfonic acid ([m-H]− = 201.9812) and
hydroxylated nitro-SMX ([m-H]− = 298.0143) and a product likely corresponding to addition of
a methyl group on the aromatic ring of NO-SMX ([m-H]− = 280.0401). All conﬁrmed products
as well as proposed structures are shown in Table C.6, Appendix C.
A comparison of the conversion rates illustrates that the different ring substituents on the
metabolites not only affect direct photolysis reaction rates, but also the principal photolysis
pathways (Figure 5.3). Among the conﬁrmed products, cleavage reactions were predominant
for SMX and Ac-SMX, whereas the nitro-group was very resistant to phototransformation
and the nitroso group mainly underwent modiﬁcations of the substituent. Despite the
nitro-group being a very potent chromophore, nitroaromatics are known to have very short
triplet life-times188; this may explain the low reactivity of NO2-SMX. Irradiation experiments
with nitrobenzene effectively found it to be photostable under natural sunlight189. The
photochemistry of nitroso-aromatics has also received much attention, and some have been
shown to oxidize photochemically to nitro-compounds190,191. Several reaction schemes,
involving either C-N bond dissociation or excitation to the ﬁrst singlet state, followed by
intersystem crossing were proposed, but none could be ascertained191.
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Whatever the pathway, these observations are in line with the photooxidation of NO-SMX to
NO2-SMXobserved here. The transformation ofNO-SMX to SMX constitutes a photoreduction,
and thus requires the presence of an electron donor. In our experimental system, trace
amounts of methanol may have played this role. In environmental systems, potential electron
donors include organic matter or chloride, though their effect on the photoreduction of
NO-SMX was not speciﬁcally addressed herein.
The main products of SMX and Ac-SMX resulted from δ- and γ-cleavage. The acetyl-group
may have a stabilizing effect on the C-S bond as δ-cleavage was predominant, while both N-S
and C-S bonds seemed equally susceptible to cleavage during SMX-photolysis. β-cleavage,
involving cleavage of the substituent, was observed for all target compounds, but was not
quantiﬁed due to the lack of analytical standard. Accurate masses corresponding to the
desulfonation-products of SMX and its metabolites were observed for every compound.
Extrusion of SO2 was already identiﬁed as an important direct photolysis pathway for similar
sulfa-drugs (sulfapyridine and sulfmethazine) and their acetylatedmetabolites187. The relative
importance of this pathway could not be quantiﬁed here due to lack of standards. Finally
it may be worth recalling that nitroso- and nitro-substituted compounds already showed
opposite behavior to SMX and Ac-SMX regarding the correlation between spectral overlap
and reaction rate constant. Thus it seems that the nitro-/nitroso- group affects the photo-
excitation and resulting pathways of sulfonamides. Evidently, further research using model
compounds would be required to fully elucidate the mechanisms.
5.3.4 Contribution of direct photolysis to the degradation of SMX metabolites in
Lake Geneva
Water samples from Lake Geneva were investigated to conﬁrm the presence of human
metabolites of SMX in the environment, and to analyze observed concentrations with respect
to their excretion fractions and relative photolability. Over 70 lake water samples from 2
sampling sites and various depths (0–30 m) in Lake Geneva were analyzed for the presence of
the two most abundantly excreted metabolites of SMX, Ac-SMX and SMX-glucuronide. Both
metabolites were detected, but their frequency of detection varied with compound, sampling
site and season. SMX-glucuronide was only detected at a low frequency (9% of samples).
The observed concentrations were systematically and signiﬁcantly lower than SMX (Figure
5.4), despite their comparable excretion fractions. This is consistent with our ﬁnding that
SMX-glucuronide is the most photolabile of all compounds targeted in this study. Given the
rapid photolysis, combined with the unstable nature of the glucuronide bond, which can also
be microbially cleaved167, a low frequency of detection and low environmental concentrations
are expected. Ac-SMX, on the other hand, is excreted in higher amounts than SMX, but
nevertheless was detected at a lower frequency (Ac-SMX: 43%; SMX: 94%). Furthermore, the
concentrations of Ac-SMX detected in the lake were signiﬁcantly lower than SMX.
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Figure 5.4: Measured concentrations (ng·L−1) of SMX and its humanmetabolites SMX-glucuronide and
Ac-SMX in Lake Geneva. f=frequency of detection. Boxes represent 25th percentile, median and 75th
percentile. The whiskers are determined by the 5th and 95th percentiles and the stars show the mean
value
The present study found Ac-SMX to be slightly more resistant to direct photolysis than SMX,
hence the lower concentrations observed for Ac-SMX in lake water may indicate that other
processes such as indirect photolysis processes and biodegradation may also contribute to the
total degradation in the investigated environment. In fact, previous research showed that Ac-
SMXbiodegrades twice as fast as SMX inwater-sediment tests167. Considering lake parameters
and past research82, we expect a minor contribution of indirect photolysis processes to the
total degradation of SMX. However, the susceptibility of human metabolites of SMX to indirect
processes is still to be determined.
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5.4 Environmental relevance
This study observed an abiotic production of SMX from NO-SMX. In the present case, owing to
the low fraction SMX excreted as NO-SMX, the low conversion back to the parent compound
and the relatively high photolability of SMX, the back-transformation of NO-SMX to SMX
may not be of high environmental relevance. However, actual environmental concentrations
of NO-SMX in lake water would be necessary for a better assessment. Nevertheless, this is
the ﬁrst evidence that photolytic back-transformation of a human metabolite to its parent
compound can occur, which in essence presents an environmental source of SMX. Likewise, it
is pertinent to recall that NO2-SMX, the main photoproduct of NO-SMX photolysis, was also
found to retransform to SMX under reducing conditions169, thus representing an additional
abiotic source of SMX. As such, further studies should be pursued to investigate the yield of
NO-SMX back-transformation under different environmental conditions, where the process
may be more signiﬁcant. Moreover, the back-transformation of other nitroso-metabolites
should also be considered. Furthermore, a recent study effectively found a potential increase
of the ecotoxicological risk due to the presence of, among others, SMX metabolites in surface
waters185. The knowledge that some metabolites retain certain biological activity, combined
with their potential to retransform to the parent compound, underlines the importance
of considering human metabolites in environmental ﬁeld work and including product
identiﬁcation in degradation studies.
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6 Conclusion and Perspectives
Contamination of surface waters with trace levels of pharmaceuticals and other chemical
residues from everyday life applications is an acknowledged environmental concern world-
wide. The environmental implications of low concentrations of these compounds in the
aquatic environment are still far from being understood, yet an extensive area of research has
developed around the thematic of micropollutants in surface waters.
In the case of Lake Geneva, the presence of micropollutants is a legitimate worry, considering
that over 70% of the 1.5 million inhabitants surrounding the lake rely on this immense natural
reservoir as their drinking water resource. Moreover, the lake also serves for recreational
purposes and as a natural habitat to an abundance of fauna and ﬂora. Finally, it functions as a
natural treatment plant in that it receives efﬂuent wastewater from numerous treatment plants
along the lake, which are well-acknowledged point-sources of pharmaceuticals to surface
waters.
The sustainable development of this and other lakes world-wide is a global necessity, given the
growing water demand and anthropogenic pressure associated with the increasing population.
In order to preserve and contribute to a durable development of Lake Geneva, with respect to
water quality, it is necessary to assess the physical, chemical, microbiological, and ecological
dynamics of mid-sized lakes which are inﬂuenced by anthropogenic activity. Accordingly,
in regard to micropollutants, understanding the dynamics, fate and consequences of the
release of these substances in water is essential to evaluate potential risks. Such insight
involves an entire suite of research ﬁelds, namely analytical, environmental and organic
chemistry, ecotoxicology and hydrology. The interdisciplinarity of the problematic was
illustrated throughout the four research chapters of this thesis. The work has led to the
following key conclusions:
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Direct discharge of efﬂuent wastewater into lakes leads to the formation of a plume
with elevated micropollutant concentrations during the period of thermal
stratiﬁcation
The ﬁrst step in assessing the risk associated with the presence of micropollutants in
Lake Geneva consisted in determining their concentrations in the lake. A large variety of
pharmaceuticals and other micropollutants have been observed in surface waters around
the world, with rising frequency of detection. Often, however, the spatio-temporal aspects of
concentration ﬂuctuations were not considered. Moreover, the impact of direct discharge of
efﬂuent wastewater into a lake had never been investigated. These aspects were highlighted in
Chapter 2, which investigated the occurrence of 39 priority micropollutants (pharmaceuticals
from various classes, pesticides and corrosion-inhibitors). A 10-month water sampling
campaign in the Vidy Bay of Lake Geneva showed that wastewater directly discharged into the
lake does not readily mix with the surrounding water column during certain periods of the
year. Indeed, during the warm season, thermal stratiﬁcation prevents vertical mixing between
the surface and the bottom layers of the lake. This leads to a plume of elevated concentrations
of micropollutants above the outfall at the level of the thermocline. In winter, homogeneous
temperature proﬁles allow enhanced mixing of the water column and, consequently, uniform
micropollutant concentrations at all depths.
Over 200 water samples were collected and analyzed during this campaign in order to conﬁrm
the presence of a plume and get a sense of its spatio-temporal variability and extent. Despite
rapid recent advances in sample preparation techniques and detection methods, determining
concentrations of these pollutants in water samples still remains a tedious and costly task.
This illustrates one of the limitations of punctual ﬁeld sampling when investigating dynamic
and variable processes.
In this sense, the relation between micropollutants and electrical conductivity discovered in
this study represents a simple tool to estimate the concentrations of these compounds around
the wastewater outfall. Indeed, the concentrations of wastewater-derived micropollutants
within the plume were found to be closely correlated to the value of electrical conductivity.
Ultimately, it is a measure of the wastewater dilution, thus the correlation is conserved for
conductivity measurements greater than the background, i.e. within the plume. This relation
was observed for the speciﬁc setting of Vidy Bay, and is likely validated in other aquatic
environments receiving efﬂuent wastewater, owing to the high ion concentrations of the latter.
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The spreading of the plume can be captured beyond individual sampling points by
combining hydrodynamic considerations with environmental degradation processes
To fully evaluate the implications of the micropollutant plume, both its spatial extent and
temporal variability must be known. Models represent a complementary approach to
overcome the limitations of punctual sampling and/or to augment measured data. As the
spatial distribution of a chemical is simultaneously affected by transport and transformation
processes, knowledge of these processes and their underlying physical-chemical parameters
is required. In surface waters, photolysis has been recognized as a major transformation
process for many polar organic contaminants, in particular those having resisted biological
treatment in wastewater treatment plants. The inherent interdisciplinarity of understanding
the spreading of the micropollutant plume was exempliﬁed in Chapter 3. It proposed a model
coupling 3Dparticle tracking, the product of an associated project on lake hydrodynamics, and
photodegradation of micropollutants. Though unconventional, particle tracking represented
the idealmethod to combine depth-dependent photolysis and 3-dimensional plume spreading
in the objective of predicting the concentration of micropollutants in the vicinity of the
wastewater outfall under typical wind scenarios and seasons relevant to Vidy Bay. To assess
the importance of photolysis for the targeted compounds in Vidy Bay, photolysis kinetics were
determined via a series of direct and indirect photolysis experiments under a solar simulator
and then extrapolated to environmental conditions.
As expected, photodegradation was an important removal mechanism for many micropol-
lutants and thus contributed to a reduction in their concentrations over time and distance
from the WW outfall, especially for surface plumes in winter. In contrast, during thermal
stratiﬁcation, the importance of photodegradation processes in attenuating the plume extent
was greatly reduced, due to light screening by the water column.
The micropollutant plume causes a potential ecotoxicological risk
Ultimately, the underlying motivation of delineating the plume and its concentrations is
to assess whether the measured and predicted concentrations of micropollutants in Vidy
Bay exhibit an environmental risk. Though present at low concentrations, pharmaceuticals
are designed to be biologically active and the existence of adverse effects on aquatic fauna
and ﬂora is well-acknowledged. Moreover, in the environment, a myriad of compounds
are present; these can interact with each other resulting in additive or potentially even
synergistic mixture effects. The zone of potential ecotoxicological risk for the mixture of
targeted micropollutants was delineated by combining the individual risk of each substance
determined using ecotoxicity data obtained from literature.
Direct discharge of efﬂuent wastewater into the Bay resulted in a limited zone that surpassed
water quality criteria for micropollutant concentrations. The coupled hydrodynamic-
photolysis model conﬁrmed the ﬁeld measurements, which indicated that the risk is most
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pronounced and the affected zone is largest in summer: a stretch of up to 300 m to the east and
the west of the wastewater outfall may exhibit a potential ecotoxicological risk. It should be
noted, however, that this risk assessment only takes into account the (24) wastewater-derived
micropollutants targeted in this study. Hence, the inclusion of additional compounds would
likely increase the ecotoxicological risk and the affected area.
The total ecotoxicological risk can be mainly attributed to a few compounds
Overall, the coupled hydrodynamic-photolysis model applied to ecotoxicological risk assess-
ment allows for the identiﬁcation of critical situations and well as important parameters.
Analysis of various scenarios showed that wind conditions and solar irradiation play an
essential role in determining the zone of potential ecotoxicological risk. On the one hand,
winds govern hydrodynamic currents and mixing processes. On the other, the intensity of
solar irradiation will inﬂuence photodegradation kinetics and thermal stratiﬁcation. Thus,
the risk zone varies greatly according to these environmental factors, over which we have no
control.
Nevertheless, we may exert our inﬂuence by preventing the release of micropollutants to the
environment. Indeed, as ultimately only a few compounds contributed signiﬁcantly to the
total ecotoxicological risk, these should be considered priority substances for wastewater
treatment plant optimization and further monitoring campaigns. Among the problematic
compounds, antibiotics were the major pharmaceutical class that contributed to the risk. This
ecotoxicological risk adds on to the existing concern of the spreading of antibiotic resistant
bacteria also associated to the presence of antibiotics in surface waters.
Human metabolites of pharmaceuticals lead to an increased ecotoxicological risk
and may present a source of parent compound in the environment
Recent research efforts have shifted towards identifying photolysis products of pharmaceuti-
cals, as well as the presence and fate of their humanmetabolites, as bothmay also present a risk
to the aquatic ecosystem. Some metabolites are not only more pharmacologically active than
the parent compound, but were also found to back-transform to the active pharmaceutical,
for example during biological wastewater treatment. Similarly, photodegradation processes
may yield photoproducts that are more persistent than the parent compound and retain
toxicological relevance.
The occurrence of various human metabolites of pharmaceutical in Vidy Bay was investigated
in Chapter 4. Their concentration proﬁles at the WWTP discharge location displayed a
plume-like feature, conﬁrming that wastewater efﬂuent represents the main source of human
metabolites to the lake. Nevertheless, the metabolites targeted in this study were determined
to be more susceptible to environmental degradation processes than their parent.
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In continuation, the propensity of selected human metabolites to undergo photodegradation
was more fundamentally addressed in Chapter 5. Unlike observed ﬁeld data, almost all
investigated metabolites were found to be more photostable that the parent compound,
indicating that other transformation processes such as indirect photolysis processes and
biodegradation may also contribute to the total degradation in the investigated environment.
Assuming a worst-case scenario, in which pharmaceuticals and their metabolites present
a similar ecotoxicological impact, the presence of human metabolites led to an increased
environmental risk. In addition, identiﬁcation of the major phototransformation products of
several human metabolites showed that one was retransformed back to the parent compound
via a photoreduction. This is the ﬁrst evidence for photolytic transformation of a human
metabolite back to its parent compound. As such, human metabolites could represent an
environmental source of pharmaceuticals in the environment.
Future research needs
In the past decade, notable advances have been made in assessing the occurrence, fate, effects
and risks of pharmaceuticals in the environment. Yet, throughout this work, a number of
unanswered questions arise pertaining to the limitations of current methods in assessing the
fate of contaminants and the actual consequences of their presence in the environment.
Understanding the fate of contaminants in water constitutes an essential step in the
ecotoxicological risk determination. For instance, some compounds may be toxicologically
relevant, but exhibit low persistence and thus do not represent a threat to the environment.
An entire ﬁeld of research is dedicated to assessing the propensity of individual compounds
to undergo various degradation processes and to identifying the factors that inﬂuence these
transformations. The necessary parameters required to model their fate in water, such as for
instance the quantum yield of direct photolysis, may be determined in the well-controlled
environment of a laboratory via simple black-box type experiments. However, a fundamental
understanding of the factors inﬂuencing these processes ﬁnally gives rise to molecular or
intramolecular-level models to predict e.g. the magnitude of indirect processes based on water
characteristics, and perhaps in the near future the quantum yields of direct photolysis based
on chemical structure. To date, a number of intrinsic compound properties and structural
information allow estimations of partitioning between phases or reaction rates with given
compounds (QSAR, quantitative structure activity relationships). Research is developing in
the ﬁeld to predict biotransformation pathways (QSBR, quantitative structure-biodegradation
relationships) and oxidative transformation processes. A promising, yet challenging area
of research thus constitutes the prediction of susceptibility to photodegrade or even the
nature of phototransformation products, based on chemical structure and quantum chemical
calculations. Such predictions would address the lack of experimental data which is needed to
parameterize exposure or risk models.
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Chapter 6. Conclusion and Perspectives
Similarly, a lack of pertinent experimental data may be noted in the ﬁeld of ecotoxicology.
Common toxicity tests use a small selection of laboratory organisms and focus on acute
effects. Yet, aquatic organisms are generally exposed to low levels of micropollutants over
their entire lifetime, inducing chronic toxicity or more subtle effects, which are still unknown.
Additional questions arise regarding toxicity of human metabolites of pharmaceuticals and
transformation products. Considering the overwhelming number of compounds, human
metabolites and transformation products, complete experimental assessment of their toxicity
is unrealistic. Therefore, future research should focus on the development of simple screening
tests (effect-based approach) coupled to computational prediction methods (i.e. methods that
estimate metabolite or transformation product toxicity based on the structure and toxicity of
the parent) as a ﬁrst-tier toxicity assessment. In this sense, pre-existing clinical information
of pharmaceuticals may also be useful to infer adverse effects, or to assess relative effects of
transformation products or metabolites compared to parent compounds. Filling in these gaps
will lead to more realistic risk assessments with lower uncertainty
Finally, models are insigniﬁcant without environmental or experimental data. The ﬁeld of
analytical chemistry has made tremendous advances, with on-line extraction devices and high-
resolution mass spectrometry. Nonetheless, progress can still be made in sample preparation
techniques, coping with matrix effects, lowering detection limits and identifying non-target
compounds and transformation products.
So, there’s a micropollutant plume in the lake... now what?
With respect to the sustainable development of Lake Geneva, which is above all an immense
drinking water reservoir, what solutions can be envisioned? Knowledge of a baseline
concentration of various micropollutants in the lake, along with at least one localized zone
of elevated toxicity associated with micropollutants should trigger some reactions within the
affected population and their decision makers.
End-of-pipe solutions, consisting in the improvement of wastewater treatment technologies
to decrease the load discharged to surface waters represent an efﬁcient and timely solution.
The ineffectiveness of conventional wastewater treatment systems is a key component in the
problematic presence of these compounds in surface waters. Alternative approaches and
advanced technologies show promising results with respect to removal of micropollutants;
nevertheless, currently no treatment technology can completely remove all pharmaceuticals
and other contaminants. This highlights the importance of identifying the micropollutants
which present a high risk to the environment as was done in this work. Ultimately, a handful of
pharmaceuticals and one pesticide contributed signiﬁcantly to the ecotoxicological risk. These
priority micropollutants should be the focus of treatment optimization, all while preventing
the formation of toxic by-products, which may occur with some technologies.
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Centralized treatment plants, such as the Vidy WWTP, lead to massive point-source release.
This may be prevented by decentralization of sewage treatment, which delocalizes the dis-
charge and increases the dilution of efﬂuent,hence avoiding the formation of micropollutant
hot spots. Yet, this approach does not solve the issue of overall micropollutant release if
conventional treatment technologies are maintained. As such, passive treatment systems,
such as constructed wetlands or lagoons present a promising alternative in areas where land
space is sufﬁcient.
On a longer-term, preventing entry of micropollutants into the sewer system should also be
considered. Various approaches along the “pipeline” of micropollutants are already under
investigation, namely segregation of sources (no-mix toilet, separate treatment of hospital
wastewater), improvement of drug disposal information, more considerate prescription of
pharmaceuticals by doctors and correct usage by patients, and green-pharmaceutical industry.
The adverse effects associated with the presence of trace concentrations of micropollutants in
surface waters are undisputed. Many questions remain as to their full extent and the potential
human health risks. Currently, there is little evidence showing adverse effects on human
health. Yet, facing these uncertainties, the precautionary principle should be applied and
preventing entry of micropollutants to the environment is worth the extra cost.
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Figure A.1: Proﬁles of electrical conductivity (EC), ions Na+ and Cl− and pharmaceuticals above the
WWTP discharge point in April 2010.
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Figure A.2: Seasonal comparison of measured concentrations of pharmaceuticals (top ﬁgure) at the
WWTP outfall (white) and at the reference points (green). Concentrations are generally lower at the
reference point with a more perceptible difference in summer. In contrast, concentrations of pesticides
(bottom ﬁgure) show no signiﬁcant differences betweenWWTP outfall and reference points (note that
uncharacteristic compounds, namely carbamazepin, benzotriazol, methylbenzotriazol and carbendazim,
were removed for the analysis). Boxes represent 25th percentile, median and 75th percentile. The
whiskers are determined by the 10th and 90th percentiles. Stars show the mean value. Mean values of
pharmaceuticals are pulled towards higher values by outliers (e.g. high concentrations in plume).
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Figure A.3: Concentration depth proﬁles for pharmaceuticals (top) and non-pharmaceuticals (bottom)
above the WWTP discharge point (left) and above the down-stream reference point (REF down) (right)
in April 2010. Concentrations are relative to the concentration detected at the bottom. A small
concentration peak at REF down (-10 m) was observed only on this occasion (April 2010). EC: electrical
conductivity, T: temperature, Atn: atenolol, Cbz: carbamazepin, Cip: ciproﬂoxacin, Dfc: diclofenac, Gbp:
gabapentin, Met: metoprolol, Nor: norﬂoxacin, Par: paracetamol, Sot: sotalol, Smx: sulfamethoxazol,
Tri: trimetoprim, Atr: atrazin, Ben: benzotriazol, Car: carbendazim, Irg: irgarol, Iso: isoproturon, Mec:
mecoprop, Mbz: methylbenzotriazol, Pro: propiconazol, Ter: terbutryn.
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Figure A.4: Chronology of risk quotient (RQ) in plume for all micropollutants. Pharmaceuticals in blue
and non-pharmaceuticals in orange.
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Table A.1: Retention times (RT) and deuterated surrogate standard (Surr. Std) or assigned deuterated
surrogate standard with corresponding mean relative recovery (25th and 75th percentile of averaged
monthly recoveries).
Compound UPLC RT [min] Surr. Std Mean Recovery
atenolol 3.5 atenolol-d7 0.99-1.08
atrazin 13.2 atrazine-d5 0.63-0.67
azithromycin 11.5 azithromycin-d3 0.90-1.01
benzotriazol 7.2 benzotriazol-d4 0.64-0.74
bezaﬁbrat 14.1 bezaﬁbrat-d4 1.26-1.41
carbamazepin 12.7 carbamazepine-d10 0.82-0.92
carbendazim 6.0 gabapentine-d4
chloridazon 9.3 primidon-d5
ciproﬂoxacin 8.4 ciproﬂoxacin-d8 0.43-0.75
clarithromycin 14.0 bezaﬁbrat-d4
clindamycin 12.0 carbamazepine-d10
cloﬁbric acid 13.8 ketoprofen-d3
diclofenac 15.0 diclofenac-d4 0.71-0.88
diuron 13.0 atrazine-d5
gabapentin 5.8 gabapentine-d4 1.06-1.13
gemﬁbrozil 15.8 simvastatin-d6
iopamidol 1.7 paracetamol-d3
iopromid 4.0 iopromide-d3 1.09-1.19
IPBC 13.0 atrazine-d5
irgarol 13.4 irgarol-d9 0.39-0.48
isoproturon 13.3 isoproturon-d6 0.89-0.98
ketoprofen 13.7 ketoprofen-d3 1.40-1.46
mecoprop 14.2 bezaﬁbrat-d4
mefenamic acid 15.7 mefenamic acid-d3 0.27-0.51
methylbenzotriazol 10.1 azithromycin-d3
metoprolol 9.3 primidon-d5 0.98-1.02
metronidazol 2.4 paracetamol-d3
naproxen 13.9 ketoprofen-d3
morﬂoxacin 8.1 oﬂoxacin-d8
oﬂoxacin 7.9 oﬂoxacin-d8 0.59-0.74
paracetamol 3.3 paracetamol-d3 0.82-0.94
primidon 9.2 primidon-d5 1.05-1.21
propiconazol 15.2 diclofenac-d4
propranolol 11.7 azithromycin-d3
simvastatin 16.3 simvastatin-d6 0.49-0.69
sotalol 2.4 paracetamol-d3
sulfamethoxazol 7.8 sulfamethoxazol-d4 0.68-.89
terbutryn 13.0 atrazine-d5
trimethoprim 7.0 metoprolol-d5
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Uncertainty budget
Themain sources of uncertainty of determined concentrations are i) the uncertainty associated
to recovery, ii) the uncertainty linked to repeatability of measurements and iii) the uncertainty
associated with calibration. Each uncertainty is quantiﬁed as a standard deviation (SD)
(gaussian distribution) to show the extent of the variance around the cited value. The main
sources of uncertainty are clariﬁed below:
Recovery uncertainty (SDR) Extraction recoveries were determined for the 20 deuterated
surrogates and for each sampling day. Measured sample concentrations of each substance
were corrected by the average extraction efﬁciency of its corresponding deuterated surrogate.
The uncertainty of recovery arises from the uncertainty linked to using the monthly
average recovery, rather than individual sample recoveries, to determine the micropollutant
concentrations in each sample. The uncertainty of recovery was thus expressed as the SD of
all individual recoveries for a given compound over the entire sampling period. Substances
lacking deuterated surrogates were attributed the SDR of their assigned surrogate compound.
Repeatability uncertainty (SDrep) The uncertainty associated with repeatability is repre-
sented by the variability of the overall method reproducibility tests. In these tests, two sets of
eight replicates of lake water were spiked with all 39 micropollutants to concentration of 3 and
70 ng·L−1, respectively, and were put through the entire sample workup procedure (extraction-
UPLC-MS/MS-calculation of concentration via calibration curves). For replicates spiked to
70 ng·L−1, the SD of entire procedure was lower than 15% of the calculated concentration for
the large majority of the compounds. The SD increased for replicates spiked to 3 ng·L−1, yet
remained below 20% for most compounds. The SD from reproducibility tests performed with
3 ng·L−1 was used to calculate the total uncertainty.
Calibration uncertainty (SDcal ) The uncertainty of calibration is linked to using a calibration
curve technique to interpolate the concentration of a given compound in the sample. This
source of uncertainty was found to be smaller than i) and ii) and is already included in the
uncertainty budget in ii). Indeed, the higher SD for replicates spiked with only 3 ng·L−1 is due
to an increase in uncertainty of the calibration. Indeed, the lower concentration lies towards
the lower end of the calibration curve, thus uncertainty increases.
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The total uncertainty combines the individual sources of uncertainty according to the following
equation, assuming individual uncertainties are not correlated:
SDtot =
√
SD2R +SD2rep +SD2cal (A.1)
As SDcal is small and already included SDrep , the worst case total SD simpliﬁes to:
SDtot =
√
SD2R +SD2rep (A.2)
The above described method used to estimate uncertainties in analytical procedures using
chromatographic techniques was adapted from the method proposed by Koneiczka et al.192.
SDR and SDrep , as well as the total relative uncertainty linked to each individual compound
are listed in table A.2 hereafter.
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Table A.2: Total uncertainty of each individual compound computed from STDrep2 (or when missing
SDrep1) and SDR according to equation A.2.
Compound SDrep11 SDrep22 SDR SDtot
atenolol 0.07 0.25 0.14 0.28
atrazin 0.08 0.14 0.3 0.33
azithromycin 0.1 0.11 0.18 0.21
benzotriazol 0.07 0.09 0.22 0.24
bezaﬁbrat 0.15 0.33 0.18 0.38
carbamazepin 0.06 0.15 0.22 0.27
carbendazim 0.08 0.07 0.18 0.31
chloridazon 0.07 0.08 0.16 0.35
ciproﬂoxacin 0.11 0.2 0.3 0.27
clarithromycin 0.23 0.09 0.18 0.16
clindamycin 0.07 0.09 0.22 0.23
cloﬁbric acid 0.25 0.22 0.21 0.47
diclofenac 0.08 0.29 0.34 0.38
diuron 0.14 0.13 0.3 0.25
gabapentin 0.08 0.11 0.18 0.51
gemﬁbrozil 0.1 0.24 0.55 0.28
iopamidol 0.09 0.08 0.2 0.56
iopromid 0.1 - 0.21 0.23
IPBC 0.18 0.3 0.3 0.42
irgarol 0.11 0.16 0.41 0.21
isoproturon 0.16 0.29 0.25 0.29
ketoprofen 0.14 0.1 0.21 0.11
mecoprop 0.17 0.15 0.18 0.15
mefenamic acid 0.25 0.26 0.49 0.26
methylbenzotriazol 0.06 0.09 0.18 0.09
metoprolol 0.06 0.09 0.14 0.1
metronidazol 0.07 0.13 0.2 0.23
naproxen 0.24 0.16 0.21 0.16
norﬂoxacin 0.11 0.11 0.25 0.11
oﬂoxacin 0.18 0.12 0.25 0.13
paracetamol 0.09 0.06 0.2 0.06
primidon 0.06 0.09 0.16 0.09
propiconazol 0.09 0.14 0.34 0.14
propranolol 0.07 0.18 0.18 0.18
simvastatin 0.08 0.24 0.55 0.25
sotalol 0.08 0.11 0.2 0.11
sulfamethoxazol 0.1 0.13 0.35 0.13
terbutryn 0.11 0.2 0.3 0.21
trimethoprim 0.06 0.12 0.14 0.12
1SDrep1: SD of eight replicate samples spiked with 39 micropollutants to a concentration of 70 ng·L−1
2SDrep2: SD of eight replicate samples spiked with 39 micropollutants to a concentration of 3 ng·L−1
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Table A.3: Predicted no-effect concentrations (PNECs) of individual compounds and method used to
derive PNEC.
PNEC (ng·L−1)3 Method4 Source
atenolol 33’400 SF Perazzolo et al. 20102
atrazin 420 SSD Chèvre et al. 200667
azithromycin 10 SF present study (Table A.4)
benzotriazol 30’000 - OekotoxZentrum193
bezaﬁbrat 1’191 SF Perazzolo et al. 20102
carbamazepine 2’500 SF Perazzolo et al. 20102
carbendazim 100 SSD Junghans et al. 2010194
chloridazon 97 SF present study (Table A.4)
ciproﬂoxacin 5 SF Perazzolo et al. 20102
clarithromycin 60 - OekotoxZentrum193
clindamycin5 - - -
cloﬁbric acid 397 SF Perazzolo et al. 20102
diclofenac 100 SF Perazzolo et al. 20102
gabapentin 1’000’000 SF Perazzolo et al. 20102
gemﬁbrozil 751’000 SF Perazzolo et al. 20102
irgarol 1.6 SSD present study (Table A.5)
ketoprofen 15’600 SF present study (Table A.4)
mecoprop 1’000 SSD Chèvre et al. 2007195
methylbenzotriazol 75’000 - OekotoxZentrum193
metoprolol 3’200 SF Perazzolo et al. 20102
metronidazol 25’000 SF present study (Table A.4)
norﬂoxacin 40’100 SF Perazzolo et al. 20102
oﬂoxacin 500 SF present study (Table A.4)
paracetamol 9’200 SF present study (Table A.4)
primidon 54’171 SF Perazzolo, unpublished data
propiconazol 1’220 SSD Chèvre et al. 2007195
propranolol 50 SF Perazzolo et al. 20102
simvastatin 9’600 SF Perazzolo, unpublished data
sotalol 15’935 SF Perazzolo et al. 20102
sulfamethoxazol 26.8 SF Perazzolo et al. 20102
terbutryn 40 SSD Chèvre et al. 200667
trimethoprim 160’000 SF present study (Table A.4)
3PNEC or PNEC-equivalent in ng·L−1
4Method used to determine PNEC:
SF: derived from NOEC or EC50 and corrected with a safety factor (SF);
SSD: HC5 was derived from a species sensitive distribution curve (SSD) (see Table A.5 for an example), and
reported PNEC is a PNEC-equivalent equal to HC5/5.
5no ecotoxicity data
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Table A.4: PNEC values with ecotoxicity data for the three trophic levels (algae, crustaceans, ﬁsh).
PNEC values were derived according to the method reported in Perazzolo et al.2, and safety factors
chosen based on recommendations in the Technical guidance document on risk assessment68. PNEC:
predicted no-effect concentration; NOEC: no-observed effect concentration; EC50: Effect Concentration
50% (concentration at which 50% of the tested (generally acute tests) organism shows the targeted
endpoint, generally mortality); SF: safety factor used to derive PNECs.
PNEC SF Algae (type) Crustaceans Fish Sources
(μg·L−1) (μg·L−1) (μg·L−1) (μg·L−1)
azithromycin 0.0094 100 0.94 (EC50) 4.4 (NOEC) 84’000 (NOEC) 196
chloridazon 0.097 1000 97 (EC50) 180 (EC50) 199’000 (LC50) 197
ketoprofen 15.6 1000 15’600 (EC50)6 97’000 (EC50) 64’000 (LC50) 196
metronidazol 25 500 12’500 (EC50) 100’000 (EC50) 500’000 (NOEC) 196
oﬂoxacin 0.5 10 5 (NOEC) 10’000 (NOEC) 16’000 (NOEC) 198
paracetamol 9.2 1000 134’000 (EC50) 9’200 (EC50) 378’000 (EC50) 199
trimethoprim 160 100 16’000 (EC50) 100’000 (NOEC) 100’000 (NOEC) 196
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Table A.5: Ecotoxicity data (NOEC) and corresponding sources used to derive HC5 for pestide irgarol
using a species sensitive distribution (SSD) curve (see ﬁgure A.5). Algae being the most sensitive taxon to
irgarol, only algal species were considered for the SSD. NOEC: No-observed effect concentration; HC5:
Hazardous concentration 5% (concentration that affects 5% of aquatic species). ETX 2.0 software (Normal
distribution based hazardous concentration and fraction affected; software by RIVM, Bilthoven, the
Netherlands, 2004)
Species Scientiﬁc Name NOEC in μg·L−1 Source
Apium nodiﬂorum 0.2 Lambert et al. 2006200
Chara vulgaris 0.001 Lambert et al. 2006200
Chlorella fusca ssp. Vacuolata 0.506 Arrhenius et al. 2006201
Chroococcus minor 1 Zhang et al. 2008202
Dunaliella tertiolecta 0.09 DeLorenzo et al.203
Eisenia bicyclis 0.757 Okamura et al. 2000204
Elodea Canadensis 0.8 Nyström et al. 2002205
Enteromorpha intestinalis 0.05 Scarlett et al. 1997206
Fucus serratus 8 Braithwaite et al. 2005207
Lemna gibba 0.4 Van Wezel et al. 2004208
Myriophyllum spicatum 2 Lambert et al. 2006200
Navicula accomoda 0.1 Nyström et al. 2002205
Navicula pelliculosa 0.017 Van Wezel et al. 2004208
Nitzschia sp. 0.1 Nyström et al. 2002205
Porphyra yezoensis 0.543 Okamura et al. 2000204
Potamogeton pectinatus 2.53 Nyström et al. 2002205
Scenedesmus subspicatus 0.23 Van Wezel et al. 2004208
Scenedesmus vacuolatus 0.507 Arrhenius et al. 2006201
Selenastrum capricornutum 1.803 Van Wezel et al. 2004208
Skeletonema costatum 0.01 Zhang et al. 2008202
Thalassiosira pseudonana 0.1 Zhang et al. 2008202
HC5 (computed using ETX 2.0)= 0.008 μg·L−1 ⇒ PNEC-equivalent = HC5/5 = 1.6 ng·L−1
Figure A.5: Species sensitivity distribution for irgarol, using data from table A.5
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Calculation of bimolecular reaction rate constant with hydroxyl radical
Equation 3.2 from text:
k0tot ,i −k0direct ,i = k ′•OH ,i = [•OH ]ss ·k•OH ,i
Values from literature (Table 3.1) were used to estimate the [•OH]ss in each experimental
beaker containing a mixture of substances with known (from literature) and unknown bi-
molecular rate constants with •OH, via equation 3.2. Consequently, unknown bimolecular rate
constants were calculated with the estimated [•OH]ss from the corresponding experimental
beaker.
Calculation of [•OH]ss,l ake
The concentration of hydroxyl radicals in surface waters can be approximated by the ratio of
the rates of production and consumption of •OH19:
[•OH] =
kabs,NO−3 ·Φ f ,NO−3 · [NO−3 ] + kabs,NO−2 ·Φ f ,NO−2 · [NO−2 ]
k ′•OH,DOC · [DOC] + k ′•OH,HCO2−3 · [HCO
2−
3 ] + k ′•OH,CO−3 · [CO
−
3 ]
(B.1)
The values used in equation B.1 are given in Table B.1.
Table B.1: Parameters used in equation B.1
Summer Winter Unit
kabs,NO−3 1.31 · 10−5 1.89·10−6 M−1·s−1 speciﬁc rate of light absorption of nitrate, noon
Φ f ,NO−3 0.007 0.007 - quantum yield of
•OH formation by nitrate
[NO−3 ] 2.9· 10−5 2.9· 10−5 M nitrate concentration (measured)
[NO−2 ] 0 0 M nitrite concentration (measured)
k ′•OH,DOC 2.5· 104 2.5· 104 (mg C)−1s−1 reaction rate constant between •OH and DOC106
[DOC] 1.4 1.1 mg C·L−1 dissolved organic carbon concentration (measured142)
k ′•OH,HCO2−3
1· 107 1· 107 M−1·s−1 reaction rate constant between •OH and HCO2−3 209
[HCO2−3 ] 2.25· 10−3 2.25 · 10−3 M bicarbonate concentration (calculated) (a)
k ′•OH,CO−3 4· 10
8 4· 108 s−1 reaction rate constant between •OH and CO−3 209
[CO−3 ] 3.73· 10−5 9.8· 10−6 M−1·s−1 carbonate concentration (b)
[OH]ss,noon 3.95· 10−17 6.79· 10−18 M •OH steady state concentration, noon
[OH]ss,24h 1.74· 10−17 3· 10−18 M •OH steady state concentration, 24h
(a) [HCO2−3 ] = 2·[Ca2+]
(b) log[CO−3 ]= pH-pKa-log[HCO
2−
3 ]
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Important model parameters (more details found in Razmi et al.141):
Wind speed, direction: Bise: 3 m·s−1, 10◦ ; Vent: 3 m·s−1, 240◦
Radius of release: 10 m
Vertical dispersion coefﬁcient: 0.0001-0.00001 (depending on the stratiﬁcation)
Density of water: 1000 kg·m3
Horizontal dispersion coefﬁcient: t0.01 (t= particle age), recommended by Delft3D-PART
Stratiﬁcation: a classic stratiﬁcation for Lake Geneva in summer time with the thermocline
around 14-16 m depth in Vidy Bay.
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Time to steady state:
Figure B.1: Number of particles over time in different layers at REF-down (top ﬁgures) and REF-up
(bottom ﬁgures) for the Bise and Vent scenarios, respectively. The initial increase of particles indicates the
minimal travel-time from the WWTP outfall to the considered reference location. Steady state is reached
once the number of particle stabilizes.
Concentration depth proﬁles for Bise conditions:
Figure B.2: Modeled concentration depth proﬁles for diclofenac under unstratiﬁed Bise (top), and
stratiﬁed Bise (bottom) for the locations G-L marked by blue crosses in ﬁgure 3.3.
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Absolute and normalized spectrum of 300 nm bulbs, solar simulator and simu-
lated solar spectrum (SMARTS)
Figure C.1: Top: Normalized irradiance of the different experimental light sources (Rayonet -measured
from within the test tubes- and solar simulator) and of the computed SMARTS solar irradiance for a
sunny day at 47◦N (Geneva) for a summer scenario (21st June) and winter scenario (21st December)
Values are normalized over the relevant wavelength interval of 265–430nm. Note that, though the solar
simulator spectrum extends below 280 nm, excess UVB compared to the solar spectrum only amounts to
1% of the total intensity. Bottom: Absolute irradiance of the different experimental light sources (Rayonet
-measured fromwithin the test tubes- and solar simulator) and of the computed SMARTS solar irradiance
for a sunny day at 47◦N for a summer scenario (21st June) and winter scenario (21st December).
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Absorbance versus pH for pKa,2 determination
Figure C.2: Absorbance values at a single wavelength versus pH for SMX and its human metabolites.
Grey line represents the least square ﬁt of sigmoidal Boltzman function y = A1−A2
1+e
x−x0
dx
+ A2, where x0 is the
inﬂection point (i.e pKa,2 value) and A1 and A2 are, respectively, the lower and upper asymptotes. Error
reﬂects the standard deviation of x0.
Molar absorptivity at pH conditions used in photolysis experiments
Figure C.3: Absorption spectra (Molar absorptivity ε) of the irradiated target compounds at the different
experimental pH-values.
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Direct photolysis kinetics
Figure C.4: Direct photolysis kinetics: a)First-order direct photolysis kinetics for SMX and its human
metabolites; b) comparison of direct photolysis rate constants for experiments with single (50 μM, green
bars) and double concentration (100 μM blue bars).
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Examples of spectral overlap of compound absorbance and irradiance
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Figure C.5: Top panels: Spectral overlap (speciﬁc rate of light absorption k0abs,i ) of SMX in the Rayonet
setup (left) and Solar simulator setup (right). Bottom panels: Spectral overlap (speciﬁc rate of light
absorption k0abs,i ) of NO-SMX in the Rayonet setup (left) and Solar simulator setup (right). *Spectral
overlap (green shaded area): overlap of compound absorbance spectrum (blue line) and spectrum of
light source (orange line). Attention is brought to the small overlap of SMX (and similarly absorbing
compounds: Acetyl-SMX and SMX-glucuronide) in the solar simulator setup.
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Analytical methods
Composition of irradiated solutions
The irradiated solutions of the target compounds in Nanopure water were buffered using
various chemicals, depending on the desired pH, in order to maintain a stable pH in solution.
pH values measured before experiments always remained stable for the entire irradiation time.
The composition and pH of the various buffers are described below:
• acidic experiments (pH 3.2, solar simulator setup): acidic experiments (pH 3.2, solar
simulator setup): 0.1 mM citric acid, 0.5 mM HCl.
• basic experiments (pH 8.4, solar simulator setup): 2 mM sodium bicarbonate.
• basic experiments (pH 9.2, Rayonet setup): 1 mM sodium tetraborate decahydrate.
Description of isocratic and gradient modes from Table C.1
Gradients are expressed as % of eluent A over time
• Isocratic 1 run time : 5 min, 60% eluent A-40% eluent B
• Gradient 1 run time : 14 min. 0-3 min: 80% A, 3–4 min: ramp to 75%, 4–6 min: ramp
to 72%, 6–8 min: ramp to 5%, 8–10 min: 5%, 10–11 min: ramp to 80%, 11–14 min:
equilibrate at 80%.
• Gradient 2 run time : 11 min. 0 min: 95% A, 1–7 min: ramp to 75%, 7–8 min: ramp to
5%, 8–9 min: ramp to 95%, 9–11 min: equilibrate at 95%.
• Gradient 3 run time : 45 min. 0–11 min: 100% A, 11–12 min: ramp to 87%, 4–6 min:
ramp to 72%, 12–36 min: 87%, 36–37 min: ramp to 100%, 37–45 min: equilibrate at
100%.
• Gradient 4 run time : 42 min. 0–4 min: 99% A, 4–8 min: ramp to 79%, 8–17 min: 79%,
17–19 min: ramp to 63%, 19–28 min: 63%, 28–29 min: ramp to 10%, 29–31 min: 10%,
31–32 min: ramp to 99%, 32–42 min: equilibrate at 99%.
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Appendix C.
Direct photolysis calculations
The direct photolysis rate constants were determined at 3 pH values and various conditions
(light source and concentration). The degradation of all metabolites followed ﬁrst order
kinetics and degradation rate constants kobs,i were calculated using the slope of ln(At/A0)
plotted against time, where At refers to the peak area of chromatograms at time t, and A0, the
initial peak area. For experiments with relatively high concentrations of target compound
and/or large volumes, a light-screening factor was used to account for the fact that the average
light intensity in the tube was lower than in optically dilute solutions, due to self-screening by
the compound itself. The screening factor depends on the absorbance of solution, α(λ), and
on the depth of the well mixed solution, z, according to equation C.1.
SF(λ) = 1−10
−α(λ)·z
2.303 ·α(λ) · z (C.1)
The observed degradation rate constant, kobs,i , can then be corrected to yield a photolysis
rate constant representative of an optically dilute system:
k0obs,i =
kobs,i
SF(λ)
(C.2)
All reported values are corrected for light screening.
The direct photolysis quantum yields (Φi ) for the metabolites (i ) were then calculated as
follows:
Φi =
k0obs,i
k0abs,i
(C.3)
The speciﬁc rate of light absorbtion, k0abs,i , in an optically dilute solution is a function of the
light intensity, Iλ, and the decadic molar extinction coefﬁcient of the compound, ελ:
k0abs,i = 2.303 ·
∑
λ
Iλ ·ελ (C.4)
The light intensity, Iλ , of each light source was calibrated using a chemical actinometer,
p-nitroanisole (pNA). To do so, the light intensity measured spectroradiometrically, Im(λ), was
normalized by the total measured intensity over the relevant wavelength interval to give the
normalized light intensity, ρλ :
ρλ =
Im(λ)∑280−430nm
λ
Im(λ)
(C.5)
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The actual total light intensity, Iact , was determined using a pNA actinometry
Iact = kact
2.303 ·Φact∑λ (ελ,act ×ρλ) (C.6)
where kact is the 1st order degradation rate constant of pNA photolysis, Φact the known
quantum yield of pNA184 and εact (λ), the decadic molar extinction coefﬁcient of the
actinometer.
The absolute intensity at a given wavelength is then:
Iλ = Iact ·ρλ (C.7)
Error calculations
The direct photolysis rate constants correspond to average values of 2–5 experiments, each
with its respective error (95% conﬁdence interval). Accordingly, the errors associated to
the average direct photolysis rate constant correspond to the propagated errors of single
experiments. The uncertainty associated with calculated values, such as the speciﬁc rate
of light absorption or the quantum yield, was also calculated using basic propagation of
uncertainty rules and certain assumptions regarding the errors of certain quantities. More
explicitly we assume a 10% error on the irradiance measurements as for the molar absorptivity
of each compound. We also assume that the errors are independent of wavelength.
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Appendix C.
Synthesis of Sodium (5-methylisoxazol-3-yl)sulfamate
General synthetic methods. All reaction glassware was oven-dried (110 ◦C, overnight),
assembled hot, and cooled under a stream of nitrogen. Reagents and solvents were purchased
as ACS grade and were used as received, unless otherwise noted. Pyridine was dried for 2
d over 4A˚ molecular sieves prior to use. 3-Amino-5-methylisoxazole was dissolved in dry
CH2Cl2, dried over 4A˚ molecular sieves for 2 d, ﬁltered, and evaporated to dryness prior to
use. NMR spectra were obtained on a Bruker AVANCE III 400 MHz NMR spectrometer, and are
referenced to residual protiated solvent (HOD, 4.79 ppm). Accurate mass measurements were
performed by direct injection using negative-mode electrospray ionization (ESI) on a Thermo
Exactive Mass Spectrometer. Sodium (5-methylisoxazol-3-yl)sulfamate has been reported
once before; however, the yield was only 2.4%. Thus we synthesized it by adapting a more
recent procedure by Spillane and co-workers183. Sodium (5-methylisoxazol-3-yl)sulfamate. A
dry 50 mL two-neck round bottom ﬂask equipped with a magnetic stirbar was ﬁtted with a
septum and a dry septum-capped pressure-equalizing addition funnel. The ﬂask was charged
with dry pyridine (22.5 g, 280 mmol), and the ﬂask was cooled to -15◦C in a bath of ice, acetone
and NaCl. Chlorosulfonic acid (3.26 g, 28 mmol) was transferred to the addition funnel using
a ﬁxed-needle glass syringe because of the corrosiveness of chlorosulfonic acid with plastic
syringes and disposable needles. The chlorosulfonic acid was added dropwise over 30 min to
the vigorously stirred pyridine, and the reaction mixture was then stirred for an additional 75
min at -15◦C. Dry 3-amino-5-methylisoxazole (2.75 g, 28 mmol) was dissolved in dry pyridine
(4 mL) and added to the cold reaction mixture by syringe over 3 min. The ice bath was removed,
the reaction mixture was allowed to warm to room temperature, and the mixture was stirred
overnight. In air, the reaction was quenched by the addition of 2M NaOH (30 mL) to give a
solution of pH 10. The resulting solution was extracted with ether (3 x 50 mL), and the aqueous
layer was evaporated in vacuo to give pale yellow crystals, which were recrystallized from
hot 95% EtOH to give the sulfamate product (1.714 g, 9.62 mmol, 34.3%). Mp = 148 -– 255◦C,
slow decomp. 1H NMR (400 MHz, D2O): δ 6.01 (s,1H), 2.34 (s,3H) ppm. 13C NMR (100 MHz,
D2O): δ 170.3, 163.9, 95.7, 11.7 ppm. IR (ATR): 3350, 1617, 1515, 1488, 1344, 1277, 1212, 1064,
1034, 847, 780, 665, 550, 608, 534, 591 cm−1.210. IR: 3400-3190 (N-H), 1240-1210 (asym SO3),
1203-1170 (sym SO3), 1072–1040 (sym SO3), 730-660 (N-S) cm−1. HRMS (ESI) m/z calculated
for C4H5N2O4S [M-Na]– 176.9976; found, 176.9969.
X-ray Analysis. The X-ray intensity data was measured on a Bruker Kappa Apex-II Duo
CCD system equipped with a graphite monochromator. Frame integration, data reduction
and cell reﬁnement was done with the Bruker SAINT software package. The structure was
solved and reﬁned with SHELXS and OLEX2 . Hydrogen positions could be localized in a
difference electron density map and were reﬁned with isotropic temperature factors. The
crystallographic data have been deposited with the Cambridge Crystallographic data Centre,
deposition number CCDC 901298.
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Table C.2: X-ray Analysis results for Sodium (5-methylisoxazol-3-yl)sulfamate
Empirical formula C4H7N2NaO5S·H2O
Formula weight 236.18
Temperature 100(2) K
Wavelength 0.71073 A˚
Crystal system, space group Orthorhombic, Pbcm
Unit cell dimensions
a = 13.6257(9) A˚
b = 9.8236(5) A˚
c = 6.9584(5) A˚
Volume 931.41(10) A3
Z, Calculated density 4, 1.684 mg/m3
Absorption coefﬁcient 0.401 mm−1
F(000) 488
Crystal size 0.57 x 0.36 x 0.30 mm
Theta range for data collection 1.49◦ to 30.01◦
Limiting indices -19≤h≤10, -13≤k≤13, -9≤l≤9
Reﬂections collected / unique 5241 / 1387 [R(int) = 0.0151]
Completeness to theta = 30.01 ◦ 94.60%
Absorption correction SADABS, multi-scan
Max. and min. transmission 0.8892 and 0.8036
Reﬁnement method Full-matrix least-squares on F2
Data / restraints / parameters 1387 / 6 / 105
Goodness-of-ﬁt on F2 2.372
Final R indices [I>2s(I)] R1 = 0.0258, wR2 = 0.1064
R indices (all data) R1 = 0.0264, wR2 = 0.1068
Extinction coefﬁcient 0.028(5)
Largest diff. peak and hole 0.530 and -0.410 e·A˚-3
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Appendix C.
Figure C.6: Crystal structure of synthesized sodium (5-methylisoxazole-3-yl)sulfamate. Atomic
displacement parameters are drawn at the 50%.
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Conﬁrmed photoproducts and proposed structures of SMX direct photolysis
Table C.3: Photoproducts of SMX direct photolysis, with chromatographic retention time (RT) and
accurate mass observed by HR-MS in a given ionization mode (positive or negative). A structure is
proposed for each given elemental composition and was conﬁrmed for certain products with authentic
standards.
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Appendix C.
Conﬁrmed photoproducts and proposed structures of Ac-SMX direct photolysis
Table C.4: Photoproducts of Ac-SMX direct photolysis, with chromatographic retention time (RT) and
accurate mass observed by HR-MS in a given ionization mode (positive or negative). A structure is
proposed for each given elemental composition and was conﬁrmed for certain products with authentic
standards.
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Conﬁrmed photoproducts and proposed structures of Glu-SMX direct photolysis
Table C.5: Photoproducts of Glu-SMX direct photolysis, with chromatographic retention time (RT) and
accurate mass observed by HR-MS in a given ionization mode (positive or negative). A structure is
proposed for each given elemental composition and was conﬁrmed for certain products with authentic
standards.
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Appendix C.
Conﬁrmed photoproducts and proposed structures of NO-SMX direct photolysis
Table C.6: Photoproducts of NO-SMX direct photolysis, with chromatographic retention time (RT) and
accurate mass observed by HR-MS in a given ionization mode (positive or negative). A structure is
proposed for each given elemental composition and was conﬁrmed for certain products with authentic
standards.
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